CDK5
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A5A3E0 | S1068 | Sugiyama | POTEF A26C1B | SLSTFQQMWISKQEyDEsGPsIVHRKCL_____________ |
| O00115 | S70 | Sugiyama | DNASE2 DNASE2A DNL2 | QYKyLDEssGGWRDGRALINsPEGAVGRSLQPLyRSNTSQL |
| O00151 | S130 | Sugiyama | PDLIM1 CLIM1 CLP36 | PQEVLHIGsAHNRsAMPFtAsPAsSTTARVItNQyNNPAGL |
| O00267 | T806 | Sugiyama | SUPT5H SPT5 SPT5H | MYGsQtPLQDGsRtPHyGsQtPLHDGsRtPAQsGAWDPNNP |
| O00429 | S616 | EPSD|PSP | DNM1L DLP1 DRP1 | SKAEELLAEEKsKPIPIMPAsPQKGHAVNLLDVPVPVARKL |
| O00499 | T348 | PSP | BIN1 AMPHL | LPKsPsQLRKGPPVPPPPKHtPSKEVKQEQILSLFEDTFVP |
| O14497 | S366 | Sugiyama | ARID1A BAF250 BAF250A C1orf4 OSA1 SMARCF1 | AAAASGGAQQRsHHAPMsPGssGGGGQPLARtPQPssPMDQ |
| O14745 | S280 | Sugiyama | NHERF1 NHERF SLC9A3R1 | tNGEIQKENsREALAEAALEsPRPALVRsAssDtsEELNsQ |
| O14827 | S737 | GPS6|EPSD | RASGRF2 GRF2 | KsPRLCRKFSSPPPLAVSRTsSPVRARKLsLtSPLNSKIGA |
| O14939 | S134 | SIGNOR|EPSD|PSP | PLD2 | LLRHKVLMSLLPLARFAVAYsPARDAGNREMPsLPRAGPEG |
| O14976 | S456 | Sugiyama | GAK DNAJC26 | EDVRLFLDSKHPGHYAVYNLsPRTYRPSRFHNRVSECGWAA |
| O15067 | S1062 | Sugiyama | PFAS KIAA0361 | SYCLPPTFPKAsVPREPGGPsPRVAILREEGSNGDREMADA |
| O15169 | T481 | EPSD|PSP | AXIN1 AXIN | DAHEENPEsILDEHVQRVLRtPGRQsPGPGHRsPDSGHVAK |
| O15230 | S422 | Sugiyama | LAMA5 KIAA0533 KIAA1907 | GVNCERCLPGFYRSPNHPLDsPHVCRRCNCESDFTDGtCED |
| O15446 | S285 | Sugiyama | POLR1G ASE1 CAST CD3EAP PAF49 | EDKTVKQEQINTEPLEDtVLsPtKKRKRQKGTEGMEPEEGV |
| O15516 | T451 | SIGNOR|EPSD|PSP | CLOCK BHLHE8 KIAA0334 | sASsRSsRKssHtAVsDPsstPTKIPTDtstPPRQHLPAHE |
| O15516 | T461 | SIGNOR|EPSD|PSP | CLOCK BHLHE8 KIAA0334 | sHtAVsDPsstPTKIPTDtstPPRQHLPAHEKMVQRRSSFS |
| O43151 | S1445 | GPS6 | TET3 KIAA0401 | VSQNGGPSHLWGQYSGGPSMsPKRTNGVGGSWGVFSSGESP |
| O43151 | S1514 | GPS6 | TET3 KIAA0401 | PGEGQQAASHSGGRLRGKPWsPCKFGNSTSALAGPSLTEKP |
| O43237 | S194 | Sugiyama | DYNC1LI2 DNCLI2 LIC2 | ERKFVKDFQDyMEPEEGCQGsPQRRGPLtsGsDEENVALPL |
| O43464 | S400 | SIGNOR|EPSD|PSP | HTRA2 OMI PRSS25 | REPSFPDVQHGVLIHKVILGsPAHRAGLRPGDVILAIGEQM |
| O43602 | S28 | SIGNOR|iPTMNet|PSP | DCX DBCN LISX | FDERDKTSRNMRGSRMNGLPsPTHSAHCSFYRTRTLQALsN |
| O43602 | S287 | SIGNOR|iPTMNet | DCX DBCN LISX | DENECRVMKGNPSATAGPKAsPtPQKtSAKsPGPMRRsKsP |
| O43602 | S297 | SIGNOR|iPTMNet | DCX DBCN LISX | NPSATAGPKAsPtPQKtSAKsPGPMRRsKsPADsGNDQDAN |
| O43602 | S306 | SIGNOR|iPTMNet | DCX DBCN LISX | AsPtPQKtSAKsPGPMRRsKsPADsGNDQDANGTSSSQLSt |
| O43602 | S332 | SIGNOR|iPTMNet | DCX DBCN LISX | NDQDANGTSSSQLStPKsKQsPIstPtsPGSLRKHKDLYLP |
| O43602 | S339 | SIGNOR|iPTMNet | DCX DBCN LISX | TSSSQLStPKsKQsPIstPtsPGSLRKHKDLYLPLsLDDsD |
| O43602 | T289 | SIGNOR|iPTMNet | DCX DBCN LISX | NECRVMKGNPSATAGPKAsPtPQKtSAKsPGPMRRsKsPAD |
| O43602 | T326 | SIGNOR|iPTMNet | DCX DBCN LISX | sPADsGNDQDANGTSSSQLStPKsKQsPIstPtsPGSLRKH |
| O43602 | T336 | SIGNOR|iPTMNet | DCX DBCN LISX | ANGTSSSQLStPKsKQsPIstPtsPGSLRKHKDLYLPLsLD |
| O43765 | S77 | Sugiyama | SGTA SGT SGT1 | TLPEIFEAAATGKEMPQDLRsPARtPPsEEDsAEAERLKTE |
| O43815 | S373 | Sugiyama | STRN | KLQDMLANLRDVDELPsLQPsVGsPsRPsssRLPEHEINRA |
| O43852 | T65 | Sugiyama | CALU | FDyDHDAFLGAEEAKtFDQLtPEEsKERLGKIVSKIDGDKD |
| O60260 | S131 | SIGNOR|EPSD|PSP | PRKN PARK2 | VLPGDSVGLAVILHTDsRKDsPPAGsPAGRSIyNSFYVYCK |
| O60291 | S524 | Sugiyama | MGRN1 KIAA0544 RNF156 | SssPQQGTRAAsIENVLQDssPEHCGRGPPADIYLPALGPD |
| O60292 | S158 | Sugiyama | SIPA1L3 KIAA0545 SPAL3 | FHRLSRRRsKDVEFQDGWPRsPGRAFLPLRHRsssEItLSE |
| O60331 | S453 | PSP | PIP5K1C KIAA0589 | ERFFKFMSNTVFRKNsSLKSsPSKKGRGGALLAVKPLGPTA |
| O60331 | S650 | GPS6|SIGNOR|iPTMNet|EPSD|PSP | PIP5K1C KIAA0589 | EEDAPATDIyFPTDERSWVysPLHYSAQAPPAsDGEsDT__ |
| O75052 | S266 | Sugiyama | NOS1AP CAPON KIAA0464 | EGGsHTGSKVSHPQEPMLtAsPRMLLPSSSSKPPGLGTETP |
| O75122 | S541 | PSP | CLASP2 KIAA0627 | RPsVsQGCsREAsRESsRDTsPVRSFQPLASRHHSRSTGAL |
| O75223 | S136 | Sugiyama | GGCT C7orf24 CRF21 | EGKEITCRSYLMTNYESAPPsPQYKKIICMGAKENGLPLEy |
| O75369 | S1505 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | PSQEGPYMVSVKYADEEIPRsPFKVKVLPTYDASKVtAsGP |
| O75369 | S1602 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | PDKtGRYMIGVTYGGDDIPLsPyRIRAtQTGDASKCLAtGP |
| O75369 | S2274 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | AQEPGNYEVSIKFNDEHIPEsPyLVPVIAPSDDARRLTVMS |
| O75369 | T980 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | KDQEFTVDTRGAGGQGKLDVtILsPsRKVVPCLVtPVtGRE |
| O75781 | S116 | Sugiyama | PALM KIAA0270 | EVLERGDSAPATAKENAAAPsPVRAPAPsPAKEERKTEVVM |
| O75794 | S299 | Sugiyama | CDC123 C10orf7 D123 | AQEQDSPAFRCTNSEVtVQPsPyLsyRLPKDFVDLsTGEDA |
| O75821 | S189 | Sugiyama | EIF3G EIF3S4 | CPYKDtLGPMQKELAEQLGLstGEKEKLPGELEPVQAtQNK |
| O75821 | T206 | Sugiyama | EIF3G EIF3S4 | LGLstGEKEKLPGELEPVQAtQNKtGKYVPPsLRDGAsRRG |
| O75828 | S56 | Sugiyama | CBR3 SDR21C2 | TARDVARGQAAVQQLQAEGLsPRFHQLDIDDLQsIRALRDF |
| O75832 | T108 | Sugiyama | PSMD10 | IVKALLGKGAQVNAVNQNGCtPLHYAAsKNRHEIAVMLLEG |
| O94776 | S435 | Sugiyama | MTA2 MTA1L1 PID | RGtTEPHSRGHLsRPEAQsLsPyttsANRAKLLAKNRQtFL |
| O94776 | Y437 | Sugiyama | MTA2 MTA1L1 PID | tTEPHSRGHLsRPEAQsLsPyttsANRAKLLAKNRQtFLLQ |
| O94811 | S160 | GPS6|SIGNOR|EPSD|PSP | TPPP TPPP1 | VHRLIEGKAPIISGVTKAIssPtVSRLTDTTKFTGSHKERF |
| O94811 | S18 | GPS6|SIGNOR|EPSD|PSP | TPPP TPPP1 | ___MADKAKPAKAANRtPPKsPGDPsKDRAAKRLsLEsEGA |
| O94811 | T14 | GPS6|SIGNOR|EPSD|PSP | TPPP TPPP1 | _______MADKAKPAKAANRtPPKsPGDPsKDRAAKRLsLE |
| O94913 | S1493 | Sugiyama | PCF11 KIAA0824 | IYHPSCYEDYQNTSSFDCtPsPsKtPVENPLNIMLNIVKNE |
| O94916 | T135 | GPS6|SIGNOR|EPSD|PSP | NFAT5 KIAA0827 TONEBP | SNRGVsEKQLTSNTVQQHPstPKRHTVLyIsPPPEDLLDNs |
| O94979 | S799 | Sugiyama | SEC31A KIAA0905 SEC31L1 HSPC275 HSPC334 | IMQLRDRLCRAQGEPVAGHEsPKIPyEKQQLPKGRPGPVAG |
| O95218 | S153 | Sugiyama | ZRANB2 ZIS ZNF265 | KYRGKAVGPAsILKEVEDKEsEGEEEDEDEDLsKyKLDEDE |
| O95297 | S210 | Sugiyama | MPZL1 PZR UNQ849/PRO1787 | LYRRKNSKRDyTGCstsEsLsPVKQAPRKsPsDtEGLVKSL |
| O95425 | S920 | Sugiyama | SVIL | LDHNAsAtDYKFSssIENsDsPVRSILKSQAWQPLVEGsEN |
| O95817 | S291 | SIGNOR|PSP | BAG3 BIS | QGAssREGsPARsstPLHsPsPIRVHtVVDRPQQPMTHRET |
| P00558 | S399 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | CCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDALsNI__ |
| P00558 | T168 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | EAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGF |
| P00558 | T394 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | GDtAtCCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDAL |
| P01106 | S77 | PSP | MYC BHLHE39 | PPAPSEDIWKKFELLPtPPLsPsRRsGLCsPSyVAVTPFsL |
| P02545 | S22 | Sugiyama | LMNA LMN1 | ETPsQRRAtRsGAQAsstPLsPtRItRLQEKEDLQELNDRL |
| P02545 | S392 | PSP | LMNA LMN1 | EIHAYRKLLEGEEERLRLsPsPtsQRsRGRAssHssQtQGG |
| P04075 | S354 | Sugiyama | ALDOA ALDA | ANsLACQGKytPsGQAGAAAsEsLFVsNHAy__________ |
| P04075 | S356 | Sugiyama | ALDOA ALDA | sLACQGKytPsGQAGAAAsEsLFVsNHAy____________ |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | S360 | Sugiyama | ALDOA ALDA | QGKytPsGQAGAAAsEsLFVsNHAy________________ |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04075 | Y364 | Sugiyama | ALDOA ALDA | tPsGQAGAAAsEsLFVsNHAy____________________ |
| P04083 | S201 | Sugiyama | ANXA1 ANX1 LPC1 | LsLAKGDRsEDFGVNEDLADsDARALyEAGERRKGtDVNVF |
| P04150 | S203 | SIGNOR|EPSD|PSP | NR3C1 GRL | LYTTDQSTFDILQDLEFssGsPGKETNEsPWRSDLLIDENC |
| P04150 | S211 | SIGNOR|EPSD|PSP | NR3C1 GRL | FDILQDLEFssGsPGKETNEsPWRSDLLIDENCLLsPLAGE |
| P04150 | S226 | EPSD|PSP | NR3C1 GRL | KETNEsPWRSDLLIDENCLLsPLAGEDDSFLLEGNSNEDCK |
| P04156 | S43 | EPSD|PSP | PRNP ALTPRP PRIP PRP | KKRPKPGGWNTGGSRYPGQGsPGGNRYPPQGGGGWGQPHGG |
| P04406 | S210 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GPsGKLWRDGRGALQNIIPAstGAAKAVGKVIPELNGKLtG |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04406 | T211 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | PsGKLWRDGRGALQNIIPAstGAAKAVGKVIPELNGKLtGM |
| P04406 | T237 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | VGKVIPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDD |
| P04406 | Y320 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GIALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsKE_____ |
| P04637 | S15 | GPS6|SIGNOR|EPSD|PSP | TP53 P53 | ______MEEPQsDPsVEPPLsQEtFsDLWKLLPENNVLsPL |
| P04637 | S20 | SIGNOR|EPSD|PSP | TP53 P53 | _MEEPQsDPsVEPPLsQEtFsDLWKLLPENNVLsPLPsQAM |
| P04637 | S315 | SIGNOR|iPTMNet | TP53 P53 | PHHELPPGStKRALPNNTsssPQPKKKPLDGEyFTLQIRGR |
| P04637 | S33 | GPS6|SIGNOR|iPTMNet|EPSD|PSP | TP53 P53 | PLsQEtFsDLWKLLPENNVLsPLPsQAMDDLMLsPDDIEQW |
| P04637 | S46 | GPS6|SIGNOR|EPSD|PSP | TP53 P53 | LPENNVLsPLPsQAMDDLMLsPDDIEQWFtEDPGPDEAPRM |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05023 | S722 | Sugiyama | ATP1A1 | VEGCQRQGAIVAVTGDGVNDsPALKKADIGVAMGIAGSDVS |
| P05067 | T743 | GPS6|SIGNOR|EPSD | APP A4 AD1 | LKKKQYtsIHHGVVEVDAAVtPEERHLSKMQQNGyENPtyK |
| P05187 | S177 | Sugiyama | ALPP PLAP | RAKKAGKSVGVVTTTRVQHAsPAGtyAHtVNRNWysDADVP |
| P05386 | S101 | Sugiyama | RPLP1 RRP1 | APstAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD_______ |
| P05386 | S104 | Sugiyama | RPLP1 RRP1 | tAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S102 | Sugiyama | RPLP2 D11S2243E RPP2 | PAAGsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD_______ |
| P05387 | S105 | Sugiyama | RPLP2 D11S2243E RPP2 | GsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD__________ |
| P05455 | S92 | Sugiyama | SSB | LSKSKAELMEIsEDKTKIRRsPsKPLPEVTDEyKNDVKNRs |
| P06400 | S795 | EPSD|PSP | RB1 | RPPtLsPIPHIPRsPyKFPssPLRIPGGNIyIsPLKsPYKI |
| P06400 | S807 | EPSD|PSP | RB1 | RsPyKFPssPLRIPGGNIyIsPLKsPYKIsEGLPtPtKMtP |
| P06400 | S811 | SIGNOR|EPSD|PSP | RB1 | KFPssPLRIPGGNIyIsPLKsPYKIsEGLPtPtKMtPRSRI |
| P06733 | S27 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | HAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGAstGIyEAL |
| P06733 | S310 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | VsIEDPFDQDDWGAWQKFtAsAGIQVVGDDLTVtNPKRIAK |
| P06733 | S40 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | VEVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGK |
| P06733 | T323 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | AWQKFtAsAGIQVVGDDLTVtNPKRIAKAVNEKsCNCLLLK |
| P06733 | Y44 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | LFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKGVSK |
| P06744 | S455 | Sugiyama | GPI | ALMRGKSTEEARKELQAAGKsPEDLERLLPHKVFEGNRPTN |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07195 | S44 | Sugiyama | LDHB | ITVVGVGQVGMACAISILGKsLADELALVDVLEDKLKGEMM |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07196 | T21 | EPSD|PSP | NEFL NF68 NFL | MSSFSYEPYYSTSYKRRYVEtPRVHISSVRSGYSTARSAYS |
| P07205 | S399 | Sugiyama | PGK2 PGKB | CCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEALSNM__ |
| P07205 | T168 | Sugiyama | PGK2 PGKB | EAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNLPHKASGF |
| P07205 | T394 | Sugiyama | PGK2 PGKB | GDTATCCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEAL |
| P07437 | S115 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | sGAGNNWAKGHytEGAELVDsVLDVVRKEAESCDCLQGFQL |
| P07437 | S75 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | tGGKyVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| P07814 | S739 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | TKVEATKNETSAPFKERPtPsLNNNCttsEDsLVLyNRVAV |
| P07814 | S886 | GPS6|SIGNOR|EPSD|PSP|Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | EKTGKEyIPGQPPLsQssDssPtRNsEPAGLEtPEAKVLFD |
| P07814 | S999 | PSP | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | QKQNDGQRKDPsKNQGGGLsssGAGEGQGPKKQTRLGLEAK |
| P07814 | T737 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | EKTKVEATKNETSAPFKERPtPsLNNNCttsEDsLVLyNRV |
| P07858 | S216 | Sugiyama | CTSB CPSB | PPCTGEGDTPKCSKICEPGysPtyKQDKHYGYNSYSVSNSE |
| P07900 | S595 | PSP | HSP90AA1 HSP90A HSPC1 HSPCA | MKDILEKKVEKVVVSNRLVtsPCCIVtstyGWTANMERIMK |
| P08195 | S296 | Sugiyama | SLC3A2 MDU1 | DLLQIDPNFGsKEDFDsLLQsAKKKSIRVILDLTPNYRGEN |
| P08195 | S402 | Sugiyama | SLC3A2 MDU1 | SSDLQQILSLLESNKDLLLtssyLsDsGstGEHtKSLVTQY |
| P08195 | S598 | Sugiyama | SLC3A2 MDU1 | LQASDLPASASLPAKADLLLstQPGREEGsPLELERLKLEP |
| P08195 | S607 | Sugiyama | SLC3A2 MDU1 | ASLPAKADLLLstQPGREEGsPLELERLKLEPHEGLLLRFP |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | S468 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | RRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItG |
| P08238 | S497 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KEtQKsIyyItGEsKEQVANsAFVERVRKRGFEVVyMtEPI |
| P08238 | Y457 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LKLGIHEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMK |
| P08651 | S323 | Sugiyama | NFIC NFI | PssPtsSSRNWTEDMEGGIssPVKKtEMDKsPFNsPsPQDs |
| P08670 | S56 | GPS6|EPSD|PSP | VIM | RtYsLGsALRPstsRsLyAssPGGVyAtRssAVRLRssVPG |
| P08708 | S89 | Sugiyama | RPS17 RPS17L | ISIKLQEEERERRDNyVPEVsALDQEIIEVDPDtKEMLKLL |
| P08865 | T97 | Sugiyama | RPSA LAMBR LAMR1 | IssRNtGQRAVLKFAAAtGAtPIAGRFtPGTFTNQIQAAFR |
| P08908 | T314 | SIGNOR|PSP | HTR1A ADRB2RL1 ADRBRL1 | EVHRVGNSKEHLPLPSEAGPtPCAPASFERKNERNAEAKRK |
| P09234 | S17 | Sugiyama | SNRPC | ____MPKFyCDyCDtyLtHDsPsVRKTHCSGRKHKENVKDY |
| P09234 | T11 | Sugiyama | SNRPC | __________MPKFyCDyCDtyLtHDsPsVRKTHCSGRKHK |
| P09874 | S782 | SIGNOR|PSP | PARP1 ADPRT PPOL | VEMLDNLLDIEVAySLLRGGsDDssKDPIDVNyEKLKTDIK |
| P09874 | S785 | SIGNOR|PSP | PARP1 ADPRT PPOL | LDNLLDIEVAySLLRGGsDDssKDPIDVNyEKLKTDIKVVD |
| P09874 | S786 | SIGNOR|PSP | PARP1 ADPRT PPOL | DNLLDIEVAySLLRGGsDDssKDPIDVNyEKLKTDIKVVDR |
| P09923 | S174 | Sugiyama | ALPI | RAKQAGKSVGVVTTTRVQHAsPAGtyAHtVNRNWysDADMP |
| P0CG38 | S1068 | Sugiyama | POTEI | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG39 | S1031 | Sugiyama | POTEJ | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0DPH7 | T56 | Sugiyama | TUBA3C TUBA2 | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVVD |
| P10275 | S310 | EPSD|PSP | AR DHTR NR3C4 | CKGsLLDDSAGKstEDTAEYsPFKGGYTKGLEGESLGCSGS |
| P10275 | S83 | SIGNOR|EPSD|PSP | AR DHTR NR3C4 | QQQQQQQQQQQQQQQQQQETsPRQQQQQQGEDGsPQAHRRG |
| P10412 | T18 | Sugiyama | H1-4 H1F4 HIST1H1E | ___MsEtAPAAPAAPAPAEKtPVKKKARKsAGAAKRKAsGP |
| P10636 | S214 | GPS6 | MAPT MAPTL MTBT1 TAU | GDLHQEGPPLKGAGGKERPGsKEEVDEDRDVDESsPQDsPP |
| P10636 | S235 | GPS6|SIGNOR | MAPT MAPTL MTBT1 TAU | KEEVDEDRDVDESsPQDsPPsKAsPAQDGRPPQTAAREATS |
| P10636 | S396 | GPS6 | MAPT MAPTL MTBT1 TAU | ARMVSKSKDGtGSDDKKAKTsTRSsAKtLKNRPCLsPKHPT |
| P10636 | S516 | SIGNOR | MAPT MAPTL MTBT1 TAU | PKtPPsSGEPPKsGDRsGyssPGsPGtPGsRsRtPsLPtPP |
| P10636 | S519 | SIGNOR | MAPT MAPTL MTBT1 TAU | PPsSGEPPKsGDRsGyssPGsPGtPGsRsRtPsLPtPPTRE |
| P10636 | S531 | SIGNOR | MAPT MAPTL MTBT1 TAU | RsGyssPGsPGtPGsRsRtPsLPtPPTREPKKVAVVRtPPK |
| P10636 | S552 | SIGNOR | MAPT MAPTL MTBT1 TAU | LPtPPTREPKKVAVVRtPPKsPssAKSRLQTAPVPMPDLKN |
| P10636 | S713 | SIGNOR | MAPT MAPTL MTBT1 TAU | LTFRENAKAKTDHGAEIVyKsPVVsGDtsPRHLsNVsstGs |
| P10636 | S721 | SIGNOR | MAPT MAPTL MTBT1 TAU | AKTDHGAEIVyKsPVVsGDtsPRHLsNVsstGsIDMVDsPQ |
| P10636 | T173 | iPTMNet | MAPT MAPTL MTBT1 TAU | MPGAPLLPEGPREATRQPsGtGPEDTEGGRHAPELLKHQLL |
| P10636 | T498 | SIGNOR | MAPT MAPTL MTBT1 TAU | GQKGQANATRIPAKtPPAPKtPPsSGEPPKsGDRsGyssPG |
| P10636 | T522 | SIGNOR | MAPT MAPTL MTBT1 TAU | SGEPPKsGDRsGyssPGsPGtPGsRsRtPsLPtPPTREPKK |
| P10636 | T529 | SIGNOR | MAPT MAPTL MTBT1 TAU | GDRsGyssPGsPGtPGsRsRtPsLPtPPTREPKKVAVVRtP |
| P10636 | T534 | SIGNOR | MAPT MAPTL MTBT1 TAU | yssPGsPGtPGsRsRtPsLPtPPTREPKKVAVVRtPPKsPs |
| P10636 | T548 | SIGNOR | MAPT MAPTL MTBT1 TAU | RtPsLPtPPTREPKKVAVVRtPPKsPssAKSRLQTAPVPMP |
| P10809 | S225 | Sugiyama | HSPD1 HSP60 | KtLNDELEIIEGMKFDRGyIsPyFINtsKGQKCEFQDAyVL |
| P10809 | S70 | Sugiyama | HSPD1 HSP60 | AVAVTMGPKGRtVIIEQsWGsPKVTKDGVtVAKsIDLKDKY |
| P11142 | S329 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | LFRGtLDPVEKALRDAKLDKsQIHDIVLVGGstRIPKIQKL |
| P11142 | S340 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | ALRDAKLDKsQIHDIVLVGGstRIPKIQKLLQDFFNGKELN |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P11142 | T37 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P11142 | T38 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P11142 | T45 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPtN |
| P11142 | T47 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | EIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPtNtV |
| P11142 | T66 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQsD |
| P11274 | T385 | Sugiyama | BCR BCR1 D22S11 | DKsRsPsQNsQQsFDSssPPtPQCHKRHRHCPVVVSEATIV |
| P12268 | S122 | Sugiyama | IMPDH2 IMPD2 | NEVRKVKKyEQGFITDPVVLsPKDRVRDVFEAKARHGFCGI |
| P12270 | S2155 | Sugiyama | TPR | PstPtLVVPHRtDGFAEAIHsPQVAGVPRFRFGPPEDMPQT |
| P12277 | S164 | Sugiyama | CKB CKBB | PHCsRGERRAIEKLAVEALssLDGDLAGRyyALKsMtEAEQ |
| P12277 | T35 | Sugiyama | CKB CKBB | PAEDEFPDLSAHNNHMAKVLtPELyAELRAKSTPSGFTLDD |
| P12277 | Y39 | Sugiyama | CKB CKBB | EFPDLSAHNNHMAKVLtPELyAELRAKSTPSGFTLDDVIQT |
| P12931 | S75 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | SRC SRC1 | APAAAEPKLFGGFNssDtVtsPQRAGPLAGGVTTFVALyDY |
| P13489 | S178 | Sugiyama | RNH1 PRI RNH | SCEPLASVLRAKPDFKELtVsNNDINEAGVRVLCQGLKDSP |
| P13637 | S712 | Sugiyama | ATP1A3 | VEGCQRQGAIVAVTGDGVNDsPALKKADIGVAMGIAGSDVS |
| P13639 | S593 | Sugiyama | EEF2 EF2 | SDPVVsyREtVsEEsNVLCLsKsPNKHNRLyMKARPFPDGL |
| P13639 | S595 | Sugiyama | EEF2 EF2 | PVVsyREtVsEEsNVLCLsKsPNKHNRLyMKARPFPDGLAE |
| P13639 | Y579 | Sugiyama | EEF2 EF2 | KDLEEDHACIPIKKSDPVVsyREtVsEEsNVLCLsKsPNKH |
| P13798 | S185 | Sugiyama | APEH D3F15S2 D3S48E DNF15S2 | VAEKKRPKAEsFFQTKALDVsAsDDEIARLKKPDQAIKGDQ |
| P14416 | S321 | SIGNOR|EPSD|PSP | DRD2 | SHHQLTLPDPSHHGLHSTPDsPAKPEKNGHAKDHPKIAKIF |
| P14618 | S202 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | SLQVKQKGADFLVtEVENGGsLGsKKGVNLPGAAVDLPAVs |
| P14618 | S205 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | VKQKGADFLVtEVENGGsLGsKKGVNLPGAAVDLPAVsEKD |
| P14618 | S37 | PSP|Sugiyama | PKM OIP3 PK2 PK3 PKM2 | QLHAAMADTFLEHMCRLDIDsPPItARNtGIICtIGPAsRs |
| P14618 | S77 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | sVEtLKEMIKsGMNVARLNFsHGtHEyHAEtIKNVRtAtEs |
| P14618 | T87 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | sGMNVARLNFsHGtHEyHAEtIKNVRtAtEsFAsDPILyRP |
| P14625 | S515 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | GVIEDHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEKQ |
| P14625 | S552 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | KEKQDKIyFMAGsSRKEAEssPFVERLLKKGyEVIyLTEPV |
| P14625 | S64 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | tDDEVVQREEEAIQLDGLNAsQIRELREKSEKFAFQAEVNR |
| P14866 | S101 | Sugiyama | HNRNPL HNRPL P/OKcl.14 | GAAGGGGGGENyDDPHKtPAsPVVHIRGLIDGVVEADLVEA |
| P14868 | S249 | Sugiyama | DARS1 DARS PIG40 | EGGANVFTVSYFKNNAyLAQsPQLyKQMCICADFEKVFSIG |
| P15311 | T235 | SIGNOR|iPTMNet | EZR VIL2 | DLWLGVDALGLNIYEKDDKLtPKIGFPWSEIRNIsFNDKKF |
| P15336 | T71 | Sugiyama | ATF2 CREB2 CREBP1 | MtLKFGPARNDsVIVADQtPtPtRFLKNCEEVGLFNELAsP |
| P15927 | S23 | EPSD|PSP | RPA2 REPA2 RPA32 RPA34 | NsGFEsYGsssYGGAGGYtQsPGGFGsPAPsQAEKKSRARA |
| P15927 | S29 | EPSD|PSP | RPA2 REPA2 RPA32 RPA34 | YGsssYGGAGGYtQsPGGFGsPAPsQAEKKSRARAQHIVPC |
| P15927 | S33 | EPSD|PSP | RPA2 REPA2 RPA32 RPA34 | sYGGAGGYtQsPGGFGsPAPsQAEKKSRARAQHIVPCTIsQ |
| P16152 | S56 | Sugiyama | CBR1 CBR CRN SDR21C1 | TARDVTRGQAAVQQLQAEGLsPRFHQLDIDDLQsIRALRDF |
| P16278 | S434 | Sugiyama | GLB1 ELNR1 | GFVLYRTTLPQDCSNPAPLssPLNGVHDRAyVAVDGIPQGV |
| P16949 | S38 | SIGNOR|Sugiyama | STMN1 C1orf215 LAP18 OP18 | QAFELILsPRsKEsVPEFPLsPPKKKDLsLEEIQKKLEAAE |
| P17544 | T53 | Sugiyama | ATF7 ATFA | MTLKFGPARtDsVIIADQtPtPtRFLKNCEEVGLFNELASS |
| P17600 | S551 | SIGNOR|iPTMNet | SYN1 | RQSRPVAGGPGAPPAARPPAsPsPQRQAGPPQATRQTsVSG |
| P17600 | S553 | SIGNOR|iPTMNet | SYN1 | SRPVAGGPGAPPAARPPAsPsPQRQAGPPQATRQTsVSGPA |
| P17600 | S62 | iPTMNet | SYN1 | ATPGPGTATAERSSGVAPAAsPAAPsPGssGGGGFFSSLSN |
| P17600 | S67 | iPTMNet | SYN1 | GTATAERSSGVAPAAsPAAPsPGssGGGGFFSSLSNAVKQT |
| P17706 | S304 | iPTMNet|Sugiyama | PTPN2 PTPT | SIQKRWKELsKEDLsPAFDHsPNKIMtEKYNGNRIGLEEEK |
| P18124 | T17 | Sugiyama | RPL7 | ____MEGVEEKKKEVPAVPEtLKKKRRNFAELKIKRLRKKF |
| P18621 | T79 | Sugiyama | RPL17 | PFRRYNGGVGRCAQAKQWGWtQGRWPKKSAEFLLHMLKNAE |
| P18669 | S31 | Sugiyama | PGAM1 PGAMA CDABP0006 | HGEsAWNLENRFsGWyDADLsPAGHEEAKRGGQALRDAGyE |
| P18858 | S51 | Sugiyama | LIG1 | TEPPPKAALKEWNGVVsEsDsPVKRPGRKAARVLGsEGEEE |
| P18887 | T453 | Sugiyama | XRCC1 | PQTKtKPtQAAGPssPQKPPtPEEtKAAsPVLQEDIDIEGV |
| P20700 | T575 | Sugiyama | LMNB1 LMN2 LMNB | EEEEEAAGVVVEEELFHQQGtPRASNRSCAIM_________ |
| P20810 | S295 | Sugiyama | CAST | QEKKRKVEKDtMsDQALEALsAsLGTRQAEPELDLRsIKEV |
| P20810 | S297 | Sugiyama | CAST | KKRKVEKDtMsDQALEALsAsLGTRQAEPELDLRsIKEVDE |
| P21333 | S1084 | Sugiyama | FLNA FLN FLN1 | PTKPSKVKAFGPGLQGGsAGsPARFtIDTKGAGTGGLGLTV |
| P21333 | S1459 | Sugiyama | FLNA FLN FLN1 | KVPVHDVTDASKVKCsGPGLsPGMVRANLPQsFQVDTSKAG |
| P21333 | S1533 | Sugiyama | FLNA FLN FLN1 | PSREGPysIsVLyGDEEVPRsPFKVKVLPTHDASKVKAsGP |
| P21333 | S1630 | Sugiyama | FLNA FLN FLN1 | PDVTGRYTILIKYGGDEIPFsPyRVRAVPTGDASKCTVTVS |
| P21333 | S2510 | Sugiyama | FLNA FLN FLN1 | MAPGsYLISIKYGGPYHIGGsPFKAKVTGPRLVsNHsLHEt |
| P21860 | S1123 | SIGNOR|iPTMNet | ERBB3 HER3 | GsEAELQEKVSMCRSRSRSRsPRPRGDSAYHSQRHSLLTPV |
| P21860 | T873 | SIGNOR|iPTMNet | ERBB3 HER3 | FGVADLLPPDDKQLLYSEAKtPIKWMALESIHFGKYTHQSD |
| P22102 | S106 | Sugiyama | GART PGFT PRGS | LRsAGVQCFGPTAEAAQLEssKRFAKEFMDRHGIPTAQWKA |
| P22234 | S27 | Sugiyama | PAICS ADE2 AIRC PAIS | LNIGKKLYEGKtKEVyELLDsPGKVLLQsKDQItAGNAARK |
| P22626 | S225 | Sugiyama | HNRNPA2B1 HNRPA2B1 | GNFGFGDsRGGGGNFGPGPGsNFRGGsDGyGsGRGFGDGyN |
| P22626 | S259 | Sugiyama | HNRNPA2B1 HNRPA2B1 | GFGDGyNGyGGGPGGGNFGGsPGyGGGRGGYGGGGPGYGNQ |
| P22681 | S900 | Sugiyama | CBL CBL2 RNF55 | IAQNNIEMAKNILREFVSIssPAHVAT______________ |
| P23396 | S224 | Sugiyama | RPS3 OK/SW-cl.26 | LPDHVsIVEPKDEILPttPIsEQKGGKPEPPAMPQPVPtA_ |
| P23396 | T220 | Sugiyama | RPS3 OK/SW-cl.26 | PKKPLPDHVsIVEPKDEILPttPIsEQKGGKPEPPAMPQPV |
| P23396 | T221 | Sugiyama | RPS3 OK/SW-cl.26 | KKPLPDHVsIVEPKDEILPttPIsEQKGGKPEPPAMPQPVP |
| P23526 | T185 | Sugiyama | AHCY SAHH | yKMMANGILKVPAINVNDsVtKsKFDNLyGCRESLIDGIKR |
| P23921 | S559 | Sugiyama | RRM1 RR1 | ALEASCDLAKEQGPyEtyEGsPVsKGILQYDMWNVTPTDLW |
| P23921 | S562 | Sugiyama | RRM1 RR1 | ASCDLAKEQGPyEtyEGsPVsKGILQYDMWNVTPTDLWDWK |
| P24928 | S1875 | Sugiyama | POLR2A POLR2 | PtsPKysPtsPKysPtsPKysPtsPtysPttPKysPtsPty |
| P24928 | Y1909 | Sugiyama | POLR2A POLR2 | sPtsPtysPtsPVytPtsPKysPtsPtysPtsPKysPtsPt |
| P25054 | S1100 | Sugiyama | APC DP2.5 | ESTDDKHLKFQPHFGQQECVsPYRSRGANGSETNRVGSNHG |
| P25054 | S2533 | Sugiyama | APC DP2.5 | PTIEYNDGRPAKRHDIARsHsEsPSRLPINRSGTWKREHSK |
| P25205 | T722 | Sugiyama | MCM3 | GDsyDPyDFsDtEEEMPQVHtPKTADsQEtKEsQKVELsES |
| P25398 | Y127 | Sugiyama | RPS12 | sCVVVKDYGKESQAKDVIEEyFKCKK_______________ |
| P25786 | S14 | Sugiyama | PSMA1 HC2 NU PROS30 PSC2 | _______MFRNQyDNDVtVWsPQGRIHQIEYAMEAVKQGSA |
| P26358 | S154 | SIGNOR|EPSD|PSP | DNMT1 AIM CXXC9 DNMT | KPRTPRRsKsDGEAKPEPsPsPRITRKSTRQttITSHFAKG |
| P27348 | S45 | Sugiyama | YWHAQ | CMKAVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSI |
| P27695 | T233 | SIGNOR|PSP | APEX1 APE APE1 APEX APX HAP1 REF1 | VAHEEIDLRNPKGNKKNAGFtPQERQGFGELLQAVPLADSF |
| P27797 | T34 | Sugiyama | CALR CRTC | LAVAEPAVYFKEQFLDGDGWtsRWIEsKHKSDFGKFVLssG |
| P27816 | S280 | Sugiyama | MAP4 | LAKDMALATKTEVALAKDMEsPtKLDVtLAKDMQPSMESDM |
| P27816 | T571 | Sugiyama | MAP4 | ALKTEAPLAKDGVLtLANNVtPAKDVPPLsEtEAtPVPIKD |
| P27824 | S583 | Sugiyama | CANX | VsQEEEDRKPKAEEDEILNRsPRNRKPRRE___________ |
| P28072 | T69 | Sugiyama | PSMB6 LMPY Y | GADSRTTtGsyIANRVTDKLtPIHDRIFCCRSGSAADTQAV |
| P29474 | S114 | GPS6|SIGNOR|EPSD|PSP | NOS3 | CTPRRCLGSLVFPRKLQGRPsPGPPAPEQLLSQARDFINQY |
| P29692 | S133 | Sugiyama | EEF1D EF1D | NVLEKssPGHRAtAPQtQHVsPMRQVEPPAKKPAtPAEDDE |
| P29692 | S60 | Sugiyama | EEF1D EF1D | ENGAsVILRDIARARENIQKsLAGssGPGAssGtsGDHGEL |
| P29692 | S64 | Sugiyama | EEF1D EF1D | sVILRDIARARENIQKsLAGssGPGAssGtsGDHGELVVRI |
| P29692 | T129 | Sugiyama | EEF1D EF1D | EARLNVLEKssPGHRAtAPQtQHVsPMRQVEPPAKKPAtPA |
| P29966 | S27 | Sugiyama | MARCKS MACS PRKCSL | KTAAKGEAAAERPGEAAVAssPsKANGQENGHVKVNGDAsP |
| P30041 | T44 | Sugiyama | PRDX6 AOP2 KIAA0106 | RFHDFLGDSWGILFSHPRDFtPVCttELGRAAKLAPEFAKR |
| P30041 | T49 | Sugiyama | PRDX6 AOP2 KIAA0106 | LGDSWGILFSHPRDFtPVCttELGRAAKLAPEFAKRNVKLI |
| P30050 | S165 | Sugiyama | RPL12 | GRHPHDIIDDINsGAVECPAs____________________ |
| P30086 | T42 | SIGNOR|PSP|Sugiyama | PEBP1 PBP PEBP | QHPLHVTYAGAAVDELGKVLtPtQVKNRPtsIsWDGLDsGK |
| P30101 | S443 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | LsKDPNIVIAKMDAtANDVPsPyEVRGFPtIyFsPANKKLN |
| P30101 | S456 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | AtANDVPsPyEVRGFPtIyFsPANKKLNPKKyEGGRELsDF |
| P30101 | Y445 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | KDPNIVIAKMDAtANDVPsPyEVRGFPtIyFsPANKKLNPK |
| P31146 | T424 | SIGNOR | CORO1A CORO1 | LRVNRGLDtGRRRAAPEAsGtPssDAVSRLEEEMRKLQATV |
| P31943 | S104 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | EVFKSNNVEMDWVLKHtGPNsPDtANDGFVRLRGLPFGCSK |
| P31943 | T100 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | HRyVEVFKSNNVEMDWVLKHtGPNsPDtANDGFVRLRGLPF |
| P31946 | S47 | Sugiyama | YWHAB | AMKAVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P31947 | S45 | Sugiyama | SFN HME1 | FMKGAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsI |
| P31948 | S460 | Sugiyama | STIP1 | AMKDytKAMDVYQKALDLDssCKEAADGYQRCMMAQyNRHD |
| P33316 | S99 | Sugiyama | DUT | KGELPKAGGsPAPGPEtPAIsPsKRARPAEVGGMQLRFARL |
| P33316 | T95 | Sugiyama | DUT | AAGWKGELPKAGGsPAPGPEtPAIsPsKRARPAEVGGMQLR |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P34931 | T39 | Sugiyama | HSPA1L | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P34931 | T40 | Sugiyama | HSPA1L | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P34931 | T47 | Sugiyama | HSPA1L | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPQN |
| P34931 | T49 | Sugiyama | HSPA1L | EIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPQNTV |
| P34932 | T365 | Sugiyama | HSPA4 APG2 HSPH2 | TRIPAVKEKISKFFGKELsttLNADEAVTRGCALQCAILsP |
| P35222 | S191 | GPS6|EPSD|PSP | CTNNB1 CTNNB OK/SW-cl.35 PRO2286 | AAVMVHQLsKKEAsRHAIMRsPQMVSAIVRTMQNTNDVETA |
| P35222 | S246 | GPS6|EPSD|PSP | CTNNB1 CTNNB OK/SW-cl.35 PRO2286 | EGLLAIFKSGGIPALVKMLGsPVDSVLFYAITTLHNLLLHQ |
| P35579 | S1308 | Sugiyama | MYH9 | LLsQsDSKSSKLTKDFsALEsQLQDtQELLQEENRQKLsLs |
| P35579 | T1313 | Sugiyama | MYH9 | DSKSSKLTKDFsALEsQLQDtQELLQEENRQKLsLstKLKQ |
| P35579 | T1745 | Sugiyama | MYH9 | RRLEARIAQLEEELEEEQGNtELINDRLKKANLQIDQINtD |
| P35611 | T724 | SIGNOR|PSP | ADD1 ADDA | DPGsDGSPGKSPsKKKKKFRtPsFLKKSKKKSDS_______ |
| P35612 | S604 | EPSD|PSP | ADD2 ADDB | ETAPEEPGsPAKsAPAsPVQsPAKEAEtKsPLVsPsKSLEE |
| P35612 | S617 | EPSD|PSP | ADD2 ADDB | APAsPVQsPAKEAEtKsPLVsPsKSLEEGTKKTETSKAATT |
| P35612 | S701 | EPSD|PSP | ADD2 ADDB | KDKTESVTSGPMsPEGsPsKsPsKKKKKFRTPsFLKKSKKK |
| P35968 | S229 | EPSD|PSP | KDR FLK1 VEGFR2 | YQSIMYIVVVVGYRIYDVVLsPSHGIELSVGEKLVLNCTAR |
| P35998 | T193 | Sugiyama | PSMC2 MSS1 | TYSDVGGCKEQIEKLREVVEtPLLHPERFVNLGIEPPKGVL |
| P36578 | S295 | Sugiyama | RPL4 RPL1 | sNyNLPMHKMINtDLsRILKsPEIQRALRAPRKKIHRRVLK |
| P36578 | T62 | Sugiyama | RPL4 RPL1 | TNLRKNNRQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGG |
| P36578 | T69 | Sugiyama | RPL4 RPL1 | RQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGGGtHRsGQ |
| P37231 | S273 | EPSD|PSP | PPARG NR1C3 | SFPLTKAKARAILTGKTTDKsPFVIYDMNSLMMGEDKIKFK |
| P37802 | T180 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | RNFsDNQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL_ |
| P38646 | T87 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VAVMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKR |
| P40763 | S727 | SIGNOR|EPSD|PSP | STAT3 APRF | KTKFICVtPttCsNtIDLPMsPRTLDSLMQFGNNGEGAEPS |
| P41236 | T73 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | PPP1R2 IPP2 | LAtyHPADKDyGLMKIDEPstPYHsMMGDDEDACsDtEAtE |
| P41252 | S1047 | Sugiyama | IARS1 IARS | ESHTEFIFTTIKAPLKPYPVsPsDKVLIQEKTQLKGSELEI |
| P42677 | S11 | Sugiyama | RPS27 MPS1 | __________MPLAKDLLHPsPEEEKRKHKKKRLVQsPNsy |
| P42858 | S1179 | GPS6|SIGNOR|EPSD|PSP | HTT HD IT15 | VAPGPAIKAALPSLTNPPsLsPIRRKGKEKEPGEQAsVPLs |
| P42858 | S1199 | GPS6|SIGNOR|EPSD|PSP|Sugiyama | HTT HD IT15 | sPIRRKGKEKEPGEQAsVPLsPKKGSEASAASRQSDTSGPV |
| P42858 | S432 | EPSD|PSP | HTT HD IT15 | GGRsRsGsIVELIAGGGssCsPVLsRKQKGKVLLGEEEALE |
| P42892 | S733 | Sugiyama | ECE1 | VWCSVRTPESSHEGLITDPHsPsRFRVIGSLSNSKEFSEHF |
| P42892 | S735 | Sugiyama | ECE1 | CSVRTPESSHEGLITDPHsPsRFRVIGSLSNSKEFSEHFRC |
| P46087 | S732 | Sugiyama | NOP2 NOL1 NSUN1 | AFLRQNAPPKGTDtQtPAVLsPsKtQAtLKPKDHHQPLGRA |
| P46087 | S786 | Sugiyama | NOP2 NOL1 NSUN1 | EKAAFQKQNDtPKGPQPPtVsPIRsSRPPPAKRKKsQsRGN |
| P46777 | S172 | Sugiyama | RPL5 MSTP030 | RTTTGNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNA |
| P46777 | S176 | Sugiyama | RPL5 MSTP030 | GNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNAEVHR |
| P46782 | S142 | Sugiyama | RPS5 | REDSTRIGRAGTVRRQAVDVsPLRRVNQAIWLLCTGAREAA |
| P46937 | T119 | Sugiyama | YAP1 YAP65 | PEPKsHsRQAstDAGtAGALtPQHVRAHssPAsLQLGAVsP |
| P46940 | S482 | Sugiyama | IQGAP1 KIAA0051 | LINRALESGDVNTVWKQLsssVtGLTNIEEENCQRYLDELM |
| P47756 | S192 | Sugiyama | CAPZB | TVMLWLQTNKSGsGtMNLGGsLtRQMEKDEtVsDCsPHIAN |
| P47756 | S204 | Sugiyama | CAPZB | sGtMNLGGsLtRQMEKDEtVsDCsPHIANIGRLVEDMENKI |
| P47756 | S207 | Sugiyama | CAPZB | MNLGGsLtRQMEKDEtVsDCsPHIANIGRLVEDMENKIRst |
| P47989 | T222 | EPSD|PSP | XDH XDHA | TPLDPTQEPIFPPELLRLKDtPRKQLRFEGERVTWIQASTL |
| P48681 | T1299 | SIGNOR|iPTMNet | NES Nbla00170 | GEEsREEsEEDELGETLPDStPLGFYLRsPtsPRWDPTGEQ |
| P48681 | T315 | SIGNOR|iPTMNet | NES Nbla00170 | LSLEVATYRTLLEAENsRLQtPGGGsKtsLsFQDPKLELQF |
| P48739 | S165 | Sugiyama | PITPNB | DRSQVEPADyKADEDPALFQsVKtKRGPLGPNWKKELANsP |
| P49023 | S244 | GPS6|EPSD|PSP | PXN | LEssVPsPVPAItVNQGEMssPQRVTsTQQQtRIsAssAtR |
| P49023 | S85 | EPSD|PSP | PXN | PLDQWQPSSSRFIHQQPQsssPVyGssAKtssVsNPQDsVG |
| P49368 | S244 | Sugiyama | CCT3 CCTG TRIC5 | VTHPRMRRYIKNPRIVLLDssLEyKKGEsQtDIEITREEDF |
| P49418 | S272 | GPS6|SIGNOR|iPTMNet|EPSD|PSP | AMPH AMPH1 | SGPLRIAKtPsPPEEPsPLPsPtAsPNHTLAPAsPAPARPR |
| P49418 | S276 | GPS6|SIGNOR|iPTMNet|EPSD|PSP | AMPH AMPH1 | RIAKtPsPPEEPsPLPsPtAsPNHTLAPAsPAPARPRsPsQ |
| P49418 | S285 | GPS6|SIGNOR|iPTMNet|EPSD|PSP | AMPH AMPH1 | EEPsPLPsPtAsPNHTLAPAsPAPARPRsPsQTRKGPPVPP |
| P49454 | T144 | Sugiyama | CENPF | ELERSQQAAQSADVSLNPCNtPQKIFTTPLtPsQYYSGSKY |
| P49736 | S27 | Sugiyama | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | sFtMAssPAQRRRGNDPLtssPGRssRRtDALtssPGRDLP |
| P49768 | T354 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | PSEN1 AD3 PS1 PSNL1 | GGFsEEWEAQRDsHLGPHRstPEsRAAVQELsssILAGEDP |
| P49792 | S2805 | Sugiyama | RANBP2 NUP358 | VMVPSFCKSEEPDsITKsIssPsVssETMDKPVDLsTRKEI |
| P49792 | S2810 | Sugiyama | RANBP2 NUP358 | FCKSEEPDsITKsIssPsVssETMDKPVDLsTRKEIDTDST |
| P49792 | T1144 | Sugiyama | RANBP2 NUP358 | GFRRsDDMFTFHGPGKsVFGtPtLETANKNHEtDGGsAHGD |
| P50406 | S350 | SIGNOR|PSP | HTR6 | ALGRFLPCPRCPRERQASLAsPSLRTSHSGPRPGLSLQQVL |
| P50914 | T43 | Sugiyama | RPL14 | KLVAIVDVIDQNRALVDGPCtQVRRQAMPFKCMQLTDFILK |
| P50993 | S719 | Sugiyama | ATP1A2 KIAA0778 | VEGCQRQGAIVAVTGDGVNDsPALKKADIGIAMGISGSDVS |
| P51858 | S165 | Sugiyama | HDGF HMG1L2 | AKEKNEKGALKRRAGDLLEDsPKRPKEAENPEGEEKEAAtL |
| P52209 | S126 | Sugiyama | PGD PGDH | YRDTTRRCRDLKAKGILFVGsGVsGGEEGARyGPSLMPGGN |
| P52272 | S633 | Sugiyama | HNRNPM HNRPM NAGR1 | GGGGAsFDRAIEMERGNFGGsFAGsFGGAGGHAPGVARKAC |
| P52272 | S637 | Sugiyama | HNRNPM HNRPM NAGR1 | AsFDRAIEMERGNFGGsFAGsFGGAGGHAPGVARKACQIFV |
| P52701 | S292 | Sugiyama | MSH6 GTBP | EGssDEIssGVGDsESEGLNsPVKVARKRKRMVTGNGsLKR |
| P52789 | S415 | Sugiyama | HK2 | QRIKENKGEERLRstIGVDGsVyKKHPHFAKRLHKTVRRLV |
| P53396 | S481 | Sugiyama | ACLY | ADEVAPAKKAKPAMPQDsVPsPRSLQGKSTTLFSRHTKAIV |
| P53779 | T131 | SIGNOR | MAPK10 JNK3 JNK3A PRKM10 SAPK1B | ELVLMKCVNHKNIISLLNVFtPQKTLEEFQDVYLVMELMDA |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P54652 | T38 | Sugiyama | HSPA2 | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P54652 | T39 | Sugiyama | HSPA2 | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P54652 | T46 | Sugiyama | HSPA2 | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPTN |
| P54652 | T48 | Sugiyama | HSPA2 | EIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPTNTI |
| P55081 | T267 | Sugiyama | MFAP1 | ETKKELEENKRsLAALDALNtDDENDEEEyEAWKVRELKRI |
| P55795 | S104 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | EVFKSNsVEMDWVLKHtGPNsPDtANDGFVRLRGLPFGCSK |
| P55795 | T100 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | HRyVEVFKSNsVEMDWVLKHtGPNsPDtANDGFVRLRGLPF |
| P55809 | S170 | Sugiyama | OXCT1 OXCT SCOT | AGVPAFyTPtGyGTLVQEGGsPIKYNKDGSVAIASKPREVR |
| P55809 | S509 | Sugiyama | OXCT1 OXCT SCOT | LWEGLTVDDVQKSTGCDFAVsPKLMPMQQIAN_________ |
| P56817 | T252 | SIGNOR|EPSD|PSP | BACE1 BACE KIAA1149 | GGSMIIGGIDHSLYTGSLWYtPIRREWYYEVIIVRVEINGQ |
| P60709 | S300 | Sugiyama | ACTB | NSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItAL |
| P60709 | S323 | Sugiyama | ACTB | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P60709 | S368 | Sugiyama | ACTB | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60709 | S60 | Sugiyama | ACTB | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P60709 | T324 | Sugiyama | ACTB | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P60709 | Y53 | Sugiyama | ACTB | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P61254 | S32 | Sugiyama | RPL26 | sKNRKRHFNAPsHIRRKIMssPLSKELRQKYNVRSMPIRKD |
| P61254 | T8 | Sugiyama | RPL26 | _____________MKFNPFVtsDRsKNRKRHFNAPsHIRRK |
| P61604 | T45 | Sugiyama | HSPE1 | TVTKGGIMLPEKSQGKVLQAtVVAVGsGsKGKGGEIQPVsV |
| P61916 | S40 | Sugiyama | NPC2 HE1 | EPVQFKDCGsVDGVIKEVNVsPCPtQPCQLSKGQSYSVNVT |
| P61978 | S284 | Sugiyama | HNRNPK HNRPK | MPPGRGGRPMPPSRRDyDDMsPRRGPPPPPPGRGGRGGsRA |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P61981 | S46 | Sugiyama | YWHAG | AMKNVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P62136 | T320 | SIGNOR|EPSD|PSP | PPP1CA PPP1A | DKNKGKyGQFSGLNPGGRPItPPRNsAKAKK__________ |
| P62195 | T109 | Sugiyama | PSMC5 SUG1 | VHPEGKFVVDVDKNIDINDVtPNCRVALRNDsytLHKILPN |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | S46 | Sugiyama | YWHAE | SMKKVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssI |
| P62263 | S139 | Sugiyama | RPS14 PRO2640 | LARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL________ |
| P62263 | T133 | Sugiyama | RPS14 PRO2640 | QsALRALARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL__ |
| P62263 | T140 | Sugiyama | RPS14 PRO2640 | ARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL_________ |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62736 | S325 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62736 | S62 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P62736 | T326 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P62736 | Y55 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P62750 | S43 | Sugiyama | RPL23A | KAKKAVLKGVHSHKKKKIRtsPTFRRPKTLRLRRQPKYPRK |
| P62750 | T42 | Sugiyama | RPL23A | LKAKKAVLKGVHSHKKKKIRtsPTFRRPKTLRLRRQPKYPR |
| P62826 | T66 | Sugiyama | RAN ARA24 OK/SW-cl.81 | EVHPLVFHTNRGPIKFNVWDtAGQEKFGGLRDGYYIQAQCA |
| P62942 | S9 | Sugiyama | FKBP1A FKBP1 FKBP12 | ____________MGVQVEtIsPGDGRtFPKRGQtCVVHytG |
| P63104 | S45 | Sugiyama | YWHAZ | CMKsVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssI |
| P63261 | S300 | Sugiyama | ACTG1 ACTG | NSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItAL |
| P63261 | S323 | Sugiyama | ACTG1 ACTG | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P63261 | S368 | Sugiyama | ACTG1 ACTG | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63261 | S60 | Sugiyama | ACTG1 ACTG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P63261 | T324 | Sugiyama | ACTG1 ACTG | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P63261 | Y53 | Sugiyama | ACTG1 ACTG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P63267 | S324 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P63267 | S61 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P63267 | T325 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P63267 | Y54 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P67809 | S102 | Sugiyama | YBX1 NSEP1 YB1 | EDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEA |
| P68032 | S325 | Sugiyama | ACTC1 ACTC | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | S62 | Sugiyama | ACTC1 ACTC | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68032 | T326 | Sugiyama | ACTC1 ACTC | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68032 | Y55 | Sugiyama | ACTC1 ACTC | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68104 | T432 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| P68133 | S325 | Sugiyama | ACTA1 ACTA | TTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | S62 | Sugiyama | ACTA1 ACTA | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68133 | T326 | Sugiyama | ACTA1 ACTA | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68133 | Y55 | Sugiyama | ACTA1 ACTA | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68363 | T56 | Sugiyama | TUBA1B | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVID |
| P85037 | S420 | Sugiyama | FOXK1 MNF | RGVSCFRtPFGPLssRsAPAsPtHPGLMsPRsGGLQtPECL |
| P85037 | S428 | Sugiyama | FOXK1 MNF | PFGPLssRsAPAsPtHPGLMsPRsGGLQtPECLsREGsPIP |
| P85037 | T422 | Sugiyama | FOXK1 MNF | VSCFRtPFGPLssRsAPAsPtHPGLMsPRsGGLQtPECLsR |
| Q00535 | S47 | PSP | CDK5 CDKN5 PSSALRE | HEIVALKRVRLDDDDEGVPSsALREICLLKELKHKNIVRLH |
| Q00535 | T17 | Sugiyama | CDK5 CDKN5 PSSALRE | ____MQKYEKLEKIGEGtyGtVFKAKNRETHEIVALKRVRL |
| Q01082 | S2138 | Sugiyama | SPTBN1 SPTB2 | QWDtsKGEQVsQNGLPAEQGsPRMAETVDTsEMVNGAtEQR |
| Q01105 | S161 | Sugiyama | SET | FDENPyFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTK |
| Q01105 | S166 | Sugiyama | SET | yFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQT |
| Q01105 | S168 | Sugiyama | SET | ENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQN |
| Q02078 | S408 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | MEF2A MEF2 | QGSNLSINTNQNISIKSEPIsPPRDRMTPSGFQQQQQQQQQ |
| Q02750 | T286 | SIGNOR | MAP2K1 MEK1 PRKMK1 | PDAKELELMFGCQVEGDAAEtPPRPRtPGRPLssyGMDsRP |
| Q02750 | T292 | EPSD|PSP | MAP2K1 MEK1 PRKMK1 | ELMFGCQVEGDAAEtPPRPRtPGRPLssyGMDsRPPMAIFE |
| Q04637 | S1231 | Sugiyama | EIF4G1 EIF4F EIF4G EIF4GI | tEDRDRGRDAVKREAALPPVsPLKAALsEEELEKKsKAIIE |
| Q04917 | S46 | Sugiyama | YWHAH YWHA1 | AMKAVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSI |
| Q05193 | S774 | SIGNOR|iPTMNet | DNM1 DNM | MPPPVDDSWLQVQSVPAGRRsPTSsPtPQRRAPAVPPARPG |
| Q05193 | S778 | SIGNOR|iPTMNet | DNM1 DNM | VDDSWLQVQSVPAGRRsPTSsPtPQRRAPAVPPARPGsRGP |
| Q05193 | T780 | EPSD|PSP | DNM1 DNM | DSWLQVQSVPAGRRsPTSsPtPQRRAPAVPPARPGsRGPAP |
| Q05397 | S732 | GPS6|SIGNOR|EPSD | PTK2 FAK FAK1 | PPKPsRPGYPsPRSSEGFYPsPQHMVQTNHyQVSGYPGSHG |
| Q05397 | S910 | EPSD|PSP | PTK2 FAK FAK1 | sLssPADsyNEGVKLQPQEIsPPPtANLDRSNDKVyENVTG |
| Q05639 | T432 | Sugiyama | EEF1A2 EEF1AL STN | VESFSQYPPLGRFAVRDMRQtVAVGVIKNVEKKSGGAGKVT |
| Q05682 | T730 | Sugiyama | CALD1 CAD CDM | RNIKsMWEKGNVFssPtAAGtPNKEtAGLKVGVSsRINEWL |
| Q06413 | S396 | GPS6|EPSD | MEF2C | QSSNLSLPSTQsLNIKSEPVsPPRDRTTtPSRYPQHTRHEA |
| Q06830 | T166 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | DLPVGRsVDEtLRLVQAFQFtDKHGEVCPAGWKPGsDtIKP |
| Q07666 | S35 | Sugiyama | KHDRBS1 SAM68 | sGRsGsMDPsGAHPsVRQtPsRQPPLPHRSRGGGGGSRGGA |
| Q07666 | T33 | Sugiyama | KHDRBS1 SAM68 | RssGRsGsMDPsGAHPsVRQtPsRQPPLPHRSRGGGGGSRG |
| Q07820 | T92 | EPSD|PSP | MCL1 BCL2L3 | DSRRVARPPPIGAEVPDVTAtPARLLFFAPTRRAAPLEEME |
| Q08AD1 | S1319 | Sugiyama | CAMSAP2 CAMSAP1L1 KIAA1078 | NEsVHsGKRtPRsEsVEGFLsPsRCGsRNGEKDWENAstts |
| Q09666 | S177 | Sugiyama | AHNAK PM227 | VtAytVDVTGREGAKDIDIssPEFKIKIPRHELtEISNVDV |
| Q09666 | S41 | Sugiyama | AHNAK PM227 | HGLTIAQRDDGVFVQEVtQNsPAARTGVVKEGDQIVGATIy |
| Q12778 | S249 | EPSD|PSP | FOXO1 FKHR FOXO1A | EGTGKssWWMLNPEGGKSGKsPRRRAAsMDNNSKFAKSRSR |
| Q12802 | S2728 | Sugiyama | AKAP13 BRX HT31 LBC | PsPsAPSIAKsGsLDsELsVsPKRNsISRTHKDKGPFHILS |
| Q12879 | S1232 | SIGNOR|iPTMNet | GRIN2A NMDAR2A | THCRSCLSNMPTYSGHFTMRsPFKCDACLRMGNLyDIDEDQ |
| Q12931 | S511 | Sugiyama | TRAP1 HSP75 HSPC5 | RAGtRNIyyLCAPNRHLAEHsPyyEAMKKKDTEVLFCFEQF |
| Q12931 | S568 | Sugiyama | TRAP1 HSP75 HSPC5 | ISVETDIVVDHYKEEKFEDRsPAAECLSEKETEELMAWMRN |
| Q13033 | S229 | Sugiyama | STRN3 GS2NA SG2NA | SEPNGsVETKNLEQILNGGEsPKQKGQEIKRSSGDVLETFN |
| Q13045 | S856 | Sugiyama | FLII FLIL | KNWDDVLTVDYTRNAEAVLQsPGLsGKVKRDAEKKDQMKAD |
| Q13136 | T701 | EPSD|PSP | PPFIA1 LIP1 | IPPYPAssLAsssPPGsGRstPRRIPHsPAREVDRLGVMTL |
| Q13153 | T212 | SIGNOR|iPTMNet | PAK1 | PRPEHTKsVytRsVIEPLPVtPtRDVAtsPIsPtENNttPP |
| Q13200 | S16 | Sugiyama | PSMD2 TRAP2 | _____MEEGGRDKAPVQPQQsPAAAPGGtDEKPsGKERRDA |
| Q13242 | S211 | Sugiyama | SRSF9 SFRS9 SRP30C | GYsRsRSGsRGRDsPyQsRGsPHyFsPFRPy__________ |
| Q13283 | S231 | Sugiyama | G3BP1 G3BP | QEEKPEPVLEETAPEDAQKsssPAPADIAQtVQEDLRtFsW |
| Q13283 | S232 | Sugiyama | G3BP1 G3BP | EEKPEPVLEETAPEDAQKsssPAPADIAQtVQEDLRtFsWA |
| Q13303 | S31 | PSP | KCNAB2 KCNA2B KCNK2 | ARLsLRQtGsPGMIystRYGsPKRQLQFYRNLGKSGLRVSC |
| Q13315 | S794 | SIGNOR|EPSD|PSP | ATM | GSLRNMMQLCTRCLSNCTKKsPNKIASGFFLRLLTSKLMND |
| Q13428 | T983 | Sugiyama | TCOF1 | DPNRsPAGPAAtPAQAQAAstPRKARASESTARssssEsED |
| Q13439 | T31 | Sugiyama | GOLGA4 | EEQQQLQQALAPAQAssNsstPtRMRsRtssFtEQLDEGtP |
| Q13509 | S115 | Sugiyama | TUBB3 TUBB4 | SGAGNNWAKGHytEGAELVDsVLDVVRKECENCDCLQGFQL |
| Q13509 | S75 | Sugiyama | TUBB3 TUBB4 | SSHKYVPRAILVDLEPGtMDsVRSGAFGHLFRPDNFIFGQS |
| Q13522 | S67 | SIGNOR | PPP1R1A IPP1 | sPEIDEDRIPNPHLKSTLAMsPRQRKKMtRITPTMKELQMM |
| Q13573 | S224 | Sugiyama | SNW1 SKIIP SKIP | KDPMEPPRFKINKKIPRGPPsPPAPVMHsPsRKMTVKEQQE |
| Q13573 | S232 | Sugiyama | SNW1 SKIIP SKIP | FKINKKIPRGPPsPPAPVMHsPsRKMTVKEQQEWKIPPCIS |
| Q13573 | S234 | Sugiyama | SNW1 SKIIP SKIP | INKKIPRGPPsPPAPVMHsPsRKMTVKEQQEWKIPPCISNW |
| Q13765 | S186 | Sugiyama | NACA HSD48 | sEEEEVDEtGVEVKDIELVMsQANVsRAKAVRALKNNSNDI |
| Q13765 | S191 | Sugiyama | NACA HSD48 | VDEtGVEVKDIELVMsQANVsRAKAVRALKNNSNDIVNAIM |
| Q13794 | S13 | SIGNOR|EPSD|PSP | PMAIP1 NOXA | ________MPGKKARKNAQPsPARAPAELEVECATQLRRFG |
| Q13884 | S87 | Sugiyama | SNTB1 SNT2B1 | SFCRGAGAGHPGAGGAQPPDsPAGVRTAFTDLPEQVPESIS |
| Q13885 | S115 | Sugiyama | TUBB2A TUBB2 | sGAGNNWAKGHytEGAELVDsVLDVVRKESESCDCLQGFQL |
| Q13885 | S75 | Sugiyama | TUBB2A TUBB2 | AGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q14141 | S408 | Sugiyama | SEPTIN6 KIAA0128 SEP2 SEPT6 | sLDDEVNAFKQRKTAAELLQsQGsQAGGsQtLKRDKEKKNN |
| Q14141 | S416 | Sugiyama | SEPTIN6 KIAA0128 SEP2 SEPT6 | FKQRKTAAELLQsQGsQAGGsQtLKRDKEKKNNPWLCTE__ |
| Q14157 | S416 | Sugiyama | UBAP2L KIAA0144 NICE4 | tQsPsLVQYDLKNPsDsAVHsPFtKRQAFtPsstMMEVFLQ |
| Q14157 | S609 | Sugiyama | UBAP2L KIAA0144 NICE4 | GPLYEQRSTQTRRyPssIsssPQKDLtQAKNGFSSVQATQL |
| Q14157 | T256 | Sugiyama | UBAP2L KIAA0144 NICE4 | AWRtAtEEWGtEDWNEDLsEtKIFtAsNVssVPLPAENVtI |
| Q14194 | S522 | SIGNOR|EPSD|PSP | CRMP1 DPYSL1 ULIP3 | PVyEVPAtPKYAtPAPsAKssPsKHQPPPIRNLHQSNFsLs |
| Q14194 | T509 | SIGNOR|EPSD|PSP | CRMP1 DPYSL1 ULIP3 | FGLQGVSRGMYDGPVyEVPAtPKYAtPAPsAKssPsKHQPP |
| Q14195 | S518 | SIGNOR | DPYSL3 CRMP4 DRP3 ULIP ULIP1 | MYDGPVFDLtttPKGGtPAGsARGsPTRPNPPVRNLHQSGF |
| Q14195 | S522 | EPSD|PSP | DPYSL3 CRMP4 DRP3 ULIP ULIP1 | PVFDLtttPKGGtPAGsARGsPTRPNPPVRNLHQSGFSLSG |
| Q14195 | T509 | SIGNOR | DPYSL3 CRMP4 DRP3 ULIP ULIP1 | ADLHAVPRGMYDGPVFDLtttPKGGtPAGsARGsPTRPNPP |
| Q14195 | T514 | SIGNOR | DPYSL3 CRMP4 DRP3 ULIP ULIP1 | VPRGMYDGPVFDLtttPKGGtPAGsARGsPTRPNPPVRNLH |
| Q14204 | S2410 | Sugiyama | DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325 | GEDEAQRRRKGKEDEGEEAAsPMLQIQRDAATIMQPYFTSN |
| Q14247 | S405 | Sugiyama | CTTN EMS1 | EEARRKLEEQARAKtQtPPVsPAPQPtEERLPssPVyEDAA |
| Q14247 | S418 | Sugiyama | CTTN EMS1 | KtQtPPVsPAPQPtEERLPssPVyEDAAsFKAELsyRGPVs |
| Q14247 | T145 | GPS6 | CTTN EMS1 | FGVQMDRVDQsAVGFEyQGKtEKHAsQKDyssGFGGKyGVQ |
| Q14247 | T219 | GPS6 | CTTN EMS1 | yGIDKDKVDKsAVGFEyQGKtEKHESQKDyVKGFGGKFGVQ |
| Q14676 | S793 | Sugiyama | MDC1 KIAA0170 NFBD1 | EAyGPCLsPPRAIPGDQHPEsPVHtEPMGIQGRGRQTVDKV |
| Q14697 | S58 | Sugiyama | GANAB G2AN KIAA0088 | FKtCEEssFCKRQRsIRPGLsPyRALLDSLQLGPDSLTVHL |
| Q14814 | S444 | EPSD|PSP | MEF2D | VGAALTVTTHPHISIKSEPVsPSRERsPAPPPPAVFPAARP |
| Q14847 | T104 | Sugiyama | LASP1 MLN50 | VRYKEEFEKNKGKGFsVVADtPELQRIKKTQDQIsNIKyHE |
| Q14980 | S1757 | Sugiyama | NUMA1 NMP22 NUMA | ITSKLPRtQPDGtsVPGEPAsPIsQRLPPKVEsLEsLyFtP |
| Q14980 | T2000 | Sugiyama | NUMA1 NMP22 NUMA | GITTRQQRKRVsLEPHQGPGtPEsKKATSCFPRPMtPRDRH |
| Q14C86 | S466 | Sugiyama | GAPVD1 GAPEX5 KIAA1521 RAP6 | PAKPGKSSSLEMTPyNTPQLsPATTPANKKNRLPIATRSRS |
| Q14C86 | Y460 | Sugiyama | GAPVD1 GAPEX5 KIAA1521 RAP6 | LLANLPPAKPGKSSSLEMTPyNTPQLsPATTPANKKNRLPI |
| Q15003 | S81 | Sugiyama | NCAPH BRRN BRRN1 CAPH KIAA0074 | EKERLQRRRsRVFDLQFstDsPRLLAsPsSRsIDIsATIPK |
| Q15067 | S26 | Sugiyama | ACOX1 ACOX | RRERDSASFNPELLtHILDGsPEKtRRRREIENMILNDPDF |
| Q15078 | S135 | Sugiyama | CDK5R1 CDK5R NCK5A | SGSQTGGSSSVKKAPHPAVtsAGtPKRVIVQASTSELLRCL |
| Q15078 | S8 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | CDK5R1 CDK5R NCK5A | _____________MGTVLSLsPSyRKATLFEDGAATVGHYT |
| Q15078 | T134 | Sugiyama | CDK5R1 CDK5R NCK5A | LSGSQTGGSSSVKKAPHPAVtsAGtPKRVIVQASTSELLRC |
| Q15078 | T138 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP|Sugiyama | CDK5R1 CDK5R NCK5A | QTGGSSSVKKAPHPAVtsAGtPKRVIVQASTSELLRCLGEF |
| Q15154 | S69 | Sugiyama | PCM1 | KKKFGVESDKRVTNDISPESsPGVGRRRTKTPHTFPHSRYM |
| Q15293 | T76 | Sugiyama | RCN1 RCN | FQYDHEAFLGKEDsKtFDQLtPDEsKERLGKIVDRIDNDGD |
| Q15642 | T302 | Sugiyama | TRIP10 CIP4 STOT STP | VEFEDFsQPMNRAPsDssLGtPsDGRPELRGPGRSRTKRWP |
| Q15717 | S202 | EPSD|PSP | ELAVL1 HUR | KFAANPNQNKNVALLsQLyHsPARRFGGPVHHQAQRFRFsP |
| Q15773 | S238 | Sugiyama | MLF2 | GAGGRRAEGPPRLAIQGPEDsPsRQsRRYDW__________ |
| Q15833 | T572 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | STXBP2 UNC18B | EVTRATEGKWEVLIGSSHILtPTRFLDDLKALDKKLEDIAL |
| Q15853 | S155 | GPS6|PSP | USF2 BHLHB12 | PGPAAPFPLAVIQNPFSNGGsPAAEAVSGEARFAYFPASSV |
| Q15853 | S222 | GPS6|PSP | USF2 BHLHB12 | PQDVLQTGTQRTIAPRTHPYsPKIDGTRtPRDERRRAQHNE |
| Q16204 | S244 | Sugiyama | CCDC6 D10S170 TST1 | LEAEKRILQEKLDQPVsAPPsPRDIsMEIDsPENMMRHIRF |
| Q16236 | S433 | EPSD|PSP | NFE2L2 NRF2 | QSTHVHDAQCENTPEKELPVsPGHRKtPFTKDKHSSRLEAH |
| Q16236 | T395 | EPSD|PSP | NFE2L2 NRF2 | DSEVEELDSAPGSVKQNGPKtPVHSSGDMVQPLsPSQGQST |
| Q16236 | T439 | EPSD|PSP | NFE2L2 NRF2 | DAQCENTPEKELPVsPGHRKtPFTKDKHSSRLEAHLTRDEL |
| Q16555 | S522 | SIGNOR|EPSD|PSP | DPYSL2 CRMP2 ULIP2 | PVCEVsVtPKtVtPAssAKtsPAKQQAPPVRNLHQsGFsLs |
| Q16595 | S158 | Sugiyama | FXN FRDA X25 | GDLGTYVINKQTPNKQIWLSsPSSGPKRYDWTGKNWVYSHD |
| Q16630 | T157 | Sugiyama | CPSF6 CFIM68 | SKKLMDLLPKRELHGQNPVVtPCNKQFLsQFEMQSRKTTQS |
| Q16643 | S142 | EPSD|PSP | DBN1 D0S117E | EDIDAGAIGQRLsNGLARLssPVLHRLRLREDENAEPVGtt |
| Q16665 | S687 | EPSD|PSP | HIF1A BHLHE78 MOP1 PASD8 | AsPNRAGKGVIEQTEKSHPRsPNVLsVALsQRTtVPEEELN |
| Q16762 | S38 | Sugiyama | TST | ESIRTGKLGPGLRVLDAsWysPGTREARKEYLERHVPGASF |
| Q16881 | T413 | Sugiyama | TXNRD1 GRIM12 KDRF | HGIKFIRQFVPIKVEQIEAGtPGRLRVVAQSTNSEEIIEGE |
| Q3V6T2 | S1675 | EPSD|PSP | CCDC88A APE GRDN KIAA1212 | VLQHKISETLESRHHKIKtGsPGsEVVTLQQFLEEsNKLTS |
| Q4KMP7 | T152 | Sugiyama | TBC1D10B FP2461 | sPKtEEARPsPAPGPGtPtGtPtRtPsRtAPGALTAKPPLA |
| Q4KMP7 | T154 | Sugiyama | TBC1D10B FP2461 | KtEEARPsPAPGPGtPtGtPtRtPsRtAPGALTAKPPLAPK |
| Q4KMP7 | T156 | Sugiyama | TBC1D10B FP2461 | EEARPsPAPGPGtPtGtPtRtPsRtAPGALTAKPPLAPKPG |
| Q4V328 | S655 | Sugiyama | GRIPAP1 KIAA1167 | ILTNSKSRSGLEELVLsEMNsPSRtQtGDsssIssFsYREI |
| Q53EL6 | S94 | Sugiyama | PDCD4 H731 | GDsVsDsGsDALRSGLtVPtsPKGRLLDRRSRSGKGRGLPK |
| Q58FF7 | S370 | Sugiyama | HSP90AB3P HSP90BC | KETQKSTYYITGESKEQVANsAFVERVRKQGFEVVYMTEPI |
| Q5JSH3 | S96 | Sugiyama | WDR44 RPH11 | QLEDDsLDSKGKELsDQAtAsPIVARTDLSNIPGLLAIDQV |
| Q5S007 | S1627 | EPSD|PSP | LRRK2 PARK8 | MAQILtVKVEGCPKHPKGIIsRRDVEKFLSKKRKFPKNYMs |
| Q5T200 | S879 | Sugiyama | ZC3H13 KIAA0853 | EKHRLLsQVVRPQEsRsLsPsHLTEDRQGRWKEEDRKPERK |
| Q5T4S7 | S181 | Sugiyama | UBR4 KIAA0462 KIAA1307 RBAF600 | PQTVKTLSDVEDQKELAsPVsPELRQKEVQMNFLNQLTSVF |
| Q5VT52 | S965 | Sugiyama | RPRD2 KIAA0460 HSPC099 | NsLsQsttGHLSLPQKQyPDsPHPVPHRsLFsPQNtLAAPT |
| Q5VTE0 | T432 | Sugiyama | EEF1A1P5 EEF1AL3 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| Q5VV41 | S191 | Sugiyama | ARHGEF16 EPHEXIN4 NBR | IQLsPKLQALAEEPsQPHtRsPAKNKKTLGRKRGHKGsFKD |
| Q69YN4 | S1579 | Sugiyama | VIRMA KIAA1429 MSTP054 | CCSDFDLHSELERsFLsEPssPGRtKTTKGFKLGKHKHETF |
| Q6H8Q1 | S296 | Sugiyama | ABLIM2 KIAA1808 | tRtssEsIIsVPAsstsGsPsRVIYAKLGGEILDYRDLAAL |
| Q6KC79 | S350 | Sugiyama | NIPBL IDN3 SCC2 | KLGKDEKEQSEKAAMyDIIssPsKDSTKLTLRLSRVRssDM |
| Q6P1L8 | S49 | Sugiyama | MRPL14 MRPL32 RPML32 | LSAIQKMTRVRVVDNSALGNsPyHRAPRCIHVYKKNGVGKV |
| Q6PEY2 | T56 | Sugiyama | TUBA3E | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVVD |
| Q6PID6 | S197 | Sugiyama | TTC33 | QQKVAQRIKKSEAPAEVtHFsPKSIPDYDFESDEIVAVCAA |
| Q6PKG0 | S774 | Sugiyama | LARP1 KIAA0731 LARP | LFGAPEPstIARsLPttVPEsPNyRNtRtPRtPRtPQLKDS |
| Q6S8J3 | S1068 | Sugiyama | POTEE A26C1A POTE2 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q6VN20 | S365 | Sugiyama | RANBP10 KIAA1464 | DSEVRSLSSRsPKsQDsyPGsPsLsPRHGPsssHMHNTGAD |
| Q6VN20 | S369 | Sugiyama | RANBP10 KIAA1464 | RSLSSRsPKsQDsyPGsPsLsPRHGPsssHMHNTGADsPsC |
| Q6ZN18 | S24 | Sugiyama | AEBP2 | AItDMADLEELsRLsPLPPGsPGsAARGRAEPPEEEEEEEE |
| Q71RC2 | S594 | Sugiyama | LARP4 PP13296 | GLNQttIPVsPPsttKPsRAstAsPCNNNINAAtAVALQEP |
| Q71U36 | T56 | Sugiyama | TUBA1A TUBA3 | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVID |
| Q7KZI7 | S619 | Sugiyama | MARK2 EMK1 | AGQLRQVRDQQNLPyGVtPAsPsGHsQGRRGAsGsIFSKFT |
| Q7Z5J4 | S345 | Sugiyama | RAI1 KIAA1820 | DAAVRTPEQyyQtFsPsssHsPARSVGRSPSYSSTPSPLMP |
| Q7Z5K2 | S226 | Sugiyama | WAPL FOE KIAA0261 WAPAL | ETNDTWNSQFGKRPEsPsEIsPIKGsVRTGLFEWDNDFEDI |
| Q7Z6M1 | S137 | Sugiyama | RABEPK RAB9P40 | QVLNPETRTWTTPEVtsPPPsPRTFHTSSAAIGNQLYVFGG |
| Q86TN4 | S240 | Sugiyama | TRPT1 | LRPTRKPLSLAGDEEtECQssPKHssRERRRIQQ_______ |
| Q86VM9 | S613 | Sugiyama | ZC3H18 NHN1 | SGSRSRsRsFsssPsPsPtPsPHRPsIRTKGEPAPPPGKAG |
| Q86VM9 | S618 | Sugiyama | ZC3H18 NHN1 | RsRsFsssPsPsPtPsPHRPsIRTKGEPAPPPGKAGEKSVK |
| Q86VM9 | T611 | Sugiyama | ZC3H18 NHN1 | SFSGSRSRsRsFsssPsPsPtPsPHRPsIRTKGEPAPPPGK |
| Q86VP6 | S376 | Sugiyama | CAND1 KIAA0829 TIP120 TIP120A | CLDAVVSTRHEMLPEFyKTVsPALISRFKEREENVKADVFH |
| Q86YP4 | S114 | Sugiyama | GATAD2A | SERRPPsPDVIVLsDNEQPssPRVNGLttVALKETSTEALM |
| Q8IV63 | S108 | SIGNOR|PSP | VRK3 | TLSSSERSKGSGSRPPtPKSsPQKTRKsPQVtRGsPQKTsC |
| Q8IVD9 | S340 | Sugiyama | NUDCD3 KIAA1068 | PQSHELKVHEMLKKGWDAEGsPFRGQRFDPAMFNIsPGAVQ |
| Q8IWR1 | S308 | SIGNOR|PSP | TRIM59 RNF104 TRIM57 TSBF1 | EWSRTEIGQIKNVLIPKMKIsPKRMSCSWPGKDEKEVEFLK |
| Q8IWU2 | S1450 | SIGNOR|EPSD|PSP | LMTK2 AATYK2 BREK KIAA1079 KPI2 LMR2 | SKTTSNLLSSKPSLQTSKYFsPPPPARSTEQSWPHSAPySR |
| Q8IWW6 | S450 | Sugiyama | ARHGAP12 | NDKESPTASKPCFPENESSPsSPKHQDTASSPKDQEKyGLL |
| Q8IXQ3 | S67 | Sugiyama | C9orf40 | LGVPEQHRKRKIDAGTMAEPsAsPsKRRDsGDNsAPsGQER |
| Q8N556 | S265 | Sugiyama | AFAP1 AFAP | KEAYSGCSGPVDSECPPPPssPVHKAELEKKLssERPssDG |
| Q8N556 | S668 | Sugiyama | AFAP1 AFAP | AGGVTLGLAIEPKsGtssPQsPVFRHRtLENsPIssCDtsD |
| Q8NBJ5 | S612 | Sugiyama | COLGALT1 GLT25D1 PSEC0241 | QKMREQQALSREAKNsDVLQsPLDsAARDEL__________ |
| Q8NBJ7 | S264 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | AAEQDMRVLRGAsWIDtADGsANHRARVttRMGNtPDsAsD |
| Q8NEB9 | T159 | SIGNOR|EPSD|PSP | PIK3C3 VPS34 | GMHDLKVWPNVEADGSEPTKtPGRTsSTLSEDQMSRLAKLT |
| Q8NEB9 | T668 | SIGNOR|EPSD|PSP | PIK3C3 VPS34 | LQIISLMDKLLRKENLDLKLtPYKVLATSTKHGFMQFIQSV |
| Q8NEL9 | S11 | PSP | DDHD1 KIAA1705 | __________MNyPGRGsPRsPEHNGRGGGGGAWELGSDAR |
| Q8NEL9 | S727 | PSP | DDHD1 KIAA1705 | KEPtsVSENEGIstIPsPVtsPVLsRRHYGESITNIGKASI |
| Q8NEN9 | S519 | Sugiyama | PDZD8 PDZK8 | EDLAsDVRAQNEFKDEAQsLsHsPKRVPtTLsIKPLGAIsP |
| Q8NEN9 | S521 | Sugiyama | PDZD8 PDZK8 | LAsDVRAQNEFKDEAQsLsHsPKRVPtTLsIKPLGAIsPVL |
| Q8NEN9 | S989 | Sugiyama | PDZD8 PDZK8 | KHtPNtsDNEGsDtEVCGPNsPsKRGNSTGIKLVRKEGGLD |
| Q8NEZ5 | S160 | PSP | FBXO22 FBX22 | PKQCQVLGIVTPGIVVTPMGsGsNRPQEIEIGESGFALLFP |
| Q8NEZ5 | S162 | PSP | FBXO22 FBX22 | QCQVLGIVTPGIVVTPMGsGsNRPQEIEIGESGFALLFPQI |
| Q8NFD5 | S1744 | Sugiyama | ARID1B BAF250B DAN15 KIAA1235 OSA2 | ALDTINILLYDDSTVATFNLsQLSGFLELLVEYFRKCLIDI |
| Q8TBN0 | T181 | Sugiyama | RAB3IL1 | VItstPAsPNRELHPQLLsPtKAGPRKGHSRHKstsstLCP |
| Q8TCS8 | S754 | Sugiyama | PNPT1 PNPASE | KYFGRDPADGRMRLSRKVLQsPAtTVVRTLNDRssIVMGEP |
| Q8TD19 | S868 | Sugiyama | NEK9 KIAA1995 NEK8 NERCC | LQGLKVAsEAPLEHKPQVEAssPRLNPAVtCAGKGtPLtPP |
| Q8TDN4 | S313 | SIGNOR | CABLES1 CABLES | EtLEDIEENAPLRRCRtLSGsPRPKNFKKIHFIKNMRQHDT |
| Q8TEQ6 | S648 | Sugiyama | GEMIN5 | ITEPYRTLSGHTAKITsVAWsPHHDGRLVSASYDGTAQVWD |
| Q8TEW0 | S728 | Sugiyama | PARD3 PAR3 PAR3A | DDRERRIsHsLysGIEGLDEsPsRNAALsRIMGESGKYQLS |
| Q8WVM8 | S303 | Sugiyama | SCFD1 C14orf163 KIAA0917 STXBP1L2 FKSG23 | DVLDFHLNRVNLEEssGVENsPAGARPKRKNKKsYDLtPVD |
| Q8WVV9 | S75 | Sugiyama | HNRNPLL HNRPLL SRRF BLOCK24 | GGGRsFsQPEAGGsHHKVsVsPVVHVRGLCEsVVEADLVEA |
| Q8WWM7 | S111 | Sugiyama | ATXN2L A2D A2LG A2LP A2RP | PGAAAIGsARGQstGKGPPQsPVFEGVyNNSRMLHFLTAVV |
| Q8WX93 | S484 | Sugiyama | PALLD KIAA0992 CGI-151 | VRGAPPLQVQWFRQGsEIQDsPDFRILQKKPRSTAEPEEIC |
| Q8WXG6 | S1270 | Sugiyama | MADD DENN IG20 KIAA0358 | STIFGKAHSLKPSIKEKLAGsPIRTSEDVSQRVYLYEGLLG |
| Q8WYQ5 | S95 | Sugiyama | DGCR8 C22orf12 DGCRK6 LP4941 | LSKGSFSKGRLLIDPNCsGHsPRTARHAPAVRKFSPDLKLL |
| Q92530 | S153 | Sugiyama | PSMF1 | RIVSGIITPIHEQWEKANVssPHREFPPAtAREVDPLRIPP |
| Q92558 | S310 | iPTMNet | WASF1 KIAA0269 SCAR1 WAVE1 | AKPIPTCISsAtGLIENRPQsPAtGRTPVFVsPtPPPPPPP |
| Q92558 | S397 | iPTMNet | WASF1 KIAA0269 SCAR1 WAVE1 | IAPGVLHPAPPPIAPPLVQPsPPVARAAPVCETVPVHPLPQ |
| Q92558 | S441 | iPTMNet | WASF1 KIAA0269 SCAR1 WAVE1 | QGLPPPPPPPPLPPPGIRPSsPVTVTALAHPPSGLHPTPST |
| Q92576 | S1614 | Sugiyama | PHF3 KIAA0244 | KRQLQEDQENNLQDNQtsNssPCRsNVGKGNIDGNVsCsEN |
| Q969H0 | S349 | GPS6 | FBXW7 FBW7 FBX30 SEL10 | GIDEPLHIKRRKVIKPGFIHsPWKSAYIRQHRIDTNWRRGE |
| Q969H0 | S372 | GPS6 | FBXW7 FBW7 FBX30 SEL10 | KSAYIRQHRIDTNWRRGELKsPKVLKGHDDHVITCLQFCGN |
| Q96AC1 | T416 | Sugiyama | FERMT2 KIND2 MIG2 PLEKHC1 | WCTFKDTSISCYKSKEESsGtPAHQMNLRGCEVTPDVNISG |
| Q96BY7 | S1583 | Sugiyama | ATG2B C14orf103 | KDFGIVPPTSPAKsYIsPHssPsHtPTRHGRNTVCGGKGRN |
| Q96BY7 | S1585 | Sugiyama | ATG2B C14orf103 | FGIVPPTSPAKsYIsPHssPsHtPTRHGRNTVCGGKGRNHD |
| Q96C19 | S74 | PSP|Sugiyama | EFHD2 SWS1 | ELSAKLLRRADLNQGIGEPQsPsRRVFNPytEFKEFSRKQI |
| Q96C19 | S76 | Sugiyama | EFHD2 SWS1 | SAKLLRRADLNQGIGEPQsPsRRVFNPytEFKEFSRKQIKD |
| Q96DX5 | S201 | Sugiyama | ASB9 | ACVKKLLESGADVNQGKGQDsPLHAVARTASEELACLLMDF |
| Q96G46 | T99 | Sugiyama | DUS3L | DGQtADGQtEEAAEPGEQLQtQKRARGQNKGRPHVKPTNYD |
| Q96KR7 | S318 | SIGNOR|EPSD|PSP | PHACTR3 C20orf101 SCAPIN1 | HRALATKHRQDSFQGRESKGsPKKRLDVRLSRTSSVERGKE |
| Q96MH2 | S76 | Sugiyama | HEXIM2 L3 | EDLAGAVGGLGWNsRsPRtQsPGGCsAEAVLARKKHRRRPS |
| Q96QB1 | S557 | SIGNOR|PSP | DLC1 ARHGAP7 KIAA1723 STARD12 | KWTFQRDSKRWsRLEEFDVFsPKQDLVPGsPDDSHPKDGPs |
| Q96QB1 | S642 | SIGNOR|PSP | DLC1 ARHGAP7 KIAA1723 STARD12 | ISVCSSSNLAGNDDSFGSLPsPKELSSFSFSMKGHEKTAKS |
| Q96QB1 | S859 | SIGNOR|PSP | DLC1 ARHGAP7 KIAA1723 STARD12 | RtGsFHGPGHISLRRENSSDsPKELKRRNsSSSMSSRLSIY |
| Q96QB1 | S946 | SIGNOR|PSP | DLC1 ARHGAP7 KIAA1723 STARD12 | KFSDEGDSDSALDSVSPCPssPKQIHLDVDNDRTTPSDLDS |
| Q96RR4 | S129 | SIGNOR | CAMKK2 CAMKKB KIAA0787 | LAAGGsLDMNGRCICPsLPysPVssPQssPRLPRRPTVESH |
| Q96RR4 | S133 | SIGNOR | CAMKK2 CAMKKB KIAA0787 | GsLDMNGRCICPsLPysPVssPQssPRLPRRPTVESHHVSI |
| Q96RR4 | S137 | SIGNOR | CAMKK2 CAMKKB KIAA0787 | MNGRCICPsLPysPVssPQssPRLPRRPTVESHHVSITGMQ |
| Q99459 | T385 | Sugiyama | CDC5L KIAA0432 PCDC5RP | EAQNLMALtNVDtPLKGGLNtPLHEsDFsGVtPQRQVVQtP |
| Q99459 | T396 | Sugiyama | CDC5L KIAA0432 PCDC5RP | DtPLKGGLNtPLHEsDFsGVtPQRQVVQtPNtVLstPFRtP |
| Q99460 | T311 | Sugiyama | PSMD1 | EKDsDsMEtEEKTSsAFVGKtPEAsPEPKDQTLKMIKILSG |
| Q99490 | S279 | SIGNOR | AGAP2 CENTG1 KIAA0167 | GAGARGKLSPRKGKSKTLDNsDLHPGPPAGSPPPLTLPPTP |
| Q9BQ52 | S199 | Sugiyama | ELAC2 HPC2 | TVyQIPIHSEQRRGKHQPWQsPERPLsRLsPERssDsEsNE |
| Q9BQE3 | S439 | Sugiyama | TUBA1C TUBA6 | SEAREDMAALEKDyEEVGADsADGEDEGEEy__________ |
| Q9BQE3 | T56 | Sugiyama | TUBA1C TUBA6 | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVID |
| Q9BQE9 | S122 | Sugiyama | BCL7B | QLKVDsstNssPsPQQsEsLsPAHtsDFRtDDsQPPTLGQE |
| Q9BQG0 | S11 | Sugiyama | MYBBP1A P160 | __________MEsRDPAQPMsPGEAtQsGARPADRYGLLKH |
| Q9BQG0 | S1166 | Sugiyama | MYBBP1A P160 | RPKLEKKDAKEIPsAtQsPIsKKRKKKGFLPETKKRKKRKs |
| Q9BRP1 | S20 | Sugiyama | PDCD2L | _MAAVLKPVLLGLRDAPVHGsPTGPGAWTASKLGGIPDALP |
| Q9BTC0 | S1030 | Sugiyama | DIDO1 C20orf158 DATF1 KIAA0333 | KSILAKPsssPDPRYLsVPPsPNIstsEsRsPPEGDtTLFL |
| Q9BTU6 | S51 | Sugiyama | PI4K2A | VPGGAVRVAAAAGsGPsPPGsPGHDRERQPLLDRARGAAAQ |
| Q9BVA1 | S115 | Sugiyama | TUBB2B | sGAGNNWAKGHytEGAELVDsVLDVVRKESESCDCLQGFQL |
| Q9BVA1 | S75 | Sugiyama | TUBB2B | tGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q9BX68 | T47 | Sugiyama | HINT2 | QVRGAAGVTDGNEVAKAQQAtPGGAAPtIFsRILDKsLPAD |
| Q9BXB4 | S181 | Sugiyama | OSBPL11 ORP11 OSBP12 | IGKNNPPLKsRsFsLAsssNsPIsQRRPsQNAIsFFNVGHS |
| Q9BYX7 | S368 | Sugiyama | POTEKP ACTBL3 FKSG30 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q9C0C2 | S435 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | DAHLRPtsLVQRRFsEGVLQsPsQDQEKLGGsLAALPQGQG |
| Q9GZM8 | S198 | SIGNOR|iPTMNet | NDEL1 EOPA MITAP1 NUDEL | RQELAVRERQQEVTRKsAPssPTLDCEKMDSAVQAsLsLPA |
| Q9GZM8 | S231 | SIGNOR|iPTMNet | NDEL1 EOPA MITAP1 NUDEL | QAsLsLPAtPVGKGTENTFPsPKAIPNGFGTsPLtPSARIs |
| Q9GZM8 | S242 | SIGNOR|iPTMNet | NDEL1 EOPA MITAP1 NUDEL | GKGTENTFPsPKAIPNGFGTsPLtPSARIsALNIVGDLLRK |
| Q9GZM8 | T219 | SIGNOR|iPTMNet | NDEL1 EOPA MITAP1 NUDEL | PTLDCEKMDSAVQAsLsLPAtPVGKGTENTFPsPKAIPNGF |
| Q9GZM8 | T245 | iPTMNet | NDEL1 EOPA MITAP1 NUDEL | TENTFPsPKAIPNGFGTsPLtPSARIsALNIVGDLLRKVGA |
| Q9GZT9 | S125 | Sugiyama | EGLN1 C1orf12 PNAS-118 PNAS-137 | GDAAKGKVKAKPPADPAAAAsPCRAAAGGQGsAVAAEAEPG |
| Q9H0E9 | T77 | Sugiyama | BRD8 SMAP SMAP2 | DWFSQKHCASQYSELLEttEtPKRKRGEKGEVVETVEDVIV |
| Q9H2C0 | S52 | Sugiyama | GAN GAN1 KLHL16 | AHLVLDGEEIPVQKNILAAAsPYIRTKLNYNPPKDDGSTYK |
| Q9H2D6 | S1955 | Sugiyama | TRIOBP KIAA1662 TARA HRIHFB2122 | KADGQRQALDyVELsPLtQAsPQRARTPARTPDRLAKQEEL |
| Q9H2U2 | S317 | Sugiyama | PPA2 HSPC124 | DSPFRCtQEEARsLVEsVsssPNKEsNEEEQVWHFLGK___ |
| Q9H488 | S264 | Sugiyama | POFUT1 FUT12 KIAA0180 | DWKNACAMLKDGTAGSHFMAsPQCVGySRSTAAPLTMTMCL |
| Q9H6F5 | S102 | Sugiyama | CCDC86 CYCLON | QGQPEPGAAsPQRQQDLHLEsPQRQPEysPEsPRCQPKPSE |
| Q9H6F5 | S113 | Sugiyama | CCDC86 CYCLON | QRQQDLHLEsPQRQPEysPEsPRCQPKPSEEAPKCsQDQGV |
| Q9H6F5 | S91 | Sugiyama | CCDC86 CYCLON | RLQQGAGLEsPQGQPEPGAAsPQRQQDLHLEsPQRQPEysP |
| Q9H6F5 | Y109 | Sugiyama | CCDC86 CYCLON | AAsPQRQQDLHLEsPQRQPEysPEsPRCQPKPSEEAPKCsQ |
| Q9H7L9 | S228 | SIGNOR | SUDS3 SAP45 SDS3 | NYLLTDEQIMEDLRTLNKLKsPKRPAsPssPEHLPAtPAEs |
| Q9NQR4 | S207 | Sugiyama | NIT2 CUA002 | HWELLQRSRAVDNQVyVAtAsPARDDKASYVAWGHSTVVNP |
| Q9NQT8 | T506 | SIGNOR | KIF13B GAKIN KIAA0639 | MGILPEHCIIDITSEGQVMLtPQKNTRTFVNGSsVSSPIQL |
| Q9NQX3 | S270 | Sugiyama | GPHN GPH KIAA1385 | SRGVQVLPRDTAsLsttPsEsPRAQAtsRLstAsCPtPKVQ |
| Q9NR19 | S267 | PSP | ACSS2 ACAS2 | CIVVKHLGRAELGMGDstsQsPPIKRSCPDVQISWNQGIDL |
| Q9NR30 | S71 | Sugiyama | DDX21 | VFPKAKQVKKKAEPSEVDMNsPKSKKAKKKEEPSQNDIsPK |
| Q9NRA8 | S115 | Sugiyama | EIF4ENIF1 | VRRIVDPRERVKEDDLDVVLsPQRRsFGGGCHVTAAVSSRR |
| Q9NUU7 | S85 | Sugiyama | DDX19A DDX19L | IRSNLVDNtNQVEVLQRDPNsPLysVKsFEELRLKPQLLQG |
| Q9NXR1 | T191 | EPSD|PSP | NDE1 NUDE | DEARDLRQELAVQQKQEKPRtPMPSsVEAERTDTAVQAtGs |
| Q9NY27 | S226 | Sugiyama | PPP4R2 SBBI57 | QNEEKNHSDsstsEsEVssVsPLKNKHPDEDAVEAEGHEVK |
| Q9NYB0 | S203 | Sugiyama | TERF2IP DRIP5 RAP1 PP8000 | RYLKHLRGQEHKyLLGDAPVsPssQKLKRKAEEDPEAADsG |
| Q9NYF8 | S290 | Sugiyama | BCLAF1 BTF KIAA0164 | ERsGsGsVGNGssRysPsQNsPIHHIPsRRsPAKtIAPQNA |
| Q9NYV4 | S249 | Sugiyama | CDK12 CRK7 CRKRS KIAA0904 | DSSKQDDsPsGAsYGQDyDLsPsRsHtssNYDsYKKsPGsT |
| Q9NZ72 | S68 | SIGNOR|EPSD|PSP | STMN3 SCLIP | RAsGQsFEVILKsPSDLsPEsPMLssPPKKKDtsLEELQKR |
| Q9NZ72 | S73 | SIGNOR|EPSD|PSP | STMN3 SCLIP | sFEVILKsPSDLsPEsPMLssPPKKKDtsLEELQKRLEAAE |
| Q9NZB2 | S990 | Sugiyama | FAM120A C9orf10 KIAA0183 OSSA | FPLQVVSVGGPARGRPRGVIstPVIRTFGRGGRYYGRGYKN |
| Q9NZB2 | T991 | Sugiyama | FAM120A C9orf10 KIAA0183 OSSA | PLQVVSVGGPARGRPRGVIstPVIRTFGRGGRYYGRGYKNQ |
| Q9NZJ0 | S425 | Sugiyama | DTL CDT2 CDW1 DCAF2 L2DTL RAMP | TVGWAsQKKKESRPGLVTVtssQstPAKAPRAKCNPsNssP |
| Q9NZJ0 | T429 | Sugiyama | DTL CDT2 CDW1 DCAF2 L2DTL RAMP | AsQKKKESRPGLVTVtssQstPAKAPRAKCNPsNssPssAA |
| Q9NZT2 | S378 | Sugiyama | OGFR | LERsQGDEAGGHGEDRPEPLsPKEsKKRKLELSRREQPPTE |
| Q9P270 | S48 | Sugiyama | SLAIN2 KIAA1458 | NEQLRSRsGAVQGAGsLGPGsPVRAGAsIPssGAAsPRGFP |
| Q9UBC2 | S235 | Sugiyama | EPS15L1 EPS15R | KKtVFPGAVPVLPAsPPPKDsLRstPsHGsVssLNstGsLs |
| Q9UBC2 | S255 | Sugiyama | EPS15L1 EPS15R | sLRstPsHGsVssLNstGsLsPKHsLKQTQPTVNWVVPVAD |
| Q9UD71 | T75 | GPS6|SIGNOR|EPSD | PPP1R1B DARPP32 | QRASGEGHHLKsKRPNPCAYtPPSLKAVQRIAESHLQSIsN |
| Q9UEY8 | S677 | Sugiyama | ADD3 ADDL | NIEITIKsPEKIEEVLsPEGsPsKsPsKKKKKFRTPsFLKK |
| Q9UEY8 | S681 | Sugiyama | ADD3 ADDL | TIKsPEKIEEVLsPEGsPsKsPsKKKKKFRTPsFLKKNKKK |
| Q9UG63 | S512 | Sugiyama | ABCF2 HUSSY-18 | EKEEMRKIIGRYGLTGKQQVsPIRNLSDGQKCRVCLAWLAW |
| Q9UI10 | T86 | Sugiyama | EIF2B4 EIF2BD | AAQCQVGPTRELPESGIQLGtPREKVPAGRSKAELRAERRA |
| Q9UI12 | S367 | Sugiyama | ATP6V1H CGI-11 | QDLSSFDEySSELKSGRLEWsPVHKSEKFWRENAVRLNEKN |
| Q9UJU6 | S232 | Sugiyama | DBNL CMAP SH3P7 PP5423 | RELREAARREQRyQEQGGEAsPQRtWEQQQEVVSRNRNEQE |
| Q9UKA9 | S434 | Sugiyama | PTBP2 NPTB PTB PTBLP | TVQLPREGLDDQGLTKDFGNsPLHRFKKPGSKNFQNIFPPS |
| Q9UKS6 | S344 | Sugiyama | PACSIN3 | tLtsIVPTRDGTAPPPQsPGsPGtGQDEEWsDEEsPRKAAT |
| Q9UKS6 | T347 | Sugiyama | PACSIN3 | sIVPTRDGTAPPPQsPGsPGtGQDEEWsDEEsPRKAATGVR |
| Q9UKV3 | S256 | Sugiyama | ACIN1 ACINUS KIAA0670 | AAKLsEGsQPAEEEEDQEtPsRNLRVRADRNLKTEEEEEEE |
| Q9UKV3 | T254 | Sugiyama | ACIN1 ACINUS KIAA0670 | ARAAKLsEGsQPAEEEEDQEtPsRNLRVRADRNLKTEEEEE |
| Q9UKV5 | S516 | SIGNOR|EPSD|PSP | AMFR RNF45 | GRIQVPFPTQRsDsIRPALNsPVERPssDQEEGETSAQTER |
| Q9ULD2 | S1255 | Sugiyama | MTUS1 ATBP ATIP GK1 KIAA1288 MTSG1 | HNGDLCsPKRsPtssAIPLQsPRNsGsFPsPsIsPR_____ |
| Q9ULW0 | S486 | SIGNOR|PSP | TPX2 C20orf1 C20orf2 DIL2 HCA519 | ILEDVVGVPEKKVLPITVPKsPAFALKNRIRMPtKEDEEED |
| Q9UM11 | S163 | EPSD|PSP | FZR1 CDH1 FYR FZR KIAA1242 | NDVsPYsLsPVSNKSQKLLRsPRKPTRKISKIPFKVLDAPE |
| Q9UM11 | S40 | EPSD|PSP | FZR1 CDH1 FYR FZR KIAA1242 | TMPRVTEMRRTLtPAssPVssPsKHGDRFIPSRAGANWSVN |
| Q9UM11 | T121 | EPSD|PSP | FZR1 CDH1 FYR FZR KIAA1242 | GAGIEKVQDPQTEDRRLQPstPEKKGLFTYSLsTKRssPDD |
| Q9UMR2 | S86 | Sugiyama | DDX19B DBP5 DDX19 TDBP | IRSNLVDNtNQVEVLQRDPNsPLysVKsFEELRLKPQLLQG |
| Q9UNX3 | S32 | Sugiyama | RPL26L1 RPL26P1 | sKNRKRHFNAPSHVRRKIMssPLSKELRQKYNVRSMPIRKD |
| Q9UNX3 | T8 | Sugiyama | RPL26L1 RPL26P1 | _____________MKFNPFVtsDRsKNRKRHFNAPSHVRRK |
| Q9UPQ0 | S523 | Sugiyama | LIMCH1 KIAA1102 | VETTIARASVLDtsMsAGsGsPsKTVtPKAVPMLtPKPYsQ |
| Q9UPQ3 | S521 | Sugiyama | AGAP1 CENTG2 KIAA1099 | SVCSSPSISSTTSPKLDPPPsPHANRKKHRRKKSTSNFKAD |
| Q9UQ35 | S1657 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | RSGSSSKGRGPsPEGssstEssPEHPPKSRTARRGsRSsPE |
| Q9UQ35 | T866 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sGtPPRQGsItsPQANEQsVtPQRRsCFEssPDPELKsRtP |
| Q9UQL6 | S279 | EPSD|PSP | HDAC5 KIAA0600 | sEPNLKVRSRLKQKVAERRssPLLRRKDGTVIStFKKRAVE |
| Q9Y210 | S14 | EPSD|PSP | TRPC6 TRP6 | _______MsQsPAFGPRRGssPRGAAGAAARRNESQDyLLM |
| Q9Y266 | S139 | Sugiyama | NUDC | IDQKKDAENHEAQLKNGsLDsPGKQDtEEDEEEDEKDKGKL |
| Q9Y2V2 | S41 | Sugiyama | CARHSP1 | LDtPRsRERsPsPLRGNVVPsPLPtRRtRtFsAtVRASQGP |
| Q9Y2X3 | S514 | Sugiyama | NOP58 NOL5 NOP5 HSPC120 | KHIKEEPLsEEEPCtstAIAsPEKKKKKKKKRENED_____ |
| Q9Y371 | T145 | GPS6|EPSD | SH3GLB1 KIAA0491 CGI-61 | QKRIGTADRELIQTSALNFLtPLRNFIEGDYKTIAKERKLL |
| Q9Y490 | S425 | SIGNOR|EPSD|PSP | TLN1 KIAA1027 TLN | sKDHFGLEGDEEstMLEDsVsPKKstVLQQQyNRVGKVEHG |
| Q9Y4P8 | T415 | Sugiyama | WIPI2 CGI-50 | LVTQTYGAAAGKGTYVPssPtRLAYTDDLGAVGGACLEDEA |
| Q9Y5S2 | S1693 | Sugiyama | CDC42BPB KIAA1124 | stKHstPsNssNPsGPPsPNsPHRsQLPLEGLEQPACDT__ |
| Q9Y5U2 | S146 | Sugiyama | TSSC4 | LAPsGRsPVEGLGRAHRsPAsPRVPPVPDYVAHPERWTKYS |
| Q9Y5Z4 | S181 | Sugiyama | HEBP2 C6orf34 SOUL | ILREDGKVFDEKVYYTAGYNsPVKLLNRNNEVWLIQKNEPT |
| Q9Y673 | S62 | Sugiyama | ALG5 HSPC149 | EEKFFLNAKGQKETLPSIWDsPtKQLSVVVPSYNEEKRLPV |
| Q9Y6G9 | S207 | Sugiyama | DYNC1LI1 DNCLI1 | EQKLIRDFQEyVEPGEDFPAsPQRRNtAsQEDKDDsVVLPL |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Chromatin organization | R-HSA-4839726 | 8.614498e-11 | 10.065 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 4.087117e-10 | 9.389 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.274703e-09 | 8.895 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 2.458084e-09 | 8.609 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.154959e-06 | 5.937 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 2.209796e-06 | 5.656 | 1 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 2.942922e-06 | 5.531 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 6.053342e-06 | 5.218 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 4.751280e-05 | 4.323 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.020318e-04 | 3.991 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 1.475170e-04 | 3.831 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.579254e-04 | 3.802 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.357643e-04 | 3.628 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 3.919852e-04 | 3.407 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 4.724299e-04 | 3.326 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 4.771478e-04 | 3.321 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 5.418816e-04 | 3.266 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 7.065733e-04 | 3.151 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 8.889444e-04 | 3.051 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 8.889444e-04 | 3.051 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 8.437934e-04 | 3.074 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 8.847473e-04 | 3.053 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 8.847473e-04 | 3.053 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 8.519426e-04 | 3.070 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.058238e-03 | 2.975 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.011919e-03 | 2.995 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.035112e-03 | 2.985 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.216326e-03 | 2.915 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 1.559469e-03 | 2.807 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 1.559469e-03 | 2.807 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.344434e-03 | 2.871 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.521137e-03 | 2.818 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.530678e-03 | 2.815 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.381462e-03 | 2.860 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.560163e-03 | 2.807 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.560163e-03 | 2.807 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 2.175115e-03 | 2.663 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 2.210360e-03 | 2.656 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 2.138664e-03 | 2.670 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 2.018824e-03 | 2.695 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 2.175115e-03 | 2.663 | 0 | 0 |
| S Phase | R-HSA-69242 | 2.215782e-03 | 2.654 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 2.309698e-03 | 2.636 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 2.273038e-03 | 2.643 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.552719e-03 | 2.593 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 2.680899e-03 | 2.572 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 2.953113e-03 | 2.530 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 3.358649e-03 | 2.474 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 3.588732e-03 | 2.445 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 3.642638e-03 | 2.439 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 3.697781e-03 | 2.432 | 1 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 3.642638e-03 | 2.439 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 3.674694e-03 | 2.435 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 3.932094e-03 | 2.405 | 1 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 4.031135e-03 | 2.395 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 4.476700e-03 | 2.349 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 5.084675e-03 | 2.294 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 5.469547e-03 | 2.262 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 5.345258e-03 | 2.272 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 5.790349e-03 | 2.237 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 6.488871e-03 | 2.188 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 6.566622e-03 | 2.183 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 6.753933e-03 | 2.170 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 7.512409e-03 | 2.124 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 7.623113e-03 | 2.118 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 7.623113e-03 | 2.118 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 8.086656e-03 | 2.092 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 8.819844e-03 | 2.055 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 9.218585e-03 | 2.035 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 9.390317e-03 | 2.027 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 9.450354e-03 | 2.025 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 8.833355e-03 | 2.054 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 8.783795e-03 | 2.056 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 9.218585e-03 | 2.035 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 9.718471e-03 | 2.012 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.012783e-02 | 1.994 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 1.013216e-02 | 1.994 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.020736e-02 | 1.991 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.079043e-02 | 1.967 | 1 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.290044e-02 | 1.889 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.302771e-02 | 1.885 | 1 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.246595e-02 | 1.904 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.317787e-02 | 1.880 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.337006e-02 | 1.874 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 1.359618e-02 | 1.867 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.469037e-02 | 1.833 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.444288e-02 | 1.840 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.547239e-02 | 1.810 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.549259e-02 | 1.810 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 1.686897e-02 | 1.773 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 1.686897e-02 | 1.773 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.734703e-02 | 1.761 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 1.734703e-02 | 1.761 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.769217e-02 | 1.752 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 1.832007e-02 | 1.737 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 1.832007e-02 | 1.737 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 1.832007e-02 | 1.737 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 1.855341e-02 | 1.732 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 2.168739e-02 | 1.664 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 2.168739e-02 | 1.664 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 2.258695e-02 | 1.646 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 2.543516e-02 | 1.595 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 2.507268e-02 | 1.601 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.483422e-02 | 1.605 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 2.588469e-02 | 1.587 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 2.588469e-02 | 1.587 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 2.588469e-02 | 1.587 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 2.628849e-02 | 1.580 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 2.865627e-02 | 1.543 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 2.870435e-02 | 1.542 | 1 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 2.733440e-02 | 1.563 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 3.166173e-02 | 1.499 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 3.224523e-02 | 1.492 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 3.224523e-02 | 1.492 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 3.027049e-02 | 1.519 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 3.090309e-02 | 1.510 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 3.139645e-02 | 1.503 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 3.139645e-02 | 1.503 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 3.224523e-02 | 1.492 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 2.994959e-02 | 1.524 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 3.279296e-02 | 1.484 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 3.279296e-02 | 1.484 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 3.279296e-02 | 1.484 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 3.279296e-02 | 1.484 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 3.572471e-02 | 1.447 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 3.537141e-02 | 1.451 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 3.537141e-02 | 1.451 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 3.426258e-02 | 1.465 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 3.426258e-02 | 1.465 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 3.572471e-02 | 1.447 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 3.606187e-02 | 1.443 | 0 | 0 |
| Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells | R-HSA-210746 | 3.731643e-02 | 1.428 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 3.735444e-02 | 1.428 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 3.756898e-02 | 1.425 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 3.846159e-02 | 1.415 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 4.029366e-02 | 1.395 | 1 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 4.063277e-02 | 1.391 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 4.505560e-02 | 1.346 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 4.133370e-02 | 1.384 | 1 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 4.300148e-02 | 1.367 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 5.132076e-02 | 1.290 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 5.132076e-02 | 1.290 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 5.132076e-02 | 1.290 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 5.132076e-02 | 1.290 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 5.132076e-02 | 1.290 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 5.132076e-02 | 1.290 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 5.122045e-02 | 1.291 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 5.122045e-02 | 1.291 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 5.122045e-02 | 1.291 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 5.122045e-02 | 1.291 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 5.122045e-02 | 1.291 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 5.122045e-02 | 1.291 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 5.122045e-02 | 1.291 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 4.927969e-02 | 1.307 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 4.730287e-02 | 1.325 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 4.730287e-02 | 1.325 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 5.434707e-02 | 1.265 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 4.909276e-02 | 1.309 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 5.587045e-02 | 1.253 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 5.635173e-02 | 1.249 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 5.028228e-02 | 1.299 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 4.826626e-02 | 1.316 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 4.913138e-02 | 1.309 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 5.434707e-02 | 1.265 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 5.434707e-02 | 1.265 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 5.434707e-02 | 1.265 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 5.434707e-02 | 1.265 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 5.434707e-02 | 1.265 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 5.081183e-02 | 1.294 | 1 | 1 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 5.417650e-02 | 1.266 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 5.796953e-02 | 1.237 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 5.881431e-02 | 1.231 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 5.981242e-02 | 1.223 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 6.122255e-02 | 1.213 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 6.122255e-02 | 1.213 | 0 | 0 |
| ARL13B-mediated ciliary trafficking of INPP5E | R-HSA-5624958 | 6.516592e-02 | 1.186 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 6.757708e-02 | 1.170 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 6.757708e-02 | 1.170 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 6.757708e-02 | 1.170 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 7.170209e-02 | 1.144 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 6.534898e-02 | 1.185 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 6.525937e-02 | 1.185 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 6.534898e-02 | 1.185 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 7.292027e-02 | 1.137 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 7.292027e-02 | 1.137 | 1 | 1 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 7.130274e-02 | 1.147 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 6.525937e-02 | 1.185 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 6.757708e-02 | 1.170 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 7.292027e-02 | 1.137 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 6.534898e-02 | 1.185 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 7.311882e-02 | 1.136 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 7.346413e-02 | 1.134 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 7.346413e-02 | 1.134 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 7.346413e-02 | 1.134 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 7.346413e-02 | 1.134 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 7.386712e-02 | 1.132 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 7.386712e-02 | 1.132 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 7.386712e-02 | 1.132 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 7.861320e-02 | 1.105 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 7.931820e-02 | 1.101 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 8.109853e-02 | 1.091 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 8.870412e-02 | 1.052 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 8.870412e-02 | 1.052 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 8.699971e-02 | 1.060 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 8.346603e-02 | 1.078 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 8.346603e-02 | 1.078 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 9.282054e-02 | 1.032 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 8.630115e-02 | 1.064 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 9.364373e-02 | 1.029 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 9.335892e-02 | 1.030 | 1 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 8.630115e-02 | 1.064 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 8.699971e-02 | 1.060 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 8.699971e-02 | 1.060 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 9.501984e-02 | 1.022 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 9.501984e-02 | 1.022 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 9.626876e-02 | 1.017 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 9.787011e-02 | 1.009 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 1.000232e-01 | 1.000 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 1.000232e-01 | 1.000 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 1.000232e-01 | 1.000 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 1.000232e-01 | 1.000 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.009456e-01 | 0.996 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 1.287312e-01 | 0.890 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.287312e-01 | 0.890 | 0 | 0 |
| Deletions in the AXIN1 gene destabilize the destruction complex | R-HSA-5467345 | 1.287312e-01 | 0.890 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 1.287312e-01 | 0.890 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.287312e-01 | 0.890 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 1.060916e-01 | 0.974 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.408971e-01 | 0.618 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.408971e-01 | 0.618 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.408971e-01 | 0.618 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.408971e-01 | 0.618 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 2.408971e-01 | 0.618 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.408971e-01 | 0.618 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 2.408971e-01 | 0.618 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.408971e-01 | 0.618 | 0 | 0 |
| Impaired BRCA2 translocation to the nucleus | R-HSA-9709275 | 2.408971e-01 | 0.618 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 2.408971e-01 | 0.618 | 0 | 0 |
| Impaired BRCA2 binding to SEM1 (DSS1) | R-HSA-9763198 | 2.408971e-01 | 0.618 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.408971e-01 | 0.618 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 1.519744e-01 | 0.818 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.292988e-01 | 0.888 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 1.292988e-01 | 0.888 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 1.292988e-01 | 0.888 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 2.008613e-01 | 0.697 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 2.008613e-01 | 0.697 | 0 | 0 |
| Nef mediated downregulation of CD28 cell surface expression | R-HSA-164939 | 3.386286e-01 | 0.470 | 0 | 0 |
| XAV939 stabilizes AXIN | R-HSA-5545619 | 3.386286e-01 | 0.470 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 3.386286e-01 | 0.470 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5619101 | 3.386286e-01 | 0.470 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 3.386286e-01 | 0.470 | 0 | 0 |
| Intestinal infectious diseases | R-HSA-8942233 | 3.386286e-01 | 0.470 | 0 | 0 |
| Defective SLC9A9 causes autism 16 (AUTS16) | R-HSA-5619052 | 3.386286e-01 | 0.470 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5660686 | 3.386286e-01 | 0.470 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 3.386286e-01 | 0.470 | 0 | 0 |
| Defective VWF binding to collagen type I | R-HSA-9845622 | 3.386286e-01 | 0.470 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 3.386286e-01 | 0.470 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 1.611658e-01 | 0.793 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 2.512192e-01 | 0.600 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 2.512192e-01 | 0.600 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 2.512192e-01 | 0.600 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.950890e-01 | 0.710 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 1.950890e-01 | 0.710 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 1.950890e-01 | 0.710 | 0 | 0 |
| Anchoring fibril formation | R-HSA-2214320 | 1.550846e-01 | 0.809 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 1.550846e-01 | 0.809 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 1.018049e-01 | 0.992 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 1.018049e-01 | 0.992 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 1.018049e-01 | 0.992 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 1.178396e-01 | 0.929 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 1.815157e-01 | 0.741 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 1.815157e-01 | 0.741 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 1.815157e-01 | 0.741 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 1.815157e-01 | 0.741 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 1.815157e-01 | 0.741 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 2.305488e-01 | 0.637 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 2.305488e-01 | 0.637 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 2.305488e-01 | 0.637 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 2.305488e-01 | 0.637 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 3.018599e-01 | 0.520 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 3.018599e-01 | 0.520 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 3.018599e-01 | 0.520 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 3.018599e-01 | 0.520 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 3.018599e-01 | 0.520 | 0 | 0 |
| Defective PAPSS2 causes SEMD-PA | R-HSA-3560796 | 4.237825e-01 | 0.373 | 0 | 0 |
| Glycogen storage disease type IV (GBE1) | R-HSA-3878781 | 4.237825e-01 | 0.373 | 0 | 0 |
| Defective OPLAH causes OPLAHD | R-HSA-5578998 | 4.237825e-01 | 0.373 | 0 | 0 |
| Defective VWF cleavage by ADAMTS13 variant | R-HSA-9845621 | 4.237825e-01 | 0.373 | 0 | 0 |
| Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 | R-HSA-5083633 | 4.237825e-01 | 0.373 | 0 | 0 |
| Enhanced cleavage of VWF variant by ADAMTS13 | R-HSA-9845619 | 4.237825e-01 | 0.373 | 0 | 0 |
| Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 | R-HSA-5083629 | 4.237825e-01 | 0.373 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 1.100918e-01 | 0.958 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 1.350491e-01 | 0.870 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 1.533661e-01 | 0.814 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 2.670560e-01 | 0.573 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 2.670560e-01 | 0.573 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 2.670560e-01 | 0.573 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 1.727124e-01 | 0.763 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 2.381821e-01 | 0.623 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 3.518765e-01 | 0.454 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 3.518765e-01 | 0.454 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.089109e-01 | 0.963 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 1.930007e-01 | 0.714 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 3.041615e-01 | 0.517 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 2.679161e-01 | 0.572 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 2.679161e-01 | 0.572 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.386303e-01 | 0.622 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 1.739214e-01 | 0.760 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 2.122418e-01 | 0.673 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 2.360197e-01 | 0.627 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.982580e-01 | 0.525 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 3.414619e-01 | 0.467 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 3.414619e-01 | 0.467 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 3.414619e-01 | 0.467 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 3.414619e-01 | 0.467 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 4.005907e-01 | 0.397 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 4.005907e-01 | 0.397 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 4.005907e-01 | 0.397 | 0 | 0 |
| Defective GSS causes GSS deficiency | R-HSA-5579006 | 4.979768e-01 | 0.303 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 4.979768e-01 | 0.303 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 4.979768e-01 | 0.303 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 2.319407e-01 | 0.635 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.413515e-01 | 0.850 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.413515e-01 | 0.850 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 2.585468e-01 | 0.587 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.172296e-01 | 0.931 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 2.902133e-01 | 0.537 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 2.816122e-01 | 0.550 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 3.786021e-01 | 0.422 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 3.786021e-01 | 0.422 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 3.786021e-01 | 0.422 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 3.786021e-01 | 0.422 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 3.598543e-01 | 0.444 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 3.598543e-01 | 0.444 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 3.598543e-01 | 0.444 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 4.475090e-01 | 0.349 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 4.475090e-01 | 0.349 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 2.486535e-01 | 0.604 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.582585e-01 | 0.801 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 4.152750e-01 | 0.382 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 4.152750e-01 | 0.382 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 3.157574e-01 | 0.501 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 3.906911e-01 | 0.408 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 3.906911e-01 | 0.408 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 3.906911e-01 | 0.408 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 1.629820e-01 | 0.788 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 2.334672e-01 | 0.632 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 3.375754e-01 | 0.472 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 2.837908e-01 | 0.547 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 4.213046e-01 | 0.375 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 4.213046e-01 | 0.375 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 4.512205e-01 | 0.346 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 4.922864e-01 | 0.308 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 5.626216e-01 | 0.250 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 5.626216e-01 | 0.250 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 5.626216e-01 | 0.250 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 5.626216e-01 | 0.250 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 5.626216e-01 | 0.250 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 5.626216e-01 | 0.250 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 3.346862e-01 | 0.475 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 3.817033e-01 | 0.418 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 3.256483e-01 | 0.487 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 4.515312e-01 | 0.345 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 4.515312e-01 | 0.345 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 4.515312e-01 | 0.345 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 4.515312e-01 | 0.345 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 3.555572e-01 | 0.449 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 3.706159e-01 | 0.431 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 4.862230e-01 | 0.313 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 4.862230e-01 | 0.313 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 4.862230e-01 | 0.313 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 4.862230e-01 | 0.313 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 3.464199e-01 | 0.460 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 3.887408e-01 | 0.410 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 4.507366e-01 | 0.346 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 3.898765e-01 | 0.409 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 3.898765e-01 | 0.409 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 3.625601e-01 | 0.441 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 5.346964e-01 | 0.272 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 5.346964e-01 | 0.272 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 5.346964e-01 | 0.272 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 5.346964e-01 | 0.272 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 4.769775e-01 | 0.322 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 4.769775e-01 | 0.322 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 4.769775e-01 | 0.322 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 5.201078e-01 | 0.284 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 5.201078e-01 | 0.284 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 4.699009e-01 | 0.328 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 4.699009e-01 | 0.328 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 4.668441e-01 | 0.331 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 4.668441e-01 | 0.331 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 5.102660e-01 | 0.292 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 4.640177e-01 | 0.333 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 4.967102e-01 | 0.304 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 4.967102e-01 | 0.304 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 4.967102e-01 | 0.304 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 4.729389e-01 | 0.325 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 5.129324e-01 | 0.290 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 5.129324e-01 | 0.290 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 5.129324e-01 | 0.290 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 5.280848e-01 | 0.277 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 5.280848e-01 | 0.277 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 5.385418e-01 | 0.269 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 5.527381e-01 | 0.257 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 5.527381e-01 | 0.257 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 5.527381e-01 | 0.257 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 5.746065e-01 | 0.241 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 5.746065e-01 | 0.241 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 5.746065e-01 | 0.241 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 5.746065e-01 | 0.241 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 5.746065e-01 | 0.241 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 5.746065e-01 | 0.241 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 6.189454e-01 | 0.208 | 0 | 0 |
| IRS activation | R-HSA-74713 | 6.189454e-01 | 0.208 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 6.189454e-01 | 0.208 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 6.189454e-01 | 0.208 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 6.189454e-01 | 0.208 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 6.189454e-01 | 0.208 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 6.189454e-01 | 0.208 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 5.267247e-01 | 0.278 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 5.267247e-01 | 0.278 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 5.527944e-01 | 0.257 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 5.659650e-01 | 0.247 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 5.659650e-01 | 0.247 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 5.546680e-01 | 0.256 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 5.840105e-01 | 0.234 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 5.840105e-01 | 0.234 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 5.653488e-01 | 0.248 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 5.841034e-01 | 0.234 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 6.119571e-01 | 0.213 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 6.119571e-01 | 0.213 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 6.119571e-01 | 0.213 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 5.947584e-01 | 0.226 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 5.947584e-01 | 0.226 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 5.947584e-01 | 0.226 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 6.204095e-01 | 0.207 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 6.179787e-01 | 0.209 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 6.329265e-01 | 0.199 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 6.379115e-01 | 0.195 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 6.549520e-01 | 0.184 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 6.424689e-01 | 0.192 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 6.467456e-01 | 0.189 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 6.467456e-01 | 0.189 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 6.467456e-01 | 0.189 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 6.467456e-01 | 0.189 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 6.467456e-01 | 0.189 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 6.467456e-01 | 0.189 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 6.680189e-01 | 0.175 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 6.680189e-01 | 0.175 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 6.680189e-01 | 0.175 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 6.680189e-01 | 0.175 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 6.680189e-01 | 0.175 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 6.680189e-01 | 0.175 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 6.680189e-01 | 0.175 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 6.680189e-01 | 0.175 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 6.875844e-01 | 0.163 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 6.875844e-01 | 0.163 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 6.659038e-01 | 0.177 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 6.790125e-01 | 0.168 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 6.790125e-01 | 0.168 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 7.051895e-01 | 0.152 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 6.944262e-01 | 0.158 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 7.088300e-01 | 0.149 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.568133e-01 | 0.805 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 1.013357e-01 | 0.994 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 3.152523e-01 | 0.501 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 2.219449e-01 | 0.654 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.704875e-01 | 0.768 | 1 | 1 |
| Transcription of the HIV genome | R-HSA-167172 | 6.000748e-01 | 0.222 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 6.609855e-01 | 0.180 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 1.191826e-01 | 0.924 | 1 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 1.277544e-01 | 0.894 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 2.197508e-01 | 0.658 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 1.191826e-01 | 0.924 | 1 | 1 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 1.191826e-01 | 0.924 | 1 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 1.622378e-01 | 0.790 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 3.706159e-01 | 0.431 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 3.237144e-01 | 0.490 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 2.158737e-01 | 0.666 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 6.422146e-01 | 0.192 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 2.942063e-01 | 0.531 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 4.152750e-01 | 0.382 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 2.319407e-01 | 0.635 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 6.524230e-01 | 0.185 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 1.249064e-01 | 0.903 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 3.786021e-01 | 0.422 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 3.754524e-01 | 0.425 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 5.027881e-01 | 0.299 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 6.690745e-01 | 0.175 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 5.872956e-01 | 0.231 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 2.673300e-01 | 0.573 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 3.529834e-01 | 0.452 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 6.467456e-01 | 0.189 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 2.092987e-01 | 0.679 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.930007e-01 | 0.714 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.642925e-01 | 0.784 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 2.408204e-01 | 0.618 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 4.254959e-01 | 0.371 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.360197e-01 | 0.627 | 1 | 1 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.360197e-01 | 0.627 | 1 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 6.000748e-01 | 0.222 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 2.670560e-01 | 0.573 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.372682e-01 | 0.862 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 4.069344e-01 | 0.390 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 4.432750e-01 | 0.353 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 7.088300e-01 | 0.149 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 4.464740e-01 | 0.350 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 2.092987e-01 | 0.679 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 4.259880e-01 | 0.371 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 4.432750e-01 | 0.353 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 3.435008e-01 | 0.464 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 2.138557e-01 | 0.670 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 3.041615e-01 | 0.517 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.748776e-01 | 0.757 | 1 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 3.643650e-01 | 0.438 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 4.038642e-01 | 0.394 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 3.442933e-01 | 0.463 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 6.228179e-01 | 0.206 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.588387e-01 | 0.799 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 2.564651e-01 | 0.591 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 4.066146e-01 | 0.391 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 3.906911e-01 | 0.408 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 4.071341e-01 | 0.390 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 6.668994e-01 | 0.176 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 3.289764e-01 | 0.483 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.332903e-01 | 0.875 | 1 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 4.254959e-01 | 0.371 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 3.123254e-01 | 0.505 | 1 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 2.725306e-01 | 0.565 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 1.550846e-01 | 0.809 | 0 | 0 |
| Formation of lateral plate mesoderm | R-HSA-9758920 | 3.018599e-01 | 0.520 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 1.748776e-01 | 0.757 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 3.289764e-01 | 0.483 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 2.080521e-01 | 0.682 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 4.512205e-01 | 0.346 | 1 | 1 |
| Regulation of CDH11 function | R-HSA-9762292 | 5.346964e-01 | 0.272 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 4.236091e-01 | 0.373 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 5.746065e-01 | 0.241 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 7.056465e-01 | 0.151 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.836099e-01 | 0.736 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 1.302523e-01 | 0.885 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 2.319407e-01 | 0.635 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 1.704349e-01 | 0.768 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 5.280848e-01 | 0.277 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 5.527944e-01 | 0.257 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 6.858451e-01 | 0.164 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 2.388796e-01 | 0.622 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 4.971794e-01 | 0.303 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 6.002097e-01 | 0.222 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 4.104638e-01 | 0.387 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 5.280848e-01 | 0.277 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 3.237144e-01 | 0.490 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 2.373009e-01 | 0.625 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 4.071209e-01 | 0.390 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 2.008613e-01 | 0.697 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 2.008613e-01 | 0.697 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 1.250475e-01 | 0.903 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 1.671033e-01 | 0.777 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.406747e-01 | 0.852 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 3.414619e-01 | 0.467 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 4.475090e-01 | 0.349 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 4.152750e-01 | 0.382 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 2.080521e-01 | 0.682 | 0 | 0 |
| PKA activation | R-HSA-163615 | 3.906911e-01 | 0.408 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 3.237144e-01 | 0.490 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 4.922864e-01 | 0.308 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 5.626216e-01 | 0.250 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 5.626216e-01 | 0.250 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 5.027881e-01 | 0.299 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 6.189454e-01 | 0.208 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 6.664827e-01 | 0.176 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 6.680189e-01 | 0.175 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 6.659038e-01 | 0.177 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 6.858451e-01 | 0.164 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 6.790125e-01 | 0.168 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 6.494291e-01 | 0.187 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 2.423128e-01 | 0.616 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 5.198036e-01 | 0.284 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 1.573499e-01 | 0.803 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 3.169636e-01 | 0.499 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 4.244118e-01 | 0.372 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 6.119571e-01 | 0.213 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 6.689653e-01 | 0.175 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 6.689653e-01 | 0.175 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 4.904431e-01 | 0.309 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.013357e-01 | 0.994 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 3.385649e-01 | 0.470 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 3.167178e-01 | 0.499 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 6.467456e-01 | 0.189 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 6.858451e-01 | 0.164 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 4.588962e-01 | 0.338 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 4.565458e-01 | 0.341 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 1.917712e-01 | 0.717 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.716017e-01 | 0.765 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 4.812268e-01 | 0.318 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 5.863051e-01 | 0.232 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 1.750246e-01 | 0.757 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 4.426276e-01 | 0.354 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 6.446434e-01 | 0.191 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 1.076997e-01 | 0.968 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 2.389840e-01 | 0.622 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 4.967102e-01 | 0.304 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.110383e-01 | 0.955 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.235545e-01 | 0.908 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 5.924631e-01 | 0.227 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 3.086942e-01 | 0.510 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 1.519744e-01 | 0.818 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 2.512192e-01 | 0.600 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 1.815157e-01 | 0.741 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 1.815157e-01 | 0.741 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 1.533661e-01 | 0.814 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 1.406747e-01 | 0.852 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 4.512205e-01 | 0.346 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 4.922864e-01 | 0.308 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 4.507366e-01 | 0.346 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 5.346964e-01 | 0.272 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 4.967102e-01 | 0.304 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 6.189454e-01 | 0.208 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 6.189454e-01 | 0.208 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 5.840105e-01 | 0.234 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 6.119571e-01 | 0.213 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 6.228179e-01 | 0.206 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 6.426573e-01 | 0.192 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 6.680189e-01 | 0.175 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 6.690745e-01 | 0.175 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 7.032383e-01 | 0.153 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 6.944262e-01 | 0.158 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 1.747498e-01 | 0.758 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 2.725306e-01 | 0.565 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 4.967102e-01 | 0.304 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 2.399606e-01 | 0.620 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.523638e-01 | 0.817 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 2.645903e-01 | 0.577 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 3.529834e-01 | 0.452 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 6.071856e-01 | 0.217 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 3.595826e-01 | 0.444 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 7.086124e-01 | 0.150 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 4.094285e-01 | 0.388 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 5.924631e-01 | 0.227 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 4.507366e-01 | 0.346 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 5.093113e-01 | 0.293 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 2.008613e-01 | 0.697 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 2.008613e-01 | 0.697 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 3.018599e-01 | 0.520 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 2.670560e-01 | 0.573 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 3.435008e-01 | 0.464 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.157574e-01 | 0.501 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 4.515312e-01 | 0.345 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 5.070437e-01 | 0.295 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 6.138518e-01 | 0.212 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 6.917046e-01 | 0.160 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 5.770181e-01 | 0.239 | 1 | 0 |
| Autophagy | R-HSA-9612973 | 4.441435e-01 | 0.352 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 2.166095e-01 | 0.664 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.402745e-01 | 0.853 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 5.659650e-01 | 0.247 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 6.103959e-01 | 0.214 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 3.058235e-01 | 0.515 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 5.620894e-01 | 0.250 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 2.512192e-01 | 0.600 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 3.237144e-01 | 0.490 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 3.237144e-01 | 0.490 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 4.213046e-01 | 0.375 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 5.840105e-01 | 0.234 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 6.119571e-01 | 0.213 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 6.424689e-01 | 0.192 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 6.659038e-01 | 0.177 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 6.790125e-01 | 0.168 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 7.032383e-01 | 0.153 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 4.494862e-01 | 0.347 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.756853e-01 | 0.755 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 4.922864e-01 | 0.308 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 6.119571e-01 | 0.213 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 5.659650e-01 | 0.247 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 3.771562e-01 | 0.423 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.361639e-01 | 0.866 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 2.743410e-01 | 0.562 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 4.013574e-01 | 0.396 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 5.082409e-01 | 0.294 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 5.712120e-01 | 0.243 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 4.626406e-01 | 0.335 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 6.302572e-01 | 0.200 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 4.673164e-01 | 0.330 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 6.138518e-01 | 0.212 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.406747e-01 | 0.852 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 3.555572e-01 | 0.449 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 2.355525e-01 | 0.628 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 6.479788e-01 | 0.188 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 3.887408e-01 | 0.410 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 5.743578e-01 | 0.241 | 1 | 0 |
| Signal Transduction | R-HSA-162582 | 6.183793e-01 | 0.209 | 1 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 2.408971e-01 | 0.618 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 3.386286e-01 | 0.470 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.072535e-01 | 0.970 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 4.237825e-01 | 0.373 | 0 | 0 |
| tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis | R-HSA-9708296 | 4.237825e-01 | 0.373 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 4.237825e-01 | 0.373 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 4.237825e-01 | 0.373 | 0 | 0 |
| TGFBR3 regulates activin signaling | R-HSA-9839406 | 4.237825e-01 | 0.373 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 4.005907e-01 | 0.397 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 4.979768e-01 | 0.303 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 2.012481e-01 | 0.696 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 3.786021e-01 | 0.422 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 4.475090e-01 | 0.349 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 4.475090e-01 | 0.349 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 4.152750e-01 | 0.382 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 3.906911e-01 | 0.408 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 3.906911e-01 | 0.408 | 0 | 0 |
| Alanine metabolism | R-HSA-8964540 | 5.626216e-01 | 0.250 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 4.013574e-01 | 0.396 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 4.515312e-01 | 0.345 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 5.201078e-01 | 0.284 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 5.201078e-01 | 0.284 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 3.897200e-01 | 0.409 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 5.746065e-01 | 0.241 | 0 | 0 |
| Trafficking of myristoylated proteins to the cilium | R-HSA-5624138 | 6.189454e-01 | 0.208 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 6.189454e-01 | 0.208 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 5.258600e-01 | 0.279 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 5.840105e-01 | 0.234 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 5.840105e-01 | 0.234 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 6.119571e-01 | 0.213 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 6.680189e-01 | 0.175 | 0 | 0 |
| Sensory perception of salty taste | R-HSA-9730628 | 6.680189e-01 | 0.175 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 6.790125e-01 | 0.168 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 5.380165e-01 | 0.269 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 6.388209e-01 | 0.195 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 6.388209e-01 | 0.195 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.277544e-01 | 0.894 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 4.309162e-01 | 0.366 | 1 | 0 |
| Gastrulation | R-HSA-9758941 | 6.124545e-01 | 0.213 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 2.339747e-01 | 0.631 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 6.138518e-01 | 0.212 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 2.555164e-01 | 0.593 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.523638e-01 | 0.817 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 4.512205e-01 | 0.346 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.754066e-01 | 0.756 | 1 | 1 |
| Regulation of beta-cell development | R-HSA-186712 | 2.197508e-01 | 0.658 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 5.757396e-01 | 0.240 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 6.944262e-01 | 0.158 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 5.615588e-01 | 0.251 | 1 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 4.507366e-01 | 0.346 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 7.074033e-01 | 0.150 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 4.793852e-01 | 0.319 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 4.922864e-01 | 0.308 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 4.812268e-01 | 0.318 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 5.346964e-01 | 0.272 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 5.099818e-01 | 0.292 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 6.179787e-01 | 0.209 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 6.656589e-01 | 0.177 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 6.690745e-01 | 0.175 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 6.944262e-01 | 0.158 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 6.875844e-01 | 0.163 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 6.179787e-01 | 0.209 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 7.051895e-01 | 0.152 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 4.915540e-01 | 0.308 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 3.414619e-01 | 0.467 | 0 | 0 |
| Inhibition of nitric oxide production | R-HSA-9636249 | 1.519744e-01 | 0.818 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 1.950890e-01 | 0.710 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 3.018599e-01 | 0.520 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 3.041615e-01 | 0.517 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 4.005907e-01 | 0.397 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 4.512205e-01 | 0.346 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 4.922864e-01 | 0.308 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 6.944262e-01 | 0.158 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 6.944262e-01 | 0.158 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.863732e-01 | 0.730 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 4.241592e-01 | 0.372 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 3.237144e-01 | 0.490 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 4.668441e-01 | 0.331 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 4.769775e-01 | 0.322 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 5.280848e-01 | 0.277 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 3.051099e-01 | 0.516 | 1 | 0 |
| Base Excision Repair | R-HSA-73884 | 3.915862e-01 | 0.407 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 2.679161e-01 | 0.572 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 4.013574e-01 | 0.396 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 2.851918e-01 | 0.545 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 5.659650e-01 | 0.247 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 7.032383e-01 | 0.153 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 4.259880e-01 | 0.371 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 3.167178e-01 | 0.499 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 1.210930e-01 | 0.917 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 3.298489e-01 | 0.482 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 3.386286e-01 | 0.470 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 2.512192e-01 | 0.600 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 1.533661e-01 | 0.814 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 3.289764e-01 | 0.483 | 0 | 0 |
| SLC-mediated bile acid transport | R-HSA-9958517 | 4.475090e-01 | 0.349 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 4.512205e-01 | 0.346 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 5.626216e-01 | 0.250 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 5.346964e-01 | 0.272 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 4.793852e-01 | 0.319 | 0 | 0 |
| Utilization of Ketone Bodies | R-HSA-77108 | 5.746065e-01 | 0.241 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 5.746065e-01 | 0.241 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 6.138518e-01 | 0.212 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 1.863732e-01 | 0.730 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 6.900232e-01 | 0.161 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 6.696127e-01 | 0.174 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 5.247577e-01 | 0.280 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 5.915990e-01 | 0.228 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.950890e-01 | 0.710 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.292408e-01 | 0.889 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 5.346964e-01 | 0.272 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 6.944262e-01 | 0.158 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 6.177948e-01 | 0.209 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 2.548646e-01 | 0.594 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 3.726727e-01 | 0.429 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 5.746065e-01 | 0.241 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 6.138518e-01 | 0.212 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 2.141365e-01 | 0.669 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 3.419429e-01 | 0.466 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 4.862230e-01 | 0.313 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 5.149711e-01 | 0.288 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 5.149711e-01 | 0.288 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 2.564651e-01 | 0.591 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.089109e-01 | 0.963 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 2.512192e-01 | 0.600 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.323300e-01 | 0.878 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 4.005907e-01 | 0.397 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 4.922864e-01 | 0.308 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 4.038642e-01 | 0.394 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 5.102660e-01 | 0.292 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 6.467456e-01 | 0.189 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 6.854126e-01 | 0.164 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 6.790125e-01 | 0.168 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 7.088300e-01 | 0.149 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 6.854126e-01 | 0.164 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 7.074874e-01 | 0.150 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 2.741391e-01 | 0.562 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 4.967102e-01 | 0.304 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 3.169756e-01 | 0.499 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 6.467456e-01 | 0.189 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 6.656589e-01 | 0.177 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 7.051895e-01 | 0.152 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 3.169756e-01 | 0.499 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 7.051895e-01 | 0.152 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 2.512192e-01 | 0.600 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 2.166095e-01 | 0.664 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 6.680189e-01 | 0.175 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 7.088300e-01 | 0.149 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 4.448797e-01 | 0.352 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 2.381821e-01 | 0.623 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 7.041871e-01 | 0.152 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 5.746065e-01 | 0.241 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 5.149711e-01 | 0.288 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 6.680189e-01 | 0.175 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 6.138518e-01 | 0.212 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 3.887408e-01 | 0.410 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 6.189454e-01 | 0.208 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 7.088300e-01 | 0.149 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 6.790125e-01 | 0.168 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 6.790125e-01 | 0.168 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 7.088300e-01 | 0.149 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 4.967102e-01 | 0.304 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 6.138518e-01 | 0.212 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 7.095443e-01 | 0.149 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 7.095443e-01 | 0.149 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 7.095443e-01 | 0.149 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 7.095443e-01 | 0.149 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 7.102362e-01 | 0.149 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 7.107750e-01 | 0.148 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 7.107750e-01 | 0.148 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 7.107750e-01 | 0.148 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 7.107750e-01 | 0.148 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 7.107750e-01 | 0.148 | 0 | 0 |
| Metabolism of ingested MeSeO2H into MeSeH | R-HSA-5263617 | 7.107750e-01 | 0.148 | 0 | 0 |
| Defective CHST14 causes EDS, musculocontractural type | R-HSA-3595174 | 7.107750e-01 | 0.148 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 7.107750e-01 | 0.148 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 7.107750e-01 | 0.148 | 0 | 0 |
| Intracellular metabolism of fatty acids regulates insulin secretion | R-HSA-434313 | 7.107750e-01 | 0.148 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 7.107750e-01 | 0.148 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 7.107750e-01 | 0.148 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 7.107750e-01 | 0.148 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 7.107750e-01 | 0.148 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 7.107750e-01 | 0.148 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 7.150925e-01 | 0.146 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 7.182804e-01 | 0.144 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 7.182804e-01 | 0.144 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 7.182804e-01 | 0.144 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 7.182804e-01 | 0.144 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 7.182804e-01 | 0.144 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 7.182804e-01 | 0.144 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 7.182804e-01 | 0.144 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 7.182804e-01 | 0.144 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 7.187367e-01 | 0.143 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 7.187367e-01 | 0.143 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 7.187367e-01 | 0.143 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 7.236861e-01 | 0.140 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 7.270296e-01 | 0.138 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 7.297432e-01 | 0.137 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 7.323113e-01 | 0.135 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 7.327466e-01 | 0.135 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 7.328628e-01 | 0.135 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 7.341460e-01 | 0.134 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 7.341460e-01 | 0.134 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 7.341460e-01 | 0.134 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 7.352782e-01 | 0.134 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 7.362617e-01 | 0.133 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 7.362940e-01 | 0.133 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 7.362940e-01 | 0.133 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 7.362940e-01 | 0.133 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 7.362940e-01 | 0.133 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 7.362940e-01 | 0.133 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 7.362940e-01 | 0.133 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 7.362940e-01 | 0.133 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 7.362940e-01 | 0.133 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 7.362940e-01 | 0.133 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 7.362940e-01 | 0.133 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 7.362940e-01 | 0.133 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 7.362940e-01 | 0.133 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 7.362940e-01 | 0.133 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 7.367985e-01 | 0.133 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 7.367985e-01 | 0.133 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 7.367985e-01 | 0.133 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 7.406523e-01 | 0.130 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 7.406617e-01 | 0.130 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 7.406617e-01 | 0.130 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 7.450250e-01 | 0.128 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 7.467655e-01 | 0.127 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 7.467655e-01 | 0.127 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 7.467655e-01 | 0.127 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 7.480267e-01 | 0.126 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 7.480267e-01 | 0.126 | 0 | 0 |
| Glycoprotein hormones | R-HSA-209822 | 7.480267e-01 | 0.126 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 7.480267e-01 | 0.126 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 7.480267e-01 | 0.126 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 7.480267e-01 | 0.126 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 7.480267e-01 | 0.126 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 7.480267e-01 | 0.126 | 1 | 1 |
| Cysteine formation from homocysteine | R-HSA-1614603 | 7.480267e-01 | 0.126 | 0 | 0 |
| DAG1 core M1 glycosylations | R-HSA-8932506 | 7.480267e-01 | 0.126 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 7.480267e-01 | 0.126 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 7.480267e-01 | 0.126 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 7.480267e-01 | 0.126 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 7.488705e-01 | 0.126 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 7.489581e-01 | 0.126 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 7.525289e-01 | 0.123 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 7.570616e-01 | 0.121 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 7.576294e-01 | 0.121 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 7.584059e-01 | 0.120 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 7.591392e-01 | 0.120 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 7.593771e-01 | 0.120 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 7.602630e-01 | 0.119 | 1 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 7.615158e-01 | 0.118 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 7.615158e-01 | 0.118 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 7.615158e-01 | 0.118 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 7.615158e-01 | 0.118 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 7.615158e-01 | 0.118 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 7.615158e-01 | 0.118 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 7.615158e-01 | 0.118 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 7.616052e-01 | 0.118 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 7.616052e-01 | 0.118 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 7.616052e-01 | 0.118 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 7.631737e-01 | 0.117 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 7.669423e-01 | 0.115 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 7.669423e-01 | 0.115 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 7.675628e-01 | 0.115 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 7.688864e-01 | 0.114 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 7.732402e-01 | 0.112 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 7.741102e-01 | 0.111 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 7.741102e-01 | 0.111 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 7.767955e-01 | 0.110 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 7.804823e-01 | 0.108 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 7.804823e-01 | 0.108 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 7.804823e-01 | 0.108 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 7.804823e-01 | 0.108 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 7.804823e-01 | 0.108 | 0 | 0 |
| DAG1 core M2 glycosylations | R-HSA-8932504 | 7.804823e-01 | 0.108 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 7.804823e-01 | 0.108 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 7.804823e-01 | 0.108 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 7.811549e-01 | 0.107 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 7.811549e-01 | 0.107 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 7.811549e-01 | 0.107 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 7.813278e-01 | 0.107 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 7.839802e-01 | 0.106 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 7.839802e-01 | 0.106 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 7.846174e-01 | 0.105 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 7.846174e-01 | 0.105 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 7.846174e-01 | 0.105 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 7.846174e-01 | 0.105 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 7.856999e-01 | 0.105 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 7.874453e-01 | 0.104 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 7.874453e-01 | 0.104 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 7.892601e-01 | 0.103 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 7.898290e-01 | 0.102 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 7.917196e-01 | 0.101 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 7.942250e-01 | 0.100 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 7.967250e-01 | 0.099 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 7.975163e-01 | 0.098 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 7.986253e-01 | 0.098 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 7.993614e-01 | 0.097 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 7.993614e-01 | 0.097 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 8.000108e-01 | 0.097 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 8.046762e-01 | 0.094 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 8.052508e-01 | 0.094 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 8.057264e-01 | 0.094 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 8.057264e-01 | 0.094 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 8.057264e-01 | 0.094 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 8.057264e-01 | 0.094 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 8.058318e-01 | 0.094 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 8.058318e-01 | 0.094 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 8.082261e-01 | 0.092 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 8.085647e-01 | 0.092 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 8.085647e-01 | 0.092 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 8.087591e-01 | 0.092 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 8.087591e-01 | 0.092 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 8.087591e-01 | 0.092 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 8.087591e-01 | 0.092 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 8.087591e-01 | 0.092 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 8.087591e-01 | 0.092 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 8.087591e-01 | 0.092 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 8.087591e-01 | 0.092 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 8.087591e-01 | 0.092 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 8.087591e-01 | 0.092 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 8.087591e-01 | 0.092 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 8.087591e-01 | 0.092 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 8.087591e-01 | 0.092 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 8.087591e-01 | 0.092 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 8.125904e-01 | 0.090 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 8.126586e-01 | 0.090 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 8.150644e-01 | 0.089 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 8.162804e-01 | 0.088 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 8.162804e-01 | 0.088 | 0 | 0 |
| Attachment of bacteria to epithelial cells | R-HSA-9638630 | 8.162804e-01 | 0.088 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 8.162804e-01 | 0.088 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 8.171663e-01 | 0.088 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 8.171663e-01 | 0.088 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 8.171663e-01 | 0.088 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 8.174862e-01 | 0.088 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 8.174862e-01 | 0.088 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 8.174862e-01 | 0.088 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 8.200282e-01 | 0.086 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 8.209045e-01 | 0.086 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 8.230392e-01 | 0.085 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 8.249728e-01 | 0.084 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 8.249728e-01 | 0.084 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 8.270665e-01 | 0.082 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 8.288176e-01 | 0.082 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 8.299640e-01 | 0.081 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 8.319712e-01 | 0.080 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 8.319712e-01 | 0.080 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 8.319712e-01 | 0.080 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 8.319712e-01 | 0.080 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 8.323491e-01 | 0.080 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 8.326052e-01 | 0.080 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 8.333949e-01 | 0.079 | 0 | 0 |
| Peptide hormone biosynthesis | R-HSA-209952 | 8.333949e-01 | 0.079 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 8.333949e-01 | 0.079 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 8.333949e-01 | 0.079 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 8.333949e-01 | 0.079 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 8.333949e-01 | 0.079 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 8.333949e-01 | 0.079 | 0 | 0 |
| Arachidonate production from DAG | R-HSA-426048 | 8.333949e-01 | 0.079 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 8.333949e-01 | 0.079 | 0 | 0 |
| Sperm Motility And Taxes | R-HSA-1300642 | 8.333949e-01 | 0.079 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 8.333949e-01 | 0.079 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 8.333949e-01 | 0.079 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 8.362522e-01 | 0.078 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 8.390889e-01 | 0.076 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 8.404498e-01 | 0.075 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 8.404498e-01 | 0.075 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 8.408944e-01 | 0.075 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 8.424860e-01 | 0.074 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 8.424860e-01 | 0.074 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 8.424860e-01 | 0.074 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 8.424860e-01 | 0.074 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 8.424860e-01 | 0.074 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 8.424860e-01 | 0.074 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 8.424860e-01 | 0.074 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 8.450176e-01 | 0.073 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 8.460914e-01 | 0.073 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 8.464873e-01 | 0.072 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 8.464953e-01 | 0.072 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 8.464953e-01 | 0.072 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 8.464953e-01 | 0.072 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 8.464953e-01 | 0.072 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 8.495540e-01 | 0.071 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 8.499510e-01 | 0.071 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 8.541601e-01 | 0.068 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 8.541601e-01 | 0.068 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 8.547109e-01 | 0.068 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 8.547109e-01 | 0.068 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 8.547109e-01 | 0.068 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 8.547109e-01 | 0.068 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 8.548583e-01 | 0.068 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 8.548583e-01 | 0.068 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 8.548583e-01 | 0.068 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 8.548583e-01 | 0.068 | 0 | 0 |
| Hormone ligand-binding receptors | R-HSA-375281 | 8.548583e-01 | 0.068 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 8.548583e-01 | 0.068 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 8.548583e-01 | 0.068 | 0 | 0 |
| DAG1 core M3 glycosylations | R-HSA-8932505 | 8.548583e-01 | 0.068 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 8.548583e-01 | 0.068 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 8.548583e-01 | 0.068 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 8.548583e-01 | 0.068 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 8.548583e-01 | 0.068 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 8.562015e-01 | 0.067 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 8.583931e-01 | 0.066 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 8.583931e-01 | 0.066 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 8.583931e-01 | 0.066 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 8.583931e-01 | 0.066 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 8.583931e-01 | 0.066 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 8.599152e-01 | 0.066 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 8.640259e-01 | 0.063 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 8.640259e-01 | 0.063 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 8.640259e-01 | 0.063 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 8.640259e-01 | 0.063 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 8.662135e-01 | 0.062 | 0 | 0 |
| Depurination | R-HSA-73927 | 8.662135e-01 | 0.062 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 8.678386e-01 | 0.062 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 8.682121e-01 | 0.061 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 8.728172e-01 | 0.059 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 8.728172e-01 | 0.059 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 8.733308e-01 | 0.059 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 8.733820e-01 | 0.059 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 8.735577e-01 | 0.059 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 8.735577e-01 | 0.059 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 8.735577e-01 | 0.059 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 8.735577e-01 | 0.059 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 8.735577e-01 | 0.059 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 8.735577e-01 | 0.059 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 8.735577e-01 | 0.059 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 8.735577e-01 | 0.059 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 8.735577e-01 | 0.059 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 8.735577e-01 | 0.059 | 0 | 0 |
| DS-GAG biosynthesis | R-HSA-2022923 | 8.735577e-01 | 0.059 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 8.740246e-01 | 0.058 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 8.740246e-01 | 0.058 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 8.741289e-01 | 0.058 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 8.768946e-01 | 0.057 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 8.769249e-01 | 0.057 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 8.769249e-01 | 0.057 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 8.769249e-01 | 0.057 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 8.769249e-01 | 0.057 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 8.769249e-01 | 0.057 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 8.836944e-01 | 0.054 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 8.836944e-01 | 0.054 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 8.836944e-01 | 0.054 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 8.836944e-01 | 0.054 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 8.836944e-01 | 0.054 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 8.858763e-01 | 0.053 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 8.858763e-01 | 0.053 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 8.862889e-01 | 0.052 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 8.868851e-01 | 0.052 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 8.868851e-01 | 0.052 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 8.868851e-01 | 0.052 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 8.868851e-01 | 0.052 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 8.874065e-01 | 0.052 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 8.898489e-01 | 0.051 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 8.898489e-01 | 0.051 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 8.898489e-01 | 0.051 | 0 | 0 |
| Beta oxidation of palmitoyl-CoA to myristoyl-CoA | R-HSA-77305 | 8.898489e-01 | 0.051 | 0 | 0 |
| Beta oxidation of myristoyl-CoA to lauroyl-CoA | R-HSA-77285 | 8.898489e-01 | 0.051 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.898489e-01 | 0.051 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 8.898489e-01 | 0.051 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 8.898489e-01 | 0.051 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 8.898489e-01 | 0.051 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 8.898489e-01 | 0.051 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 8.898489e-01 | 0.051 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 8.904367e-01 | 0.050 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 8.945927e-01 | 0.048 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 8.955109e-01 | 0.048 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 8.958984e-01 | 0.048 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 8.961338e-01 | 0.048 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 8.976826e-01 | 0.047 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 8.976826e-01 | 0.047 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 8.976826e-01 | 0.047 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 8.983003e-01 | 0.047 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 8.983003e-01 | 0.047 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 9.038039e-01 | 0.044 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 9.038039e-01 | 0.044 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 9.038039e-01 | 0.044 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 9.038039e-01 | 0.044 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 9.039028e-01 | 0.044 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 9.040420e-01 | 0.044 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 9.040420e-01 | 0.044 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 9.040420e-01 | 0.044 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 9.040420e-01 | 0.044 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 9.040420e-01 | 0.044 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 9.040420e-01 | 0.044 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 9.040420e-01 | 0.044 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 9.047104e-01 | 0.043 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 9.047104e-01 | 0.043 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.047104e-01 | 0.043 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 9.047104e-01 | 0.043 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 9.049967e-01 | 0.043 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.054965e-01 | 0.043 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 9.075526e-01 | 0.042 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.083421e-01 | 0.042 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 9.083421e-01 | 0.042 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.083421e-01 | 0.042 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.083421e-01 | 0.042 | 0 | 0 |
| Ketone body metabolism | R-HSA-74182 | 9.083421e-01 | 0.042 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 9.089924e-01 | 0.041 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 9.108187e-01 | 0.041 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.109687e-01 | 0.040 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 9.111130e-01 | 0.040 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 9.123326e-01 | 0.040 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.123326e-01 | 0.040 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 9.126311e-01 | 0.040 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.126311e-01 | 0.040 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 9.138585e-01 | 0.039 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.151161e-01 | 0.039 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 9.151161e-01 | 0.039 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 9.151161e-01 | 0.039 | 1 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 9.164069e-01 | 0.038 | 0 | 0 |
| Synthesis of IPs in the nucleus | R-HSA-1855191 | 9.164069e-01 | 0.038 | 0 | 0 |
| Beta oxidation of hexanoyl-CoA to butanoyl-CoA | R-HSA-77350 | 9.164069e-01 | 0.038 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 9.164069e-01 | 0.038 | 0 | 0 |
| Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA | R-HSA-77310 | 9.164069e-01 | 0.038 | 0 | 0 |
| Beta oxidation of octanoyl-CoA to hexanoyl-CoA | R-HSA-77348 | 9.164069e-01 | 0.038 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 9.164069e-01 | 0.038 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 9.164069e-01 | 0.038 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 9.164069e-01 | 0.038 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 9.177305e-01 | 0.037 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 9.179543e-01 | 0.037 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 9.179543e-01 | 0.037 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 9.179543e-01 | 0.037 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.179543e-01 | 0.037 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.179543e-01 | 0.037 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.179543e-01 | 0.037 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.179543e-01 | 0.037 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 9.179915e-01 | 0.037 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.200007e-01 | 0.036 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 9.205950e-01 | 0.036 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 9.205950e-01 | 0.036 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 9.207152e-01 | 0.036 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 9.207152e-01 | 0.036 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.207152e-01 | 0.036 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 9.207152e-01 | 0.036 | 1 | 1 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 9.217513e-01 | 0.035 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 9.217513e-01 | 0.035 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 9.247249e-01 | 0.034 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 9.253672e-01 | 0.034 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 9.257741e-01 | 0.033 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.266119e-01 | 0.033 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 9.266119e-01 | 0.033 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.266119e-01 | 0.033 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 9.266119e-01 | 0.033 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.267889e-01 | 0.033 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.267889e-01 | 0.033 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 9.271792e-01 | 0.033 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 9.271792e-01 | 0.033 | 0 | 0 |
| Transport and metabolism of PAPS | R-HSA-174362 | 9.271792e-01 | 0.033 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 9.271792e-01 | 0.033 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 9.271792e-01 | 0.033 | 0 | 0 |
| FASTK family proteins regulate processing and stability of mitochondrial RNAs | R-HSA-9837092 | 9.271792e-01 | 0.033 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 9.271792e-01 | 0.033 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 9.271792e-01 | 0.033 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 9.271792e-01 | 0.033 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 9.271792e-01 | 0.033 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 9.271792e-01 | 0.033 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.281096e-01 | 0.032 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 9.282916e-01 | 0.032 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 9.303233e-01 | 0.031 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.329249e-01 | 0.030 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 9.330533e-01 | 0.030 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.330533e-01 | 0.030 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 9.332122e-01 | 0.030 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 9.332122e-01 | 0.030 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 9.344014e-01 | 0.029 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 9.344014e-01 | 0.029 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 9.348653e-01 | 0.029 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.348653e-01 | 0.029 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 9.365638e-01 | 0.028 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 9.365638e-01 | 0.028 | 0 | 0 |
| Mineralocorticoid biosynthesis | R-HSA-193993 | 9.365638e-01 | 0.028 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 9.365638e-01 | 0.028 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 9.388280e-01 | 0.027 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 9.388280e-01 | 0.027 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 9.390933e-01 | 0.027 | 1 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 9.398089e-01 | 0.027 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 9.398089e-01 | 0.027 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.401883e-01 | 0.027 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.401883e-01 | 0.027 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.410305e-01 | 0.026 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.410305e-01 | 0.026 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.410305e-01 | 0.026 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 9.410660e-01 | 0.026 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 9.414026e-01 | 0.026 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 9.414026e-01 | 0.026 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 9.414026e-01 | 0.026 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 9.414026e-01 | 0.026 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.414026e-01 | 0.026 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.414026e-01 | 0.026 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.414026e-01 | 0.026 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 9.436773e-01 | 0.025 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 9.436773e-01 | 0.025 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 9.441457e-01 | 0.025 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 9.447395e-01 | 0.025 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 9.447395e-01 | 0.025 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 9.447395e-01 | 0.025 | 0 | 0 |
| mitochondrial fatty acid beta-oxidation of unsaturated fatty acids | R-HSA-77288 | 9.447395e-01 | 0.025 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 9.447395e-01 | 0.025 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 9.447395e-01 | 0.025 | 0 | 0 |
| Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA | R-HSA-77346 | 9.447395e-01 | 0.025 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 9.447395e-01 | 0.025 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 9.447395e-01 | 0.025 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 9.447395e-01 | 0.025 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 9.447395e-01 | 0.025 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 9.449707e-01 | 0.025 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 9.466509e-01 | 0.024 | 0 | 0 |
| Biofilm formation | R-HSA-9931953 | 9.466509e-01 | 0.024 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.466509e-01 | 0.024 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.471335e-01 | 0.024 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 9.476894e-01 | 0.023 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 9.476894e-01 | 0.023 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.476894e-01 | 0.023 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 9.476894e-01 | 0.023 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 9.476894e-01 | 0.023 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.476894e-01 | 0.023 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.476894e-01 | 0.023 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.506607e-01 | 0.022 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.517694e-01 | 0.021 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 9.518619e-01 | 0.021 | 0 | 0 |
| Sulfide oxidation to sulfate | R-HSA-1614517 | 9.518619e-01 | 0.021 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 9.518619e-01 | 0.021 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 9.518619e-01 | 0.021 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 9.518619e-01 | 0.021 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 9.518619e-01 | 0.021 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.525506e-01 | 0.021 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 9.531378e-01 | 0.021 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 9.533295e-01 | 0.021 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.533295e-01 | 0.021 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 9.533295e-01 | 0.021 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 9.533295e-01 | 0.021 | 1 | 1 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 9.533295e-01 | 0.021 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 9.535333e-01 | 0.021 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.559096e-01 | 0.020 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 9.570808e-01 | 0.019 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 9.576995e-01 | 0.019 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 9.580667e-01 | 0.019 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 9.580667e-01 | 0.019 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.580667e-01 | 0.019 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.580667e-01 | 0.019 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 9.580667e-01 | 0.019 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 9.583851e-01 | 0.018 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.601936e-01 | 0.018 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 9.603664e-01 | 0.018 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.604614e-01 | 0.018 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 9.610555e-01 | 0.017 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.614474e-01 | 0.017 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.629133e-01 | 0.016 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 9.634720e-01 | 0.016 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 9.634720e-01 | 0.016 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.634720e-01 | 0.016 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 9.634720e-01 | 0.016 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 9.634720e-01 | 0.016 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 9.634720e-01 | 0.016 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 9.634720e-01 | 0.016 | 0 | 0 |
| Methionine salvage pathway | R-HSA-1237112 | 9.634720e-01 | 0.016 | 0 | 0 |
| HDL remodeling | R-HSA-8964058 | 9.634720e-01 | 0.016 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.634720e-01 | 0.016 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 9.634720e-01 | 0.016 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 9.636516e-01 | 0.016 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.645032e-01 | 0.016 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.645032e-01 | 0.016 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.647458e-01 | 0.016 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.649713e-01 | 0.015 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 9.662692e-01 | 0.015 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.669146e-01 | 0.015 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 9.672516e-01 | 0.014 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 9.673144e-01 | 0.014 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.674132e-01 | 0.014 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.679912e-01 | 0.014 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.679912e-01 | 0.014 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.679912e-01 | 0.014 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 9.681809e-01 | 0.014 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.681809e-01 | 0.014 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 9.681809e-01 | 0.014 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 9.681809e-01 | 0.014 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.681809e-01 | 0.014 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 9.681809e-01 | 0.014 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.697122e-01 | 0.013 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 9.703386e-01 | 0.013 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 9.705902e-01 | 0.013 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.705902e-01 | 0.013 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 9.720784e-01 | 0.012 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 9.722829e-01 | 0.012 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 9.722829e-01 | 0.012 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 9.738294e-01 | 0.012 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.738294e-01 | 0.012 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.738294e-01 | 0.012 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 9.739275e-01 | 0.011 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 9.740338e-01 | 0.011 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.748701e-01 | 0.011 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.758563e-01 | 0.011 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.758563e-01 | 0.011 | 0 | 0 |
| Androgen biosynthesis | R-HSA-193048 | 9.758563e-01 | 0.011 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 9.758563e-01 | 0.011 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.758563e-01 | 0.011 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.759761e-01 | 0.011 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.766114e-01 | 0.010 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.766114e-01 | 0.010 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.767224e-01 | 0.010 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 9.767224e-01 | 0.010 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.777844e-01 | 0.010 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.781770e-01 | 0.010 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 9.783051e-01 | 0.010 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.783739e-01 | 0.009 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.787406e-01 | 0.009 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 9.789693e-01 | 0.009 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 9.789693e-01 | 0.009 | 0 | 0 |
| Reactions specific to the complex N-glycan synthesis pathway | R-HSA-975578 | 9.789693e-01 | 0.009 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 9.789693e-01 | 0.009 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 9.789693e-01 | 0.009 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 9.789693e-01 | 0.009 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.793047e-01 | 0.009 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 9.793047e-01 | 0.009 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.793047e-01 | 0.009 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 9.797716e-01 | 0.009 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.810772e-01 | 0.008 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 9.814417e-01 | 0.008 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 9.814417e-01 | 0.008 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 9.816083e-01 | 0.008 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.816083e-01 | 0.008 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.816083e-01 | 0.008 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.816627e-01 | 0.008 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.816810e-01 | 0.008 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.821696e-01 | 0.008 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.828129e-01 | 0.008 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 9.829745e-01 | 0.007 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.829924e-01 | 0.007 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.836621e-01 | 0.007 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 9.836621e-01 | 0.007 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.838482e-01 | 0.007 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 9.838780e-01 | 0.007 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 9.840432e-01 | 0.007 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 9.840432e-01 | 0.007 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.841916e-01 | 0.007 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 9.847212e-01 | 0.007 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 9.853131e-01 | 0.006 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 9.853131e-01 | 0.006 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 9.853131e-01 | 0.006 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.854922e-01 | 0.006 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.854922e-01 | 0.006 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 9.856885e-01 | 0.006 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 9.861009e-01 | 0.006 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 9.861009e-01 | 0.006 | 0 | 0 |
| Fertilization | R-HSA-1187000 | 9.861009e-01 | 0.006 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.861773e-01 | 0.006 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.862325e-01 | 0.006 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 9.862489e-01 | 0.006 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 9.862808e-01 | 0.006 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.862808e-01 | 0.006 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.865324e-01 | 0.006 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.867600e-01 | 0.006 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.871221e-01 | 0.006 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.878933e-01 | 0.005 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.878933e-01 | 0.005 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.879445e-01 | 0.005 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.880297e-01 | 0.005 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.891009e-01 | 0.005 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 9.892485e-01 | 0.005 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 9.894547e-01 | 0.005 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 9.894547e-01 | 0.005 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.894547e-01 | 0.005 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.895678e-01 | 0.005 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.898640e-01 | 0.004 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 9.898640e-01 | 0.004 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.900947e-01 | 0.004 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 9.900947e-01 | 0.004 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 9.902202e-01 | 0.004 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 9.903012e-01 | 0.004 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.903964e-01 | 0.004 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.903964e-01 | 0.004 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.907422e-01 | 0.004 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.907506e-01 | 0.004 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.908148e-01 | 0.004 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 9.908148e-01 | 0.004 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.908412e-01 | 0.004 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.910121e-01 | 0.004 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.910121e-01 | 0.004 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 9.910121e-01 | 0.004 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.910121e-01 | 0.004 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.910121e-01 | 0.004 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.919996e-01 | 0.003 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 9.919996e-01 | 0.003 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.920197e-01 | 0.003 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.920451e-01 | 0.003 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.926108e-01 | 0.003 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 9.928755e-01 | 0.003 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 9.929268e-01 | 0.003 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.929398e-01 | 0.003 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.930316e-01 | 0.003 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.930316e-01 | 0.003 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.937454e-01 | 0.003 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 9.937454e-01 | 0.003 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.937865e-01 | 0.003 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 9.938085e-01 | 0.003 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.939305e-01 | 0.003 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 9.939305e-01 | 0.003 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.941448e-01 | 0.003 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 9.942582e-01 | 0.003 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 9.943359e-01 | 0.002 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.943359e-01 | 0.002 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.943832e-01 | 0.002 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.944608e-01 | 0.002 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.944608e-01 | 0.002 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.944608e-01 | 0.002 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.947135e-01 | 0.002 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.947135e-01 | 0.002 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.947223e-01 | 0.002 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.948921e-01 | 0.002 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.948937e-01 | 0.002 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.948937e-01 | 0.002 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 9.950934e-01 | 0.002 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.952655e-01 | 0.002 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 9.953956e-01 | 0.002 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.954336e-01 | 0.002 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.954336e-01 | 0.002 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 9.956739e-01 | 0.002 | 1 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.959179e-01 | 0.002 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 9.959896e-01 | 0.002 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.959896e-01 | 0.002 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.959896e-01 | 0.002 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 9.960602e-01 | 0.002 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 9.960811e-01 | 0.002 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.961439e-01 | 0.002 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.961587e-01 | 0.002 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.961587e-01 | 0.002 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.965071e-01 | 0.002 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.965071e-01 | 0.002 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.965071e-01 | 0.002 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.965071e-01 | 0.002 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.965071e-01 | 0.002 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.965071e-01 | 0.002 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.966017e-01 | 0.001 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 9.968777e-01 | 0.001 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 9.968917e-01 | 0.001 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.969578e-01 | 0.001 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 9.969578e-01 | 0.001 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 9.973108e-01 | 0.001 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 9.973423e-01 | 0.001 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.973504e-01 | 0.001 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 9.974596e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.974755e-01 | 0.001 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.974755e-01 | 0.001 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.976811e-01 | 0.001 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.976923e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.976923e-01 | 0.001 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.977030e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.979310e-01 | 0.001 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 9.979902e-01 | 0.001 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.979902e-01 | 0.001 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.980669e-01 | 0.001 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.982496e-01 | 0.001 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.982496e-01 | 0.001 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.982496e-01 | 0.001 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.983078e-01 | 0.001 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.983078e-01 | 0.001 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.983348e-01 | 0.001 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.983790e-01 | 0.001 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 9.984755e-01 | 0.001 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 9.984755e-01 | 0.001 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.984755e-01 | 0.001 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.984755e-01 | 0.001 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.984755e-01 | 0.001 | 0 | 0 |
| N-glycan antennae elongation in the medial/trans-Golgi | R-HSA-975576 | 9.984755e-01 | 0.001 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 9.985331e-01 | 0.001 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.985683e-01 | 0.001 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.985683e-01 | 0.001 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.986220e-01 | 0.001 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.986723e-01 | 0.001 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.986723e-01 | 0.001 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.986723e-01 | 0.001 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.986723e-01 | 0.001 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.986927e-01 | 0.001 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.987109e-01 | 0.001 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.987125e-01 | 0.001 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.987357e-01 | 0.001 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.988220e-01 | 0.001 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 9.988437e-01 | 0.001 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.988437e-01 | 0.001 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.989897e-01 | 0.000 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.989897e-01 | 0.000 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.989927e-01 | 0.000 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.989930e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.990453e-01 | 0.000 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.991230e-01 | 0.000 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.991659e-01 | 0.000 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.992327e-01 | 0.000 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.992362e-01 | 0.000 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.992362e-01 | 0.000 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.992362e-01 | 0.000 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.992362e-01 | 0.000 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.992362e-01 | 0.000 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.992984e-01 | 0.000 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.992984e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.992984e-01 | 0.000 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 9.993231e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.993231e-01 | 0.000 | 0 | 0 |
| mitochondrial fatty acid beta-oxidation of saturated fatty acids | R-HSA-77286 | 9.993348e-01 | 0.000 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.993348e-01 | 0.000 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 9.993348e-01 | 0.000 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 9.993348e-01 | 0.000 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.993349e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.993360e-01 | 0.000 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.993487e-01 | 0.000 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 9.993733e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.993814e-01 | 0.000 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.994206e-01 | 0.000 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.994206e-01 | 0.000 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.994207e-01 | 0.000 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.994207e-01 | 0.000 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.994207e-01 | 0.000 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.994207e-01 | 0.000 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.994734e-01 | 0.000 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.994846e-01 | 0.000 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 9.994955e-01 | 0.000 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 9.995607e-01 | 0.000 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.995607e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.995926e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.996391e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.996391e-01 | 0.000 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.996670e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.997003e-01 | 0.000 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.997099e-01 | 0.000 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.997099e-01 | 0.000 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.997099e-01 | 0.000 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.997454e-01 | 0.000 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.997800e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.997825e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.997825e-01 | 0.000 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.997977e-01 | 0.000 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.997989e-01 | 0.000 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.998084e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.998204e-01 | 0.000 | 0 | 0 |
| Chondroitin sulfate/dermatan sulfate metabolism | R-HSA-1793185 | 9.998332e-01 | 0.000 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.998346e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.998555e-01 | 0.000 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.998601e-01 | 0.000 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.998692e-01 | 0.000 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.998803e-01 | 0.000 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.998959e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.999038e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.999108e-01 | 0.000 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.999165e-01 | 0.000 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.999165e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.999215e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.999215e-01 | 0.000 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.999232e-01 | 0.000 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.999279e-01 | 0.000 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.999326e-01 | 0.000 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.999390e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999489e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999526e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999526e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999545e-01 | 0.000 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 9.999559e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999586e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999629e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.999683e-01 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.999719e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.999746e-01 | 0.000 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.999753e-01 | 0.000 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.999832e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.999841e-01 | 0.000 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.999860e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.999862e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.999895e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999900e-01 | 0.000 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.999903e-01 | 0.000 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.999912e-01 | 0.000 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.999921e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999923e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.999930e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.999941e-01 | 0.000 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.999946e-01 | 0.000 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.999959e-01 | 0.000 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.999967e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999976e-01 | 0.000 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.999977e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999980e-01 | 0.000 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.999982e-01 | 0.000 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.999982e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999989e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999991e-01 | 0.000 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.999992e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999993e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999996e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999996e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999997e-01 | 0.000 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.999997e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999997e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999999e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 1.000000e+00 | 0.000 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 1.000000e+00 | 0.000 | 1 | 0 |
| Respiratory electron transport | R-HSA-611105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 1.000000e+00 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 1.000000e+00 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 1.000000e+00 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 1.000000e+00 | 0.000 | 1 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 1.000000e+00 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 1.000000e+00 | 0.000 | 1 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 1 | 0 |
| Disease | R-HSA-1643685 | 1.000000e+00 | 0.000 | 1 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | -0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | -0.000 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 1.000000e+00 | 0.000 | 1 | 1 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 2.240512e-09 | 8.650 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 3.137028e-09 | 8.503 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 2.757042e-07 | 6.560 | 0 | 0 |
| M Phase | R-HSA-68886 | 4.704734e-07 | 6.327 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.003328e-06 | 5.999 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.441770e-06 | 5.841 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.804695e-06 | 5.744 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 2.054666e-06 | 5.687 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 2.693589e-06 | 5.570 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 3.623499e-06 | 5.441 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 3.558551e-06 | 5.449 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 4.352699e-06 | 5.361 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 4.513049e-06 | 5.346 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 5.812948e-06 | 5.236 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 5.812948e-06 | 5.236 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 6.122997e-06 | 5.213 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 6.736840e-06 | 5.172 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 7.818522e-06 | 5.107 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.008200e-05 | 4.996 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.008200e-05 | 4.996 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.001414e-05 | 4.999 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.273828e-05 | 4.895 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.310605e-05 | 4.883 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.469117e-05 | 4.833 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.609700e-05 | 4.793 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.609700e-05 | 4.793 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.033308e-05 | 4.692 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 2.162423e-05 | 4.665 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 2.234051e-05 | 4.651 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 2.503849e-05 | 4.601 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 2.731996e-05 | 4.564 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 3.241661e-05 | 4.489 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 3.660510e-05 | 4.436 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 4.061883e-05 | 4.391 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 4.847853e-05 | 4.314 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 4.896118e-05 | 4.310 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 5.468124e-05 | 4.262 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 5.404104e-05 | 4.267 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 5.322339e-05 | 4.274 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 6.692894e-05 | 4.174 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 8.225718e-05 | 4.085 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 9.332646e-05 | 4.030 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 9.493928e-05 | 4.023 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.043652e-04 | 3.981 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 1.014587e-04 | 3.994 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.014587e-04 | 3.994 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.043652e-04 | 3.981 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.057351e-04 | 3.976 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.152414e-04 | 3.938 | 1 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.227464e-04 | 3.911 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.428810e-04 | 3.845 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.612367e-04 | 3.793 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.589851e-04 | 3.799 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 1.719617e-04 | 3.765 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 1.927687e-04 | 3.715 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 2.139343e-04 | 3.670 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 2.552624e-04 | 3.593 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 2.621322e-04 | 3.581 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 2.880277e-04 | 3.541 | 1 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 3.991786e-04 | 3.399 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 4.058506e-04 | 3.392 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 4.443046e-04 | 3.352 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 4.743968e-04 | 3.324 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 6.197656e-04 | 3.208 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 6.064008e-04 | 3.217 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 6.064008e-04 | 3.217 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 6.197656e-04 | 3.208 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 5.688572e-04 | 3.245 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 5.714180e-04 | 3.243 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 6.197656e-04 | 3.208 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 6.055441e-04 | 3.218 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 6.474469e-04 | 3.189 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 6.474469e-04 | 3.189 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 6.704851e-04 | 3.174 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 7.311056e-04 | 3.136 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 7.806124e-04 | 3.108 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 8.170185e-04 | 3.088 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 8.334543e-04 | 3.079 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 9.121513e-04 | 3.040 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 9.231184e-04 | 3.035 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 9.263869e-04 | 3.033 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 9.957503e-04 | 3.002 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.148172e-03 | 2.940 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.119059e-03 | 2.951 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.162837e-03 | 2.934 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.156904e-03 | 2.937 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.184393e-03 | 2.927 | 1 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.351985e-03 | 2.869 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.355402e-03 | 2.868 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.365653e-03 | 2.865 | 1 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 1.370457e-03 | 2.863 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 1.432756e-03 | 2.844 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.466772e-03 | 2.834 | 1 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.689173e-03 | 2.772 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 1.854143e-03 | 2.732 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.918269e-03 | 2.717 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.916126e-03 | 2.718 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.854143e-03 | 2.732 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 1.843259e-03 | 2.734 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.837094e-03 | 2.736 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.784331e-03 | 2.749 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.784331e-03 | 2.749 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.962281e-03 | 2.707 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 2.027371e-03 | 2.693 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 2.032977e-03 | 2.692 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 2.087588e-03 | 2.680 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.095541e-03 | 2.679 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 2.172601e-03 | 2.663 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 2.457147e-03 | 2.610 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 2.560892e-03 | 2.592 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 2.454997e-03 | 2.610 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 2.588214e-03 | 2.587 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.703469e-03 | 2.568 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.703469e-03 | 2.568 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.703469e-03 | 2.568 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.703469e-03 | 2.568 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 2.774932e-03 | 2.557 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 2.810587e-03 | 2.551 | 1 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 2.864907e-03 | 2.543 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 3.053612e-03 | 2.515 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 3.156869e-03 | 2.501 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 3.040707e-03 | 2.517 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 3.440854e-03 | 2.463 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 3.440854e-03 | 2.463 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 3.936044e-03 | 2.405 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 4.019003e-03 | 2.396 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 4.019003e-03 | 2.396 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 4.076238e-03 | 2.390 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 4.076238e-03 | 2.390 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 4.098335e-03 | 2.387 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 4.098335e-03 | 2.387 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 5.133641e-03 | 2.290 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 5.133641e-03 | 2.290 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 5.330835e-03 | 2.273 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 5.887182e-03 | 2.230 | 1 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 6.414342e-03 | 2.193 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 6.820326e-03 | 2.166 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 6.870293e-03 | 2.163 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 6.870293e-03 | 2.163 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 6.870293e-03 | 2.163 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 6.870293e-03 | 2.163 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 6.870293e-03 | 2.163 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 6.973406e-03 | 2.157 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 7.212553e-03 | 2.142 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 7.265138e-03 | 2.139 | 1 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 7.576807e-03 | 2.121 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 7.576807e-03 | 2.121 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 7.632340e-03 | 2.117 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 8.224788e-03 | 2.085 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 8.823926e-03 | 2.054 | 1 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 8.391913e-03 | 2.076 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 9.203941e-03 | 2.036 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 9.203941e-03 | 2.036 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 9.203941e-03 | 2.036 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 9.482233e-03 | 2.023 | 1 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 9.499251e-03 | 2.022 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 9.499251e-03 | 2.022 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 9.499251e-03 | 2.022 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 9.499251e-03 | 2.022 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 9.499251e-03 | 2.022 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 9.864995e-03 | 2.006 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 9.864995e-03 | 2.006 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 9.864995e-03 | 2.006 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 9.864995e-03 | 2.006 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 9.864995e-03 | 2.006 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 1.039258e-02 | 1.983 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.151042e-02 | 1.939 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 1.059575e-02 | 1.975 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.154483e-02 | 1.938 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.046922e-02 | 1.980 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.173032e-02 | 1.931 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.061295e-02 | 1.974 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.270742e-02 | 1.896 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 1.270742e-02 | 1.896 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.332004e-02 | 1.875 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 1.380700e-02 | 1.860 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 1.380700e-02 | 1.860 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 1.380700e-02 | 1.860 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 1.380700e-02 | 1.860 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 1.380700e-02 | 1.860 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.380700e-02 | 1.860 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.426086e-02 | 1.846 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 1.563808e-02 | 1.806 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.563808e-02 | 1.806 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.653450e-02 | 1.782 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.737550e-02 | 1.760 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.618412e-02 | 1.791 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.526897e-02 | 1.816 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.624545e-02 | 1.789 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.520329e-02 | 1.818 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.737550e-02 | 1.760 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 1.649161e-02 | 1.783 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.489590e-02 | 1.827 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.697239e-02 | 1.770 | 1 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.618412e-02 | 1.791 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.589429e-02 | 1.799 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.739496e-02 | 1.760 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.766958e-02 | 1.753 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.781434e-02 | 1.749 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.818802e-02 | 1.740 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.818802e-02 | 1.740 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.892357e-02 | 1.723 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.895195e-02 | 1.722 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.904240e-02 | 1.720 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 1.906772e-02 | 1.720 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.927310e-02 | 1.715 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 1.991102e-02 | 1.701 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 2.093602e-02 | 1.679 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 2.101297e-02 | 1.678 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 2.114872e-02 | 1.675 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 2.147475e-02 | 1.668 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.170287e-02 | 1.663 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 2.202627e-02 | 1.657 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 2.212450e-02 | 1.655 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 2.270307e-02 | 1.644 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 2.270307e-02 | 1.644 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 2.474049e-02 | 1.607 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 2.531049e-02 | 1.597 | 1 | 1 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 2.531049e-02 | 1.597 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 2.986353e-02 | 1.525 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.091710e-02 | 1.510 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 2.995626e-02 | 1.524 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 3.067262e-02 | 1.513 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 2.986353e-02 | 1.525 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 3.201772e-02 | 1.495 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 2.811399e-02 | 1.551 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 2.914505e-02 | 1.535 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 3.058406e-02 | 1.515 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 2.811399e-02 | 1.551 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.866345e-02 | 1.543 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 2.752636e-02 | 1.560 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 3.120814e-02 | 1.506 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 3.212870e-02 | 1.493 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 3.274399e-02 | 1.485 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 3.282637e-02 | 1.484 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 3.342178e-02 | 1.476 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 3.364776e-02 | 1.473 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 3.420335e-02 | 1.466 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 3.438413e-02 | 1.464 | 1 | 1 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 3.448250e-02 | 1.462 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 3.457731e-02 | 1.461 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 3.457731e-02 | 1.461 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 3.457731e-02 | 1.461 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 3.488025e-02 | 1.457 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 3.555088e-02 | 1.449 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 3.568150e-02 | 1.448 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 3.583438e-02 | 1.446 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 3.632638e-02 | 1.440 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 3.665781e-02 | 1.436 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 3.784007e-02 | 1.422 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 3.831092e-02 | 1.417 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 3.851394e-02 | 1.414 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 3.857319e-02 | 1.414 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 3.857319e-02 | 1.414 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 3.884370e-02 | 1.411 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 3.884370e-02 | 1.411 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 3.884370e-02 | 1.411 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 3.956478e-02 | 1.403 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 4.108906e-02 | 1.386 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 4.119613e-02 | 1.385 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 4.240401e-02 | 1.373 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 5.338181e-02 | 1.273 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 4.903473e-02 | 1.309 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 5.305162e-02 | 1.275 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 4.463923e-02 | 1.350 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 4.427194e-02 | 1.354 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 5.203939e-02 | 1.284 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 4.963069e-02 | 1.304 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 5.217062e-02 | 1.283 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 4.583900e-02 | 1.339 | 1 | 1 |
| Protein folding | R-HSA-391251 | 4.306243e-02 | 1.366 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 5.338181e-02 | 1.273 | 0 | 0 |
| S Phase | R-HSA-69242 | 4.325984e-02 | 1.364 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 4.273314e-02 | 1.369 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 4.682316e-02 | 1.330 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 4.986061e-02 | 1.302 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 5.179874e-02 | 1.286 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 4.903473e-02 | 1.309 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 5.106947e-02 | 1.292 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 5.305162e-02 | 1.275 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 5.346010e-02 | 1.272 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 5.381351e-02 | 1.269 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 5.660655e-02 | 1.247 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 5.713429e-02 | 1.243 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 5.713429e-02 | 1.243 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 5.820397e-02 | 1.235 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 5.820397e-02 | 1.235 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 5.906735e-02 | 1.229 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 6.027507e-02 | 1.220 | 1 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 6.027507e-02 | 1.220 | 1 | 1 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 6.027507e-02 | 1.220 | 1 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 6.039120e-02 | 1.219 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 6.039120e-02 | 1.219 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 6.039120e-02 | 1.219 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 6.187167e-02 | 1.209 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 6.248939e-02 | 1.204 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 6.252738e-02 | 1.204 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 6.518493e-02 | 1.186 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 6.518493e-02 | 1.186 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 6.584391e-02 | 1.181 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 6.587148e-02 | 1.181 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 6.594098e-02 | 1.181 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 6.822030e-02 | 1.166 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 6.822030e-02 | 1.166 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 6.822030e-02 | 1.166 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 6.877348e-02 | 1.163 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 7.111359e-02 | 1.148 | 0 | 0 |
| Deletions in the AXIN1 gene destabilize the destruction complex | R-HSA-5467345 | 7.112153e-02 | 1.148 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 7.112153e-02 | 1.148 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 7.112153e-02 | 1.148 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 7.331035e-02 | 1.135 | 0 | 0 |
| IRS activation | R-HSA-74713 | 9.519314e-02 | 1.021 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 9.519314e-02 | 1.021 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 7.185406e-02 | 1.144 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 7.185406e-02 | 1.144 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 8.189019e-02 | 1.087 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 7.375515e-02 | 1.132 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 9.081825e-02 | 1.042 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 7.421370e-02 | 1.130 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 7.421370e-02 | 1.130 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 7.421370e-02 | 1.130 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 8.050737e-02 | 1.094 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 8.710013e-02 | 1.060 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 8.621865e-02 | 1.064 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 9.398996e-02 | 1.027 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 8.189019e-02 | 1.087 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 8.351926e-02 | 1.078 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 7.181168e-02 | 1.144 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 7.285583e-02 | 1.138 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 7.185406e-02 | 1.144 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 7.421370e-02 | 1.130 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 9.081825e-02 | 1.042 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 9.257629e-02 | 1.034 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 9.519314e-02 | 1.021 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 9.257629e-02 | 1.034 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 7.375515e-02 | 1.132 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 8.920531e-02 | 1.050 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 8.684631e-02 | 1.061 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 8.428965e-02 | 1.074 | 1 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 7.683849e-02 | 1.114 | 1 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 7.772360e-02 | 1.109 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 8.636824e-02 | 1.064 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 8.205031e-02 | 1.086 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 8.116907e-02 | 1.091 | 1 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 9.257629e-02 | 1.034 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 8.189019e-02 | 1.087 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 7.211630e-02 | 1.142 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 7.407843e-02 | 1.130 | 1 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 8.993476e-02 | 1.046 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 9.398996e-02 | 1.027 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 9.519314e-02 | 1.021 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 9.257629e-02 | 1.034 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 9.212271e-02 | 1.036 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 9.760605e-02 | 1.011 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 9.961170e-02 | 1.002 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.008374e-01 | 0.996 | 0 | 0 |
| Anchoring fibril formation | R-HSA-2214320 | 1.008374e-01 | 0.996 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 1.008374e-01 | 0.996 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 1.008374e-01 | 0.996 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.008374e-01 | 0.996 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.008374e-01 | 0.996 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 1.011739e-01 | 0.995 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 1.020044e-01 | 0.991 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.038322e-01 | 0.984 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 1.038871e-01 | 0.983 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.055351e-01 | 0.977 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 1.086483e-01 | 0.964 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.091137e-01 | 0.962 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.114322e-01 | 0.953 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 1.144320e-01 | 0.941 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 1.157942e-01 | 0.936 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 1.162035e-01 | 0.935 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.162035e-01 | 0.935 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 1.162035e-01 | 0.935 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 1.162035e-01 | 0.935 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 1.164084e-01 | 0.934 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.180152e-01 | 0.928 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 1.186519e-01 | 0.926 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 1.196788e-01 | 0.922 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 1.213599e-01 | 0.916 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 1.270415e-01 | 0.896 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.279567e-01 | 0.893 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 1.282666e-01 | 0.892 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 1.282666e-01 | 0.892 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 1.303809e-01 | 0.885 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.346806e-01 | 0.871 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.371887e-01 | 0.863 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 1.371887e-01 | 0.863 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 1.390948e-01 | 0.857 | 1 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.392372e-01 | 0.856 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 1.412706e-01 | 0.850 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 1.412706e-01 | 0.850 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 1.425443e-01 | 0.846 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.433522e-01 | 0.844 | 0 | 0 |
| Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells | R-HSA-210746 | 1.433522e-01 | 0.844 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.446737e-01 | 0.840 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 1.467596e-01 | 0.833 | 0 | 0 |
| Defective VWF binding to collagen type I | R-HSA-9845622 | 1.985605e-01 | 0.702 | 0 | 0 |
| Defective MMADHC causes MMAHCD | R-HSA-3359473 | 1.985605e-01 | 0.702 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 1.689992e-01 | 0.772 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 1.953336e-01 | 0.709 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 1.492842e-01 | 0.826 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 1.492842e-01 | 0.826 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 1.492842e-01 | 0.826 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 2.221280e-01 | 0.653 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 2.221280e-01 | 0.653 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.668342e-01 | 0.778 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 1.849479e-01 | 0.733 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.849479e-01 | 0.733 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 1.849479e-01 | 0.733 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 2.035453e-01 | 0.691 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.763563e-01 | 0.754 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 1.697807e-01 | 0.770 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 2.129405e-01 | 0.672 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 1.620201e-01 | 0.790 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.643274e-01 | 0.784 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.895553e-01 | 0.722 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.895553e-01 | 0.722 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 2.007036e-01 | 0.697 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 1.831146e-01 | 0.737 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 2.035453e-01 | 0.691 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 1.831146e-01 | 0.737 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 2.142807e-01 | 0.669 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 2.142807e-01 | 0.669 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 1.953336e-01 | 0.709 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 1.668342e-01 | 0.778 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 1.686202e-01 | 0.773 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 1.668342e-01 | 0.778 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 1.680177e-01 | 0.775 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 2.038240e-01 | 0.691 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 2.129937e-01 | 0.672 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 1.668342e-01 | 0.778 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 1.985605e-01 | 0.702 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.492842e-01 | 0.826 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 2.221280e-01 | 0.653 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 2.221280e-01 | 0.653 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 2.035453e-01 | 0.691 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.643274e-01 | 0.784 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.717321e-01 | 0.765 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.576572e-01 | 0.802 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.668342e-01 | 0.778 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 1.887065e-01 | 0.724 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.686202e-01 | 0.773 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 1.786551e-01 | 0.748 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 2.182390e-01 | 0.661 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 2.013556e-01 | 0.696 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 1.643274e-01 | 0.784 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.772835e-01 | 0.751 | 1 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 1.953336e-01 | 0.709 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.544890e-01 | 0.811 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.979963e-01 | 0.703 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 2.221280e-01 | 0.653 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 2.035453e-01 | 0.691 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 2.082092e-01 | 0.682 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.697807e-01 | 0.770 | 1 | 1 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.831146e-01 | 0.737 | 1 | 1 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.831146e-01 | 0.737 | 1 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 1.547712e-01 | 0.810 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.603123e-01 | 0.795 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 2.007036e-01 | 0.697 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 1.763563e-01 | 0.754 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.686212e-01 | 0.773 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 1.897722e-01 | 0.722 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 2.120852e-01 | 0.673 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 1.572670e-01 | 0.803 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 2.174637e-01 | 0.663 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.225484e-01 | 0.653 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 2.225484e-01 | 0.653 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 2.248247e-01 | 0.648 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 2.274585e-01 | 0.643 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 2.274585e-01 | 0.643 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 2.284125e-01 | 0.641 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 2.284125e-01 | 0.641 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 2.284125e-01 | 0.641 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 2.284125e-01 | 0.641 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 2.284125e-01 | 0.641 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 2.284125e-01 | 0.641 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 2.284125e-01 | 0.641 | 1 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 2.292011e-01 | 0.640 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 2.354856e-01 | 0.628 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 2.381650e-01 | 0.623 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 2.418821e-01 | 0.616 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 2.418821e-01 | 0.616 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.418821e-01 | 0.616 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 2.418821e-01 | 0.616 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 2.422717e-01 | 0.616 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 2.422717e-01 | 0.616 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 2.424801e-01 | 0.615 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 2.424801e-01 | 0.615 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 2.555704e-01 | 0.592 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 2.555704e-01 | 0.592 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 2.555704e-01 | 0.592 | 0 | 0 |
| Enhanced cleavage of VWF variant by ADAMTS13 | R-HSA-9845619 | 2.555704e-01 | 0.592 | 0 | 0 |
| Defective VWF cleavage by ADAMTS13 variant | R-HSA-9845621 | 2.555704e-01 | 0.592 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 2.555704e-01 | 0.592 | 0 | 0 |
| Defective MMACHC causes MAHCC | R-HSA-3359474 | 3.085280e-01 | 0.511 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 3.085280e-01 | 0.511 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 3.085280e-01 | 0.511 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 3.085280e-01 | 0.511 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 3.577213e-01 | 0.446 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 3.577213e-01 | 0.446 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 3.577213e-01 | 0.446 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 3.577213e-01 | 0.446 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 3.577213e-01 | 0.446 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 3.577213e-01 | 0.446 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 2.491842e-01 | 0.603 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 2.763294e-01 | 0.559 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 2.763294e-01 | 0.559 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 2.763294e-01 | 0.559 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 2.763294e-01 | 0.559 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 4.034175e-01 | 0.394 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 4.034175e-01 | 0.394 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 4.034175e-01 | 0.394 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 4.034175e-01 | 0.394 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 3.034143e-01 | 0.518 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 3.034143e-01 | 0.518 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 3.034143e-01 | 0.518 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.614744e-01 | 0.583 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 2.614744e-01 | 0.583 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 3.303103e-01 | 0.481 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 3.303103e-01 | 0.481 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 3.303103e-01 | 0.481 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 3.303103e-01 | 0.481 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 3.303103e-01 | 0.481 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 3.303103e-01 | 0.481 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 3.303103e-01 | 0.481 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 3.303103e-01 | 0.481 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 4.458652e-01 | 0.351 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 4.458652e-01 | 0.351 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 4.458652e-01 | 0.351 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 4.458652e-01 | 0.351 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 4.458652e-01 | 0.351 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 4.458652e-01 | 0.351 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 4.458652e-01 | 0.351 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 4.458652e-01 | 0.351 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 2.440994e-01 | 0.612 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 2.440994e-01 | 0.612 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 2.600165e-01 | 0.585 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 2.600165e-01 | 0.585 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 4.852950e-01 | 0.314 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 4.852950e-01 | 0.314 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 4.852950e-01 | 0.314 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 4.852950e-01 | 0.314 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 3.411163e-01 | 0.467 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 4.088450e-01 | 0.388 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 4.088450e-01 | 0.388 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 3.610507e-01 | 0.442 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 3.610507e-01 | 0.442 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 2.719395e-01 | 0.566 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 2.843868e-01 | 0.546 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 2.969549e-01 | 0.527 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 3.583262e-01 | 0.446 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 3.223889e-01 | 0.492 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 3.352227e-01 | 0.475 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 3.044223e-01 | 0.517 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 3.913663e-01 | 0.407 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 3.913663e-01 | 0.407 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 4.826195e-01 | 0.316 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 4.584652e-01 | 0.339 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 4.584652e-01 | 0.339 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 4.772341e-01 | 0.321 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 4.564708e-01 | 0.341 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 4.564708e-01 | 0.341 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 4.564708e-01 | 0.341 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.681296e-01 | 0.330 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 4.007864e-01 | 0.397 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 4.118883e-01 | 0.385 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 3.151722e-01 | 0.501 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 4.564708e-01 | 0.341 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 2.761263e-01 | 0.559 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 3.412684e-01 | 0.467 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 4.772341e-01 | 0.321 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 4.772341e-01 | 0.321 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 3.583262e-01 | 0.446 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 4.564708e-01 | 0.341 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 4.112504e-01 | 0.386 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 2.812567e-01 | 0.551 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 4.681296e-01 | 0.330 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 3.486811e-01 | 0.458 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 2.491842e-01 | 0.603 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 4.403781e-01 | 0.356 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 4.564708e-01 | 0.341 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 3.583262e-01 | 0.446 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 3.824394e-01 | 0.417 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 3.577213e-01 | 0.446 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 3.577213e-01 | 0.446 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 4.034175e-01 | 0.394 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 4.034175e-01 | 0.394 | 1 | 1 |
| NF-kB is activated and signals survival | R-HSA-209560 | 3.034143e-01 | 0.518 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 2.614744e-01 | 0.583 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 3.303103e-01 | 0.481 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 2.682733e-01 | 0.571 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 4.724611e-01 | 0.326 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 3.407894e-01 | 0.468 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 2.701062e-01 | 0.568 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 2.963155e-01 | 0.528 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 4.490266e-01 | 0.348 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 2.676540e-01 | 0.572 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 3.303103e-01 | 0.481 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 4.254057e-01 | 0.371 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 4.034175e-01 | 0.394 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 3.831117e-01 | 0.417 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 3.252521e-01 | 0.488 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 4.586476e-01 | 0.339 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 4.724050e-01 | 0.326 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 2.789468e-01 | 0.554 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 3.248079e-01 | 0.488 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 3.617093e-01 | 0.442 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 4.340415e-01 | 0.362 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 4.826195e-01 | 0.316 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 4.826195e-01 | 0.316 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 2.848885e-01 | 0.545 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 3.034143e-01 | 0.518 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.812567e-01 | 0.551 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 4.088450e-01 | 0.388 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 3.740053e-01 | 0.427 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 2.731270e-01 | 0.564 | 0 | 0 |
| Interleukin-33 signaling | R-HSA-9014843 | 2.555704e-01 | 0.592 | 0 | 0 |
| Signalling to ERK5 | R-HSA-198765 | 2.555704e-01 | 0.592 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 3.085280e-01 | 0.511 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 3.577213e-01 | 0.446 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 4.034175e-01 | 0.394 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 3.034143e-01 | 0.518 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 4.458652e-01 | 0.351 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 3.831117e-01 | 0.417 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 4.852950e-01 | 0.314 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 2.682733e-01 | 0.571 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 3.417784e-01 | 0.466 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 3.999452e-01 | 0.398 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 4.201119e-01 | 0.377 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 3.151242e-01 | 0.502 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 3.256161e-01 | 0.487 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 3.254480e-01 | 0.488 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 4.340415e-01 | 0.362 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 4.340415e-01 | 0.362 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 2.823558e-01 | 0.549 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 3.577213e-01 | 0.446 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 3.303103e-01 | 0.481 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 3.303103e-01 | 0.481 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 3.303103e-01 | 0.481 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 3.411163e-01 | 0.467 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 3.897970e-01 | 0.409 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 4.826195e-01 | 0.316 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 4.826195e-01 | 0.316 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 4.465844e-01 | 0.350 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 3.303103e-01 | 0.481 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 4.005915e-01 | 0.397 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 4.586476e-01 | 0.339 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 3.869764e-01 | 0.412 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 3.085280e-01 | 0.511 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 3.577213e-01 | 0.446 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 2.491842e-01 | 0.603 | 0 | 0 |
| Interleukin-36 pathway | R-HSA-9014826 | 4.034175e-01 | 0.394 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 4.458652e-01 | 0.351 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 3.831117e-01 | 0.417 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 4.852950e-01 | 0.314 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 3.610507e-01 | 0.442 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 4.340415e-01 | 0.362 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 4.005915e-01 | 0.397 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 2.625332e-01 | 0.581 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 3.252521e-01 | 0.488 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 2.923923e-01 | 0.534 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 4.170771e-01 | 0.380 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 2.923923e-01 | 0.534 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 4.005915e-01 | 0.397 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 2.651822e-01 | 0.576 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 2.619324e-01 | 0.582 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 3.352227e-01 | 0.475 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 3.999452e-01 | 0.398 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 2.763294e-01 | 0.559 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 2.763294e-01 | 0.559 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 4.078024e-01 | 0.390 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 3.841227e-01 | 0.416 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 4.717518e-01 | 0.326 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 4.472065e-01 | 0.349 | 0 | 0 |
| tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis | R-HSA-9708296 | 2.555704e-01 | 0.592 | 0 | 0 |
| The NLRP1 inflammasome | R-HSA-844455 | 3.085280e-01 | 0.511 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 3.577213e-01 | 0.446 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 4.458652e-01 | 0.351 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 4.852950e-01 | 0.314 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 4.852950e-01 | 0.314 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 3.252521e-01 | 0.488 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 4.340415e-01 | 0.362 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 3.913663e-01 | 0.407 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 4.403781e-01 | 0.356 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 3.603286e-01 | 0.443 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 3.565288e-01 | 0.448 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 3.011644e-01 | 0.521 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 2.491842e-01 | 0.603 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 4.201119e-01 | 0.377 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 4.258205e-01 | 0.371 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 4.258205e-01 | 0.371 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 4.128977e-01 | 0.384 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 4.581657e-01 | 0.339 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 4.575238e-01 | 0.340 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 3.411163e-01 | 0.467 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 3.779218e-01 | 0.423 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 3.391669e-01 | 0.470 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 4.034175e-01 | 0.394 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 4.458652e-01 | 0.351 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 3.569072e-01 | 0.447 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 3.011644e-01 | 0.521 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 4.029295e-01 | 0.395 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 2.491842e-01 | 0.603 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 4.586476e-01 | 0.339 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 4.128977e-01 | 0.384 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 4.852950e-01 | 0.314 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 2.979325e-01 | 0.526 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 3.303103e-01 | 0.481 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 2.798598e-01 | 0.553 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 2.491842e-01 | 0.603 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 4.826195e-01 | 0.316 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 3.126693e-01 | 0.505 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 4.515260e-01 | 0.345 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 4.005915e-01 | 0.397 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 4.895540e-01 | 0.310 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 4.900677e-01 | 0.310 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 4.944429e-01 | 0.306 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 4.956940e-01 | 0.305 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 4.956940e-01 | 0.305 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 4.989853e-01 | 0.302 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 4.998114e-01 | 0.301 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 5.059232e-01 | 0.296 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 5.059232e-01 | 0.296 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 5.059232e-01 | 0.296 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 5.059232e-01 | 0.296 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 5.059232e-01 | 0.296 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 5.059232e-01 | 0.296 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 5.059232e-01 | 0.296 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 5.059232e-01 | 0.296 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 5.071063e-01 | 0.295 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 5.138213e-01 | 0.289 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 5.138213e-01 | 0.289 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 5.138213e-01 | 0.289 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 5.144252e-01 | 0.289 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 5.219213e-01 | 0.282 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 5.219213e-01 | 0.282 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 5.219213e-01 | 0.282 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 5.219213e-01 | 0.282 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 5.219213e-01 | 0.282 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 5.219213e-01 | 0.282 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 5.219213e-01 | 0.282 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 5.219213e-01 | 0.282 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 5.219213e-01 | 0.282 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 5.219213e-01 | 0.282 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 5.219213e-01 | 0.282 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 5.219213e-01 | 0.282 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 5.219213e-01 | 0.282 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 5.219213e-01 | 0.282 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 5.266870e-01 | 0.278 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 5.266870e-01 | 0.278 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 5.266870e-01 | 0.278 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 5.285322e-01 | 0.277 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 5.285322e-01 | 0.277 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 5.297700e-01 | 0.276 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 5.315950e-01 | 0.274 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 5.315950e-01 | 0.274 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 5.341884e-01 | 0.272 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 5.365765e-01 | 0.270 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 5.436679e-01 | 0.265 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 5.458553e-01 | 0.263 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 5.472500e-01 | 0.262 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 5.484505e-01 | 0.261 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 5.489972e-01 | 0.260 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 5.489972e-01 | 0.260 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 5.489972e-01 | 0.260 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 5.490674e-01 | 0.260 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 5.490674e-01 | 0.260 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 5.497851e-01 | 0.260 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 5.504276e-01 | 0.259 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 5.504276e-01 | 0.259 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 5.504276e-01 | 0.259 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 5.520118e-01 | 0.258 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 5.559433e-01 | 0.255 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 5.559433e-01 | 0.255 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 5.559433e-01 | 0.255 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 5.559433e-01 | 0.255 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 5.559433e-01 | 0.255 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 5.559433e-01 | 0.255 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 5.559433e-01 | 0.255 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 5.559433e-01 | 0.255 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 5.559433e-01 | 0.255 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 5.559433e-01 | 0.255 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 5.626738e-01 | 0.250 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 5.636933e-01 | 0.249 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 5.636933e-01 | 0.249 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 5.636933e-01 | 0.249 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 5.660127e-01 | 0.247 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 5.660127e-01 | 0.247 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 5.660127e-01 | 0.247 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 5.690811e-01 | 0.245 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 5.715962e-01 | 0.243 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 5.715962e-01 | 0.243 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 5.715962e-01 | 0.243 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 5.715962e-01 | 0.243 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 5.715962e-01 | 0.243 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 5.738000e-01 | 0.241 | 1 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 5.743776e-01 | 0.241 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 5.743776e-01 | 0.241 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 5.752833e-01 | 0.240 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 5.756401e-01 | 0.240 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 5.756401e-01 | 0.240 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 5.817476e-01 | 0.235 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 5.826285e-01 | 0.235 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 5.826285e-01 | 0.235 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 5.826285e-01 | 0.235 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 5.826285e-01 | 0.235 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 5.859239e-01 | 0.232 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 5.875461e-01 | 0.231 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 5.875461e-01 | 0.231 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 5.875461e-01 | 0.231 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 5.875461e-01 | 0.231 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 5.875461e-01 | 0.231 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 5.875461e-01 | 0.231 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 5.875461e-01 | 0.231 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 5.875461e-01 | 0.231 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 5.875461e-01 | 0.231 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 5.875461e-01 | 0.231 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 5.875461e-01 | 0.231 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 5.875461e-01 | 0.231 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 5.882698e-01 | 0.230 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 5.920308e-01 | 0.228 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 5.920308e-01 | 0.228 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 5.920308e-01 | 0.228 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 5.988343e-01 | 0.223 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 6.018671e-01 | 0.220 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 6.045662e-01 | 0.219 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 6.070815e-01 | 0.217 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 6.084244e-01 | 0.216 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 6.084244e-01 | 0.216 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 6.084244e-01 | 0.216 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 6.094410e-01 | 0.215 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 6.117285e-01 | 0.213 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 6.117285e-01 | 0.213 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 6.117285e-01 | 0.213 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 6.117285e-01 | 0.213 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 6.117285e-01 | 0.213 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 6.128974e-01 | 0.213 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 6.146217e-01 | 0.211 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 6.146217e-01 | 0.211 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 6.169016e-01 | 0.210 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 6.169016e-01 | 0.210 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 6.169016e-01 | 0.210 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 6.169016e-01 | 0.210 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 6.169016e-01 | 0.210 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 6.169016e-01 | 0.210 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 6.169016e-01 | 0.210 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 6.169016e-01 | 0.210 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 6.169016e-01 | 0.210 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 6.169016e-01 | 0.210 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 6.169016e-01 | 0.210 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 6.169016e-01 | 0.210 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 6.194676e-01 | 0.208 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 6.248832e-01 | 0.204 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 6.299844e-01 | 0.201 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 6.304210e-01 | 0.200 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 6.306908e-01 | 0.200 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 6.306908e-01 | 0.200 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 6.306908e-01 | 0.200 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 6.306908e-01 | 0.200 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 6.306908e-01 | 0.200 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 6.378048e-01 | 0.195 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 6.410988e-01 | 0.193 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 6.441693e-01 | 0.191 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 6.441693e-01 | 0.191 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 6.449180e-01 | 0.190 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 6.456128e-01 | 0.190 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 6.456128e-01 | 0.190 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 6.456128e-01 | 0.190 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 6.456128e-01 | 0.190 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 6.465068e-01 | 0.189 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 6.481736e-01 | 0.188 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 6.481736e-01 | 0.188 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 6.489224e-01 | 0.188 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 6.582315e-01 | 0.182 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 6.594198e-01 | 0.181 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 6.658972e-01 | 0.177 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 6.664314e-01 | 0.176 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 6.664314e-01 | 0.176 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 6.694978e-01 | 0.174 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 6.694978e-01 | 0.174 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 6.694978e-01 | 0.174 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 6.694978e-01 | 0.174 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 6.694978e-01 | 0.174 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 6.705434e-01 | 0.174 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 6.705434e-01 | 0.174 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 6.705434e-01 | 0.174 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 6.720005e-01 | 0.173 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 6.734885e-01 | 0.172 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 6.734885e-01 | 0.172 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 6.734885e-01 | 0.172 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 6.734885e-01 | 0.172 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 6.769916e-01 | 0.169 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 6.813508e-01 | 0.167 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 6.813508e-01 | 0.167 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 6.813508e-01 | 0.167 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 6.825462e-01 | 0.166 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 6.832282e-01 | 0.165 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 6.832282e-01 | 0.165 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 6.832282e-01 | 0.165 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 6.871245e-01 | 0.163 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 6.871245e-01 | 0.163 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 6.871245e-01 | 0.163 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 6.930247e-01 | 0.159 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 6.930247e-01 | 0.159 | 1 | 1 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 6.930247e-01 | 0.159 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 6.930247e-01 | 0.159 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 6.930247e-01 | 0.159 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 6.930247e-01 | 0.159 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 6.930247e-01 | 0.159 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 6.930247e-01 | 0.159 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 6.930247e-01 | 0.159 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 6.942386e-01 | 0.158 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 6.942386e-01 | 0.158 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 6.993255e-01 | 0.155 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 6.993255e-01 | 0.155 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 6.993255e-01 | 0.155 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 6.993255e-01 | 0.155 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 6.993255e-01 | 0.155 | 1 | 0 |
| Insulin processing | R-HSA-264876 | 6.993255e-01 | 0.155 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 7.011076e-01 | 0.154 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 7.011500e-01 | 0.154 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 7.024049e-01 | 0.153 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 7.056203e-01 | 0.151 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 7.081828e-01 | 0.150 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 7.100452e-01 | 0.149 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 7.104688e-01 | 0.148 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 7.105611e-01 | 0.148 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 7.131054e-01 | 0.147 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 7.131054e-01 | 0.147 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 7.131054e-01 | 0.147 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 7.132772e-01 | 0.147 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 7.143622e-01 | 0.146 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 7.147377e-01 | 0.146 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 7.148782e-01 | 0.146 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 7.148782e-01 | 0.146 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 7.148782e-01 | 0.146 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 7.148782e-01 | 0.146 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 7.148782e-01 | 0.146 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 7.148782e-01 | 0.146 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 7.148782e-01 | 0.146 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 7.148782e-01 | 0.146 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 7.148782e-01 | 0.146 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 7.151524e-01 | 0.146 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 7.166914e-01 | 0.145 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 7.254567e-01 | 0.139 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 7.254567e-01 | 0.139 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 7.269055e-01 | 0.139 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 7.294807e-01 | 0.137 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 7.294807e-01 | 0.137 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 7.294807e-01 | 0.137 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 7.294807e-01 | 0.137 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 7.294807e-01 | 0.137 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 7.294807e-01 | 0.137 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 7.294807e-01 | 0.137 | 0 | 0 |
| Synthesis of IPs in the nucleus | R-HSA-1855191 | 7.351771e-01 | 0.134 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 7.351771e-01 | 0.134 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 7.351771e-01 | 0.134 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 7.351771e-01 | 0.134 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 7.351771e-01 | 0.134 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 7.351771e-01 | 0.134 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 7.351771e-01 | 0.134 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 7.351771e-01 | 0.134 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 7.397658e-01 | 0.131 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 7.435718e-01 | 0.129 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 7.435718e-01 | 0.129 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 7.435718e-01 | 0.129 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 7.482510e-01 | 0.126 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 7.489048e-01 | 0.126 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 7.489048e-01 | 0.126 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 7.509101e-01 | 0.124 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 7.540320e-01 | 0.123 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 7.540320e-01 | 0.123 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 7.540320e-01 | 0.123 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 7.540320e-01 | 0.123 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 7.540320e-01 | 0.123 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 7.540320e-01 | 0.123 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 7.540320e-01 | 0.123 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 7.540320e-01 | 0.123 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 7.540320e-01 | 0.123 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 7.540320e-01 | 0.123 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 7.540320e-01 | 0.123 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 7.540320e-01 | 0.123 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 7.540488e-01 | 0.123 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 7.570289e-01 | 0.121 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 7.600134e-01 | 0.119 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 7.685843e-01 | 0.114 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 7.698708e-01 | 0.114 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 7.698708e-01 | 0.114 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 7.707206e-01 | 0.113 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 7.707206e-01 | 0.113 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 7.715456e-01 | 0.113 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 7.715456e-01 | 0.113 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 7.715456e-01 | 0.113 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 7.715456e-01 | 0.113 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 7.715456e-01 | 0.113 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 7.715456e-01 | 0.113 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 7.715456e-01 | 0.113 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 7.715456e-01 | 0.113 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 7.766869e-01 | 0.110 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 7.766869e-01 | 0.110 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 7.777943e-01 | 0.109 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 7.810340e-01 | 0.107 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 7.821170e-01 | 0.107 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 7.821170e-01 | 0.107 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 7.856405e-01 | 0.105 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 7.878131e-01 | 0.104 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 7.878131e-01 | 0.104 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 7.878131e-01 | 0.104 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 7.878131e-01 | 0.104 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 7.878131e-01 | 0.104 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 7.878131e-01 | 0.104 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 7.937872e-01 | 0.100 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 7.998221e-01 | 0.097 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 8.005117e-01 | 0.097 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 8.005117e-01 | 0.097 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 8.026867e-01 | 0.095 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 8.029231e-01 | 0.095 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 8.029231e-01 | 0.095 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 8.029231e-01 | 0.095 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 8.029231e-01 | 0.095 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 8.029231e-01 | 0.095 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 8.049012e-01 | 0.094 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 8.049012e-01 | 0.094 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 8.068739e-01 | 0.093 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 8.085612e-01 | 0.092 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 8.096932e-01 | 0.092 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 8.134653e-01 | 0.090 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 8.134653e-01 | 0.090 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 8.134653e-01 | 0.090 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 8.134653e-01 | 0.090 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 8.147551e-01 | 0.089 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 8.154790e-01 | 0.089 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 8.154790e-01 | 0.089 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 8.154790e-01 | 0.089 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 8.154790e-01 | 0.089 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 8.161770e-01 | 0.088 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 8.167216e-01 | 0.088 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 8.169580e-01 | 0.088 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 8.169580e-01 | 0.088 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 8.169580e-01 | 0.088 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 8.169580e-01 | 0.088 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 8.169580e-01 | 0.088 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 8.185151e-01 | 0.087 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 8.185151e-01 | 0.087 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 8.208335e-01 | 0.086 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 8.217874e-01 | 0.085 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 8.255406e-01 | 0.083 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 8.255406e-01 | 0.083 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 8.255406e-01 | 0.083 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 8.255406e-01 | 0.083 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.255406e-01 | 0.083 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 8.261761e-01 | 0.083 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 8.261761e-01 | 0.083 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 8.265502e-01 | 0.083 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 8.299942e-01 | 0.081 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 8.299942e-01 | 0.081 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 8.299942e-01 | 0.081 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 8.299942e-01 | 0.081 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 8.299942e-01 | 0.081 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 8.299942e-01 | 0.081 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 8.299942e-01 | 0.081 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 8.299942e-01 | 0.081 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 8.299942e-01 | 0.081 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 8.299942e-01 | 0.081 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 8.299942e-01 | 0.081 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 8.299942e-01 | 0.081 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 8.317362e-01 | 0.080 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 8.326118e-01 | 0.080 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 8.351059e-01 | 0.078 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 8.351059e-01 | 0.078 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 8.351059e-01 | 0.078 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 8.365636e-01 | 0.078 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 8.373705e-01 | 0.077 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 8.421026e-01 | 0.075 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 8.421026e-01 | 0.075 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 8.421026e-01 | 0.075 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 8.421026e-01 | 0.075 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 8.421026e-01 | 0.075 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 8.421026e-01 | 0.075 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 8.421026e-01 | 0.075 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 8.421026e-01 | 0.075 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 8.421026e-01 | 0.075 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 8.421026e-01 | 0.075 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 8.421026e-01 | 0.075 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 8.429454e-01 | 0.074 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 8.429454e-01 | 0.074 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 8.441945e-01 | 0.074 | 0 | 0 |
| Depurination | R-HSA-73927 | 8.441945e-01 | 0.074 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 8.472988e-01 | 0.072 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 8.501494e-01 | 0.071 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 8.503937e-01 | 0.070 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 8.503937e-01 | 0.070 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 8.533494e-01 | 0.069 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 8.533494e-01 | 0.069 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 8.533494e-01 | 0.069 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 8.533494e-01 | 0.069 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 8.586291e-01 | 0.066 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 8.586291e-01 | 0.066 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 8.595586e-01 | 0.066 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 8.601428e-01 | 0.065 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 8.609857e-01 | 0.065 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 8.610187e-01 | 0.065 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 8.610187e-01 | 0.065 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 8.610187e-01 | 0.065 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 8.618025e-01 | 0.065 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 8.635206e-01 | 0.064 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 8.637956e-01 | 0.064 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 8.637956e-01 | 0.064 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 8.637956e-01 | 0.064 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 8.637956e-01 | 0.064 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 8.637956e-01 | 0.064 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 8.637956e-01 | 0.064 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 8.637956e-01 | 0.064 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 8.637956e-01 | 0.064 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 8.644221e-01 | 0.063 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 8.687920e-01 | 0.061 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 8.687920e-01 | 0.061 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 8.730135e-01 | 0.059 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 8.730135e-01 | 0.059 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 8.734984e-01 | 0.059 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 8.734984e-01 | 0.059 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 8.734984e-01 | 0.059 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 8.734984e-01 | 0.059 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 8.734984e-01 | 0.059 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 8.734984e-01 | 0.059 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 8.734984e-01 | 0.059 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 8.760192e-01 | 0.057 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 8.760192e-01 | 0.057 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 8.760192e-01 | 0.057 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 8.775311e-01 | 0.057 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 8.776726e-01 | 0.057 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 8.776726e-01 | 0.057 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 8.786722e-01 | 0.056 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 8.807176e-01 | 0.055 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 8.825105e-01 | 0.054 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 8.825105e-01 | 0.054 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 8.825105e-01 | 0.054 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 8.825105e-01 | 0.054 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 8.825105e-01 | 0.054 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 8.832932e-01 | 0.054 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 8.832932e-01 | 0.054 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 8.852652e-01 | 0.053 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 8.852652e-01 | 0.053 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 8.856909e-01 | 0.053 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 8.879076e-01 | 0.052 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 8.890426e-01 | 0.051 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 8.893037e-01 | 0.051 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 8.897730e-01 | 0.051 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 8.897730e-01 | 0.051 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 8.908810e-01 | 0.050 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 8.908810e-01 | 0.050 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 8.908810e-01 | 0.050 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 8.908810e-01 | 0.050 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 8.908810e-01 | 0.050 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 8.908810e-01 | 0.050 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 8.956513e-01 | 0.048 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 8.960447e-01 | 0.048 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 8.980362e-01 | 0.047 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 8.986557e-01 | 0.046 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 8.986557e-01 | 0.046 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 8.986557e-01 | 0.046 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 8.986557e-01 | 0.046 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 8.986557e-01 | 0.046 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 8.986557e-01 | 0.046 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 8.986557e-01 | 0.046 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 8.986557e-01 | 0.046 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 8.986557e-01 | 0.046 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.004140e-01 | 0.046 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 9.019827e-01 | 0.045 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 9.058768e-01 | 0.043 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.058768e-01 | 0.043 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 9.058768e-01 | 0.043 | 0 | 0 |
| Attachment of bacteria to epithelial cells | R-HSA-9638630 | 9.058768e-01 | 0.043 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 9.058768e-01 | 0.043 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.058768e-01 | 0.043 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 9.058768e-01 | 0.043 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 9.076029e-01 | 0.042 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 9.076029e-01 | 0.042 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 9.125839e-01 | 0.040 | 0 | 0 |
| Cobalamin (Cbl) metabolism | R-HSA-9759218 | 9.125839e-01 | 0.040 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 9.125839e-01 | 0.040 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 9.125839e-01 | 0.040 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 9.125839e-01 | 0.040 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.125839e-01 | 0.040 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 9.141482e-01 | 0.039 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 9.152010e-01 | 0.038 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 9.179494e-01 | 0.037 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.188133e-01 | 0.037 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 9.188133e-01 | 0.037 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 9.188133e-01 | 0.037 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 9.188133e-01 | 0.037 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.188133e-01 | 0.037 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.189477e-01 | 0.037 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 9.245992e-01 | 0.034 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.245992e-01 | 0.034 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 9.299731e-01 | 0.032 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.299731e-01 | 0.032 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.299731e-01 | 0.032 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.314458e-01 | 0.031 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.327542e-01 | 0.030 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.333356e-01 | 0.030 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 9.333614e-01 | 0.030 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.349643e-01 | 0.029 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 9.349643e-01 | 0.029 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.349643e-01 | 0.029 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 9.384648e-01 | 0.028 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.415030e-01 | 0.026 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.423707e-01 | 0.026 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.423707e-01 | 0.026 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 9.439055e-01 | 0.025 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 9.439055e-01 | 0.025 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 9.439055e-01 | 0.025 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 9.439055e-01 | 0.025 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 9.439055e-01 | 0.025 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.439055e-01 | 0.025 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 9.439055e-01 | 0.025 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.456941e-01 | 0.024 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.457397e-01 | 0.024 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.461981e-01 | 0.024 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.479044e-01 | 0.023 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.479455e-01 | 0.023 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.495007e-01 | 0.023 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.495007e-01 | 0.023 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.516184e-01 | 0.022 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 9.516184e-01 | 0.022 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.516184e-01 | 0.022 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 9.516184e-01 | 0.022 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.516184e-01 | 0.022 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 9.516184e-01 | 0.022 | 1 | 1 |
| PCP/CE pathway | R-HSA-4086400 | 9.521662e-01 | 0.021 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.550678e-01 | 0.020 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 9.550678e-01 | 0.020 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.550678e-01 | 0.020 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.550678e-01 | 0.020 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.565984e-01 | 0.019 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.582715e-01 | 0.019 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 9.582715e-01 | 0.019 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.582715e-01 | 0.019 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.591915e-01 | 0.018 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.592677e-01 | 0.018 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.595037e-01 | 0.018 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.604131e-01 | 0.018 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.607929e-01 | 0.017 | 1 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.612470e-01 | 0.017 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.612470e-01 | 0.017 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.612470e-01 | 0.017 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.612470e-01 | 0.017 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 9.640104e-01 | 0.016 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.640104e-01 | 0.016 | 0 | 0 |
| Biofilm formation | R-HSA-9931953 | 9.640104e-01 | 0.016 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.640104e-01 | 0.016 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 9.640104e-01 | 0.016 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 9.665770e-01 | 0.015 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.665770e-01 | 0.015 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 9.671313e-01 | 0.015 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.689606e-01 | 0.014 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.689606e-01 | 0.014 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.689606e-01 | 0.014 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 9.691161e-01 | 0.014 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 9.699702e-01 | 0.013 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.711744e-01 | 0.013 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 9.732304e-01 | 0.012 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.732304e-01 | 0.012 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.732304e-01 | 0.012 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.732304e-01 | 0.012 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.732304e-01 | 0.012 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.744387e-01 | 0.011 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.744576e-01 | 0.011 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.744576e-01 | 0.011 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.751399e-01 | 0.011 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.755783e-01 | 0.011 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.768180e-01 | 0.010 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.785603e-01 | 0.009 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.785603e-01 | 0.009 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.785603e-01 | 0.009 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.785603e-01 | 0.009 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.788073e-01 | 0.009 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 9.792468e-01 | 0.009 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.800899e-01 | 0.009 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.800899e-01 | 0.009 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.801054e-01 | 0.009 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.801054e-01 | 0.009 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.803962e-01 | 0.009 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.803962e-01 | 0.009 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 9.812085e-01 | 0.008 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 9.812085e-01 | 0.008 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.812085e-01 | 0.008 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.814846e-01 | 0.008 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.815104e-01 | 0.008 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.815104e-01 | 0.008 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 9.828297e-01 | 0.008 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.828297e-01 | 0.008 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 9.830970e-01 | 0.007 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.839724e-01 | 0.007 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.840549e-01 | 0.007 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.844142e-01 | 0.007 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 9.851928e-01 | 0.006 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.851928e-01 | 0.006 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.852009e-01 | 0.006 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.852879e-01 | 0.006 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.857271e-01 | 0.006 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 9.862495e-01 | 0.006 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.863265e-01 | 0.006 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.868154e-01 | 0.006 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.870019e-01 | 0.006 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.870019e-01 | 0.006 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.872308e-01 | 0.006 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.872308e-01 | 0.006 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.872606e-01 | 0.006 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.876362e-01 | 0.005 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.880518e-01 | 0.005 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 9.881422e-01 | 0.005 | 1 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.883356e-01 | 0.005 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 9.887950e-01 | 0.005 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.889886e-01 | 0.005 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.889886e-01 | 0.005 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.894931e-01 | 0.005 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.898452e-01 | 0.004 | 1 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.899628e-01 | 0.004 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.905046e-01 | 0.004 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 9.907710e-01 | 0.004 | 1 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.918120e-01 | 0.004 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.918120e-01 | 0.004 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.922676e-01 | 0.003 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.923966e-01 | 0.003 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.929395e-01 | 0.003 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.934437e-01 | 0.003 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.936866e-01 | 0.003 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.937178e-01 | 0.003 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.937411e-01 | 0.003 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.939024e-01 | 0.003 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.939119e-01 | 0.003 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.939119e-01 | 0.003 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.941359e-01 | 0.003 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.945063e-01 | 0.002 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.947504e-01 | 0.002 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.948537e-01 | 0.002 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.949754e-01 | 0.002 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.957969e-01 | 0.002 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.960972e-01 | 0.002 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.962922e-01 | 0.002 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.963760e-01 | 0.002 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.963760e-01 | 0.002 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.965283e-01 | 0.002 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.965283e-01 | 0.002 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.967496e-01 | 0.001 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.970224e-01 | 0.001 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.970224e-01 | 0.001 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.970986e-01 | 0.001 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 9.970986e-01 | 0.001 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.973060e-01 | 0.001 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.973060e-01 | 0.001 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.974985e-01 | 0.001 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.976643e-01 | 0.001 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.976773e-01 | 0.001 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.978433e-01 | 0.001 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.979545e-01 | 0.001 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.980770e-01 | 0.001 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.986282e-01 | 0.001 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.989413e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.989669e-01 | 0.000 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.990463e-01 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.991145e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.992497e-01 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.992822e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.993443e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.994994e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.995035e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.995110e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.995460e-01 | 0.000 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.995627e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.996367e-01 | 0.000 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.996450e-01 | 0.000 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.996868e-01 | 0.000 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.997052e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.997779e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.997844e-01 | 0.000 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.998542e-01 | 0.000 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.998717e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.998894e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.999206e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.999710e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999768e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999814e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999878e-01 | 0.000 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.999881e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999890e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999926e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999930e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999961e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999963e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999967e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999976e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.999981e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.999989e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.999992e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999994e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999994e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999997e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999998e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999998e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999998e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999999e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999999e-01 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 1.000000e+00 | 0.000 | 1 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 1 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 1.000000e+00 | 0.000 | 1 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | -0.000 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 1.000000e+00 | 0.000 | 1 | 1 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 1.000000e+00 | 0.000 | 1 | 1 |